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Abstract 
 Healthcare is evolving. Reimbursement is transitioning to a model based on quality and 
patient outcomes. To remain relevant and survive this transition, providers of care must adapt 
and implement new models of care delivery that account for these changes. This toolkit was 
created as a deliverable of a Doctor of Nursing Practice dissertation that explored a successful 
primary care delivery model of a Patient-Centered Medical Home that utilized an 
interdisciplinary team approach that included nurses. Through this model high quality care was 
delivered to achieve desired outcomes, specifically, successful attestation for Stage 2 of the 
Meaningful Use Incentive Program during the first quarter of 2014. This toolkit was created as a 
result of the exploration of this model in order to inform others regarding structures and 
processes that can be integrated to meet the requirements of Stage 2 Meaningful Use. To do so, 
this toolkit describes the structure utilized by practice of interest, including the roles of vital staff 
members. Processes that result in meeting Meaningful Use objectives are also described, many in 
the form of decision trees. The toolkit also includes an example of what an investment in this 
model would entail along with guidelines for model replication. This toolkit provides a 
framework for success in meeting Meaningful Use Stage 2 requirements.    
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Introduction 
The United States healthcare system is currently in a state of reform. Reimbursement is 
advancing from a fee-for-service model to one based on value and quality outcomes. To remain 
relevant and capitalize on new reimbursement opportunities, the way care is delivered must also 
evolve.  
To spur advancement in healthcare delivery, the federal government has created various 
incentive programs. Two such programs are the Medicare and Medicaid Electronic Health 
Record (EHR) Incentive Programs, collectively known as Meaningful Use. The Meaningful Use 
Programs challenge eligible professionals (EPs) to integrate health information technology (HIT) 
in a manner that will improve care delivery and, therefore, patient outcomes. Meaningful Use is 
comprised of three stages, each building upon the previous. The first stage, Stage 1, has the set 
goal of improving data capture and sharing (HealthIT.gov, 2015). Stage 2 requires the attainment 
of all Stage 1 objectives with some additional requirements, setting the goal to advance clinical 
processes. The final stage, Stage 3, aims to improve patient health outcomes. EPs are able to 
participate in one Meaningful Use program (Medicaid or Medicare) per payment year (CMS, 
2012a). EPs who participate benefit from, not only enhancing the quality of care delivered, but 
also from the reimbursement offered through the program when the criteria associated with the 
stage pursued is successfully met.   
Despite the benefits of participating in Meaningful Use, many EPs are struggling to meet 
the demands presented by the multiple objectives required for meeting each stage of the 
program, particularly those associated with Stage 2. Therefore, a toolkit has been created by 
Centers for Medicare & Medicaid Services (CMS) to provide information and resources for 
eligible professionals, eligible hospitals, and critical access hospitals to use as they strive to 
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effectively utilize HIT and create reports reflective of its use in preparation for Stage 2 
Meaningful Use attestation (Appendix).  
This toolkit, however, does not provide suggestions regarding structures or processes that 
can aid in meeting the objectives. Therefore, this process improvement toolkit which delineates 
the structures and processes developed by the exemplar clinic, a privately owned private practice 
that successfully attested for Stage 2 Meaningful Use during the first year of attestation, was 
created. The exemplar provided by the clinic demonstrates how an interdisciplinary team and 
associated processes are utilized to improve patient care delivery. Through proper documentation 
and the creation of reports through the EHR, this practice demonstrated how Stage 2 Meaningful 
Use can be attained.   
A collection of processes that have been effective at the exemplar practice in meeting 
Stage 2 Meaningful Use core objectives as they relate to diabetes control, in particular, is 
provided in this toolkit. For this example, hemoglobin A1c levels, which are elevated in 
uncontrolled diabetes, were chosen as the outcome measure of interest. Processes utilized by the 
exemplar practice to meet Stage 2 objectives are described as they attempt to address elevated 
A1c levels and illustrate how each member of the interdisciplinary team is utilized to the fullest 
scope of their training and education. This measure was chosen as diabetes is on the rise 
(Casagrande, Fradkin, Saydah, Rust, & Cowie, 2013) and A1c is a difficult measure for primary 
care practices to address. Users of this toolkit are able to design additional workflow processes, 
utilizing the structures described, to address additional outcome measures.  
Materials derived from the exemplar practice that are found in this toolkit, include: 
 role descriptions for the innovative team member roles,  
 step-by-step instructions regarding how to create and run a population report (for A1c 
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levels, as an example) in the Allscripts electronic health record (EHR) which can be 
adapted to other EHR products per their respective reporting systems,  
 tables describing the investment required to develop the interdisciplinary team structure, 
 decision trees delineating processes and interdisciplinary team members needed to 
address abnormal results or quality indicators that require interventions identified by the 
population report,  
 a step-by-step example of how processes flow through the interdisciplinary team to 
address one patient’s needs while meeting nearly every Stage 2 objective, and  
 a discussion delineating how the remaining Stage 2 objectives can be met through this 
interdisciplinary team model.  
These documents emphasize the need for the advanced training and education of nursing 
roles within the ambulatory care setting based on the demand for processes essential to achieving 
Meaningful Use Stage 2. Practices wishing to obtain outcomes similar to those achieved by the 
exemplar practice can utilize this process improvement toolkit to guide the replication of 
structures and processes that have been vital to the success of the exemplar practice.  
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Frequently Used Abbreviations   
Accountable Care Organization ACO 
Blue Cross Blue Shield of Michigan BCBSM 
Centers for Medicare and Medicaid Services CMS 
Certified Medical Assistant CMA 
Computerized Provider Order Entry CPOE 
Department of Transportation DOT 
Electronic Health Record EHR 
Electronically Protected Health Information ePHI 
Eligible Professional EP 
Health Insurance Portability and 
Accountability Act 
HIPPA 
Health Level 7 HL7 
Hemoglobin A1c A1c 
Information Technology IT 
Licensed Practical Nurse LPN 
Michigan Care Improvement Registry MCIR 
Meaningful Use Stage 2 Objective MUO 
National Committee for Quality Assurance NCQA 
Patient-Centered Medical Home PCMH 
Physician Health Organization PHO 
Physician Quality Reporting System PQRS 
Registered Nurse RN 
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Meaningful Use Stage 2 Core Objectives 
1. Computerized provider order entry (CPOE) 
2. Generate and transmit prescriptions electronically, when permissible 
3. Record patient demographics, including sex, ethnicity, race, preferred language, 
and date of birth, within the EHR 
4. Within the EHR, record vital signs, including height/length, weight, blood 
pressure (if over the age of 3), BMI, and plot growth charts that can be displayed 
for patients under the age of 21  
5. Record smoking status for patients over the age of 12 
6. Utilize clinical decision support tools for high-priority health conditions 
7. Provide patients the ability to download, view, and transmit their personal health 
information 
8. Provide patients with a clinical summary after each visit 
9. Protect electronic health information  
10. Incorporate clinical lab-test results as structured data within the EHR 
11. Generate lists of patients with specific conditions as a means of monitoring and 
improving population health 
12. Identify patients, utilizing clinically relevant information, who should receive 
reminders for preventive and follow-up care, per patient preference 
13. Identify resources for patient-specific education utilizing certified EHR 
technology 
14. Perform medication reconciliation  
15. Provide a summary care record for each care transition or referral  
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16. Submit electronic data regarding immunizations to registries 
17. Utilize secure electronic messaging to communicate relevant health information 
to patients 
(CMS, 2012b) 
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An Interdisciplinary PCMH Model 
The model of the Patient-Centered Medical Home that is applied at the exemplar practice 
utilizes an interdisciplinary team. The image below depicts this model. 
 
(Conrad, 2014) 
This model is not hierarchical. It is patient-centered. In this way, the right team member 
can provide the patient with appropriate, timely care, within the scope of the team member’s 
education and training. Therefore, if a patient calls requesting a same-day appointment for a sick 
visit, the scheduler has the autonomy to fit the patient in the schedule. If a patient is diabetic and 
due for a foot exam, the CMA or nurse rooming the patient can ensure easy access to the 
patient’s feet for the foot exam. If a patient calls needing a refill of a chronic care medication, the 
phone nurse is also enabled to fulfill this task under the guide of specified protocols. Such a 
foundation enables team members to enact all facets of the PCMH delivery model without direct 
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supervision from a provider.  
In addition, each member of the team has access to the EHR. Through the portal, the 
patient is enabled to take an active role in promoting his or her health and is able to view 
personal health information. The EHR also enables communication with the broader healthcare 
neighborhood through health information exchanges and registries. This heightened 
communication enhances care coordination and, therefore, quality.  
As depicted in the image, incentive programs provided by payers assist in bridging the 
payment gap that exists for value-based services, enabling survival of the interdisciplinary 
PCMH model. Currently, incentive programs provide added reimbursement to the traditional fee-
for-service payment structure. As reimbursement continues to evolve, payment structures will 
shift to reimburse practices for quality and value added services. Practices will be expected to 
provide care meeting quality and outcome standards or risk payment reduction penalties from 
insurers who once provided the incentives. Therefore, it is imperative to create the structures and 
processes that will be required for sustainability. 
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Roles within the Interdisciplinary Team  
In the interdisciplinary model of the PCMH, each team member is highly valued for their 
unique skill set and abilities. This diagram below provides a depiction of the various possible 
nursing roles. Each team member can access the EHR when necessary for patient care, direct or 
indirect. This enables the effective transfer of information and enhances the team approach to 
patient care delivery. 
 
Note: Adapted from “An innovative model utilizing the interdisciplinary healthcare team in the 
primary care patient centered medical home” by Conrad, 2014. 
 
  
CMA  
CMA 
CMA 
IT Nurse 
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Role Descriptions 
Role descriptions for the staff members utilized in the interdisciplinary team at the 
exemplar practice are described in this section as they are uniquely utilized to conduct processes 
resulting in Stage 2 Meaningful Use attainment. These role descriptions can assist with 
replicating an interdisciplinary team model that uses nursing personnel. They also promote 
conversation regarding the use of staff to the fullest extent of their education and training and 
exploration regarding how all staff members can best be utilized to promote the delivery of cost 
and quality effective care.  
  
14 
 
ROLE:  Information Technology Nurse 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Practice Administrator 
to perform specific tasks related to patient care and the effective operations of the Practice.   
SPECIFIC RESPONSIBILITIES: 
 Create and run population health management reports to be addressed by the quality 
team.  
 Manage PCMH requirements and capabilities, assuring standards continue to be meet. 
 Maintain PCMH NCQA requirements for certifications and prepares for annual audits. 
 Works in collaboration with the PHO on various projects and initiatives.  
 Annually reviews care standards and standing orders with providers to assure they are 
up-to-date based on most recent clinical guidelines. 
 Acts as a liaison for quality improvement projects, such as the PQRS between the 
practice, PHO, and ACO. 
 Coordinate MU processes throughout the practice, responsible for determining how 
each measure can be achieved, modify policies and workflow as necessary to meet 
these measures. 
 Provides ongoing education to staff and providers regarding necessary processes to 
achieve MU requirements. 
 Acts as an onsite IT resource for staff regarding issues encountered on a daily basis. 
 Customizes the EHR to enhance workflow, optimize reimbursement and capture 
processes meeting incentive criteria. 
 Schedules upgrades and updates for the EHR and practice management side. 
 Coordinates with IT consultant to assure maintenance of onsite technology. 
 Attends conferences for continuing education of the EHR and discusses IT with 
vendors to broaden understanding of latest capabilities. 
 Maintain HIPPA and strict security of access codes, logins, and electronic health 
information.  
 Take initiative to perform additional responsibilities as identified as necessary. 
 Perform additional responsibilities assigned by the Practice Administrator. 
 
QUALIFICATIONS:  RN or LPN credentials required with a minimum of two years of 
experience in the clinic settings.   
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ROLE:  Clinical Quality Coordinator  
 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Practice Administrator 
to provide clinical coordination of all Practice Quality Measures.   
 
SPECIFIC RESPONSIBILITIES: 
 Provide monthly assessment of national care standards and care standards set by 
insurers along with an assessment of the measures taken to ensure their adherence. 
 In conjunction with the Practice Administrator, develop new care standards and clinical 
protocols with defined processes meeting newly identified standards. 
 Assessment, improvement, and development of current EHR adaptations as they relate 
to quality patient care with trainings for providers and staff. 
 Provide yearly assessment of payer quality programs and incentives and develop action 
plan to ensure practice processes in place to capture available monies. 
 Provides leadership and direction to the Nursing Team Coordinators for the daily 
huddles. (alerts, referrals, labs needed, care standards, refills, vitals, other) 
 Supervision of Quality Team; including Scheduling Supervisor, CMA, Patient 
Coordinator, and all clinical staff. 
 Provide clinical supervision of patient portal. 
 Provide monthly reporting to Practice Administrator and providers as to quality 
measures and processes. 
 Supervise and provide Medicare Wellness Visits; including requirements governed by 
CMS, update and maintain current policy and procedures for the appointment. 
 Develop and initiate group visits for chronic conditions; specifically diabetes and other 
conditions with Practice Care Standards in place. 
 Provide Chronic Care Coordination, including; patient education via billable phone 
encounters, nurse office visits, e-visits, and co-ordination of patient self-management 
goals in conjunction with providers. 
 Assist with clinical supervision. 
 Performs additional responsibilities as directed by the Practice Administrator, and the 
Physicians. 
 
QUALIFICATIONS:  RN Credentials required.  Experience is preferred.  
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ROLE: Nursing Team Coordinator  
 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Nursing Supervisors 
and the Clinical Quality Coordinator to provide supervision and management of the daily 
workflow and the staffing needed to perform effective patient services for the providers.  
SPECIFIC RESPONSIBILITIES: 
 Provides leadership and direction for the clinical staff assigned in their work area; 
specifically, supervising the daily huddles, maintaining communication with all team 
members, and providing oversight for the assessment and provision of services which 
meet all Practice Clinical Standards of Care.  
 Ensures that the daily flow of the scheduled patients and the efficiencies of the staff are 
maximized.  Works in conjunction with other supervisory staff promoting teamwork 
and comprehensive quality services to the patients.  Assigns specific work tasks to staff 
in their work area as time permits. 
 Communicates to the Providers, Supervisors, and Practice Administrator any needs for 
patient service; both immediate and long-term.  Engage in quality oversight of the Care 
Standards with other team members.   
 Supervises and assists the other clinical staff in the assessment, preparation and 
administration of immunizations and their documentation. Specifically, supervising the 
MCIR paperwork, the orders in the charts, the drawing up of immunizations, the 
administering of the immunizations and the completion of all documentation. 
 Working in conjunction with the Clinical Supervisors and the Quality Coordinator, 
responsible for the day-to-day mentoring, training and evaluation of new staff and 
students.  Responsible for assisting and training on new office procedures and 
equipment as needed.   
 Supervises all provider communication to patients pertinent to specific work area and 
daily needs; specifically all emergent faxes, phone calls for patient education, refills 
and any daily paperwork which needs completion. 
 Supervises and ensures that patients receiving narcotic prescriptions have a current 
narcotic contract and all office procedures are followed for random drug screening and 
oversight of narcotic use.   
 Assists Providers with examinations and procedures as needed.  Update all health 
maintenance items for the patients and order testing and procedures as outlined by 
Practice Standards of Care.   
 Schedules same day appointments for outpatient procedures and communicates dates, 
times and patient prep information to the patient. 
 Performs all aspects of the RN/LPN job responsibilities as described in those job 
descriptions. 
 Performs additional responsibilities as directed by the Clinical Supervisor, Practice 
Administrator, Team Leaders and/or the Providers. 
 
QUALIFICATIONS:  RN or LPN credentials required.  Experience in the Practice is required.  
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ROLE:  Quality Team Member 
 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Practice Administrator 
and the Quality Clinical Coordinator, to perform patient related duties which increase the 
effective operations of the Practice.  
SPECIFIC RESPONSIBILITIES: 
 Receives monthly performance reports from the Reporting Module regarding patient 
needs based on a variety of chronic illness care standards and insurance requirements. 
Works these reports by monitoring charts and outside consults, calling patients and 
generating reminders to the providers. 
 Receives insurance qualification forms after patient visits to be verified and processed 
according to insurer’s guidelines. 
 Follows up daily with Central Scheduling at the local hospital to make certain patients’ 
ordered test has been scheduled and patients notified. Checks the Queue in the EHR to 
keep abreast of daily orders from the providers as well. 
 As needed, schedules appointments for outpatient procedures at out-lying hospitals and 
offices, and communicates dates, times and patient prep information to the patient. 
 Follows up with ordered hospital tests to make sure they were performed, that the 
Provider saw the results and that the patients were notified.  Accesses the hospital EHR, 
as needed, to obtain necessary records. 
 Makes certain the procedure box in the patients’ EHR chart shows that the order was 
final and reviewed.  Checks the aggregate procedure box daily for tests which have not 
been resulted.  Follows up as necessary. 
 Performs a daily check of the Output Queue to find patients’ orders which may need 
prior authorizations for testing.  Contacts appropriate prior authorization management 
company via phone, fax, or webpage to obtain the prior authorization.  As needed, 
contacts the patient and/or the facility regarding the decision.   
 Working in conjunction with the IT nurse, performs a periodic immunization audit 
which includes searching MCIR records, running office reports on immunizations 
scheduled and given, searching charts for proper documentation and correcting as 
needed. 
 Prints out MCIR reports for new patient office visits, records immunization history in 
the EHR and prints out MCIR reports for patients as requested.   
 Maintains system for accurately recording and reporting patient conditions in the 
medical record. 
 Maintains confidentiality of patient information according to Practice policies and 
governmental regulations such as HIPAA and others. 
 Follows provider’s directives regarding communication to patient; i.e. test results, 
provider orders, and patient education. 
 Participates in all training and monthly clinical meetings as required for clinical staff. 
 Performs additional responsibilities as directed by the Clinical Supervisor, Practice 
Administrator, Team Leaders and/or the Providers. 
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QUALIFICATIONS:  CMA, LPN or RN credentials required.  At least two years of experience 
is required. Must have successfully completed the Drug Screening Training given at the Practice. 
Demonstrated ability in computer skills and knowledge of internet is necessary. 
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ROLE:  Phone Nurse 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Clinical Supervisor to 
receive incoming requests from patients, relay messages to providers, and follow up by making 
return calls with advice or results from providers in order to increase the effective operations of 
the Practice. 
SPECIFIC RESPONSIBILITIES: 
 Takes incoming calls, as able, pulls charts, and maintains system for accurately 
recording and reporting patient information, conditions, and/or requests in the medical 
record. 
 Retrieves messages from the phone audix in a timely manner so that patient issues are 
addressed as soon as possible. 
 Maintains confidentiality of patient information according to Practice policies and 
governmental regulations such as HIPAA and others.  Reports all reportable diseases to 
the Health Department. 
 Handles problems or requests from patients who walk into the office without an 
appointment.  Reads TB tests, documents results, and gives patient the needed proof of 
results. 
 Make action items to alert phone nurse of procedures and testing needing to be 
scheduled. Calls patients to assure appointments have been scheduled for repeat tests. 
Daily checks nurse message box for charts containing prior authorizations awaiting 
approval and those awaiting patient response.  
 When caught up on phone nurse inbox, checks for messages in message nurse inbox 
that which need to be addressed. Assists nurses in clinical area if necessary. 
 Makes effort to contact patients in message nurse inbox every other day to weekly until 
patients are notified of results or provider instructions are received.  
 Schedules appointments for outpatient procedures and communicates dates, times and 
prep information to patients.  Records pertinent test in Providers’ appointment book. 
 Follows providers’ directives regarding communication to patient; i.e., normal and 
abnormal test results, Providers’ orders and patient education. Explains abnormal test 
findings.  Calls medical prescriptions to pharmacies.   
 Performs additional responsibilities as directed by the Clinical Supervisor, Practice 
Administrator, Team Leaders and/or the Providers. 
 
QUALIFICATIONS:  RN or LPN Credentials required.  Experience with the Providers and 
with this Practice is required.  
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ROLE:  Point of Care Registered Nurse/Licensed Practical Nurse 
 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Clinical Supervisor to 
perform patient related duties which increase the effective operations of the Practice.  
SPECIFIC RESPONSIBLITIES: 
 Performs routine pre-examination procedures including taking vital signs and assessing 
and recording objective and subjective data concerning patient’s presenting condition. 
 Assists Providers with examinations and procedures. 
 Prepares charts for upcoming patient visits. Identifies patient needs that must be updated 
such as annual blood work or annual physical. Based on protocols, orders appropriate 
testing. Communicates with scheduling, as appropriate, to coordinate changes in plan of 
care with patient.   
 Performs patient care measures including injections, minor dressing changes and routine 
laboratory tests and treatments as directed by providers and standing orders. 
 Prepares and cleans the patient area; sets up equipment, cleans and facilitates room set up 
after procedure. Maintains a clean and safe environment for patients and co-workers. 
 Calibrates and checks equipment according to schedule or prior to use. 
 Maintains system for accurately recording and reporting patient conditions in the medical 
record; verifying patient insurance and demographic information. 
 Maintains confidentiality of patient information according to Practice policies and 
governmental regulations such as HIPAA and others. 
 Follows provider’s directives regarding communication to patient; i.e., normal and 
abnormal test results, provider orders, and patient education. Explains abnormal test 
findings.   
 Calls Medical prescriptions to pharmacies either by phone or using e-prescribe. 
 Work from protocols and utilize CPOE, as needed.   
 Schedules appointments for outpatient procedures and communicates dates, times and 
patient prep information to the patient. 
 Performs substance abuse testing consistent with non-DOT and DOT guidelines and 
Practice Policies and Procedures.  Works with occupational clients to perform these tests 
as ordered.  Communicates appropriately with occupational clients regarding patient 
issues.   
 Obtain updated patient narcotic contracts, as needed. 
 Performs additional responsibilities as directed by the Clinical Supervisor, Practice 
Administrator, Team Leaders and/or the Providers. 
 
Qualifications:  RN or LPN credentials required.  Experience is preferred.  
 
ROLE:  Point of Care Certified Medical Assistant 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Clinical Supervisor to 
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perform patient related duties which increase the effective operations of the Practice.  
SPECIFIC RESPONSIBILITIES: 
 Performs routine pre-examination procedures including taking vital signs and assessing 
and recording objective and subjective data concerning patient’s presenting condition. 
 Assists Providers with examinations and procedures. 
 Performs Patient care measures including injections, minor dressing changes and 
routine laboratory tests and treatments as directed by Providers. 
 Prepares and cleans the patient area; sets up equipment, cleans and facilitates room set 
up after procedure. Maintains a clean and safe environment for patients and co-workers. 
 Maintains system for accurately recording and reporting patient conditions in the 
medical record; verifying patient insurance and demographic information. 
 Work from protocols and utilize CPOE, as needed.   
 Maintains confidentiality of patient information according to Practice policies and 
governmental regulations such as HIPAA and others. 
 Follows provider’s directives regarding communication to patient; i.e. test results, 
provider orders, and patient education. 
 Schedules appointments for outpatient procedures and communicates dates, times and 
patient prep information to the patient. 
 Performs additional responsibilities as directed by the Clinical Supervisor, Practice 
Administrator, Team Leaders and/or the Providers. 
 
QUALIFICATIONS:  CMA credentials required.  Experience is preferred.  
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ROLE:  Referral Specialist 
GENERAL RESPONSIBILITIES:  Under the direct supervision of the Practice Administrator, 
will assist in the effective operation of the practice by serving in the front office.   
SPECIFIC RESPONSIBILITIES: 
 Assures the receipt of referral notes, correspondence, surgical notes, consultations, test 
interpretations, and other medical information 
 Verifies accuracy of patient information, such as name, numbers and dates for 
recording on transcribed reports 
 Responsible for data entry and maintenance via Michigan Health Connect 
 Send electronic clinical record via e-fax to offices receiving patient referrals 
 Fax authorizations for medical information release to noted destinations 
 Ensures correct grammar, punctuation and spelling while maintaining the meaning of 
the sentence in transcribed reports 
 Request referral consultations for patients as directed by providers by sending a patient 
summery via eFax if the receiving facility has the capability of receiving ePHI 
 For facilities not capable of receiving ePHI, referral consultations are to be requested 
over the phone and faxed 
 Once a referral is accepted, documents the date, time, and location in the patient chart 
 Maintaining an up-to-date referral resource book so that appropriate referral 
information is available 
 Responsible for ordering office supplies as needed 
 Perform additional responsibilities as directed by the Practice Administrator and/or the 
team leaders and the physicians 
 
QUALIFICATIONS:  At least 2 years of experience in transcription as well as competencies in 
Word and other basic computer software. Must have excellent communication skills. 
 
 
 
Please Note: Role descriptions have been modified and updated from those provided by the 
Clinic to meet the needs of this project.   
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Example of the Investment of an Interdisciplinary Team Model 
 Implementing an interdisciplinary team is an investment. There are upfront costs to hiring 
highly trained personal above the standard staffing grid. The exemplar practice gradually 
increased the number of FTEs allotted for various types of staff members. In this way, an abrupt 
increased toll on the staffing budget was avoided as the model developed and was personalized 
to the needs of the practice. Table 1 depicts the number of staff members employed by the 
exemplar practice during the model development. Table 2 provides the cost of investment for 
each position based on year while Table 3 reveals overall payroll expenses for this model each 
year. This information is included to serve as a guide. Payroll expenses should be reflective of 
standards based on geographical location and other extenuating factors.  
Table 1 
Number of FTEs by Year 
Title/Credential  For the Year 
2009 
For the Year 
2010 
For the Year 
2011 
For the Year 
2012 
For the Year 
2013 
MA 5.1 5.4 5.6 5.9 5.7 
Quality 
Department MA 
1.25 1.25 1.5 1.5 2 
LPN 3 3 3.5 3.3 3.4 
RN 3.85 5 5.4 6.2 6.3 
      Table 2 
Average Wage per FTE 
Title/Credential For the Year 
2009 
For the Year 
2010 
For the Year 
2011 
For the Year 
2012 
For the Year 
2013 
MA $25,430.17 $25,005.90 $25,926.37 $26,537.78 $27,249.69 
Quality 
Department MA 
$37,458.38 $37,983.82 $34,686.34 $32,906.65 $30,219.13 
LPN $38,154.41 $37,808.80 $36,957.98 $37,428.76 $41,652.84 
RN $43,823.19 $42,023.36 $41,486.84 $41,260.73 $42,632.70 
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Table 3 
Payroll Expense 
Title/Credential For the Year 
2009 
For the Year 
2010 
For the Year 
2011 
For the Year 
2012 
For the Year 
2013 
MA $129,693.85 $135,031.88 $145,187.66 156,572.91 $155,323.21 
Quality 
Department 
MA 
$46,822.98 $47,479.77 $52,029.51 $49440.98 $60,438.25 
LPN $114,463.22 $113,426.40 $129,352.93 $123,514.91 $141,619.65 
RN $169,104.29 $210,116.81 $224,028.91 $255,816.52 $268,586.02 
Total Payroll 
Expense 
$460,084.34 $506,054.86 $550,599.01 $585,345.32 $625,967.13 
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Utilizing the Interdisciplinary Team to Conduct Processes Vital to Stage 2 Attainment 
 There are a number of ways a practice can meet the requirements of Stage 2 Meaningful 
Use objectives (MUOs). The following documents demonstrate how the exemplar practice was 
able to do so. This practice not only created an innovative interdisciplinary staffing structure that 
supports the demands of Meaningful Use Stage 2 as described in the previous sections, but 
developed processes that utilize each team member to the fullest extent of their education and 
training, enabling the fulfillment of Stage 2 objectives. The following documents describe some 
of these processes and reveal a need for an interdisciplinary team approach to care delivery. 
From these documents, parties interested in this interdisciplinary model are able to identify 
staffing roles needed for the various processes to be successful. Doing so can inform the 
translation of these processes into a format that would be successful within their particular EHR.  
 The following documents are presented in the order the practice would approach a patient 
who has diabetes mellitus (DM), beginning with the identification of patients with DM who have 
an elevated A1c and require a follow-up visit. Decision trees are included that demonstrate how 
staff members approach these patients to bring them in to that appointment. A step-by-step guide 
revealing how the exemplar practice meets the needs of Stage 2 Meaningful Use during the 
patient visit through discharge is provided. Lastly, a description of processes utilized to satisfy 
the requirements of Stage 2 Meaningful Use that were not addressed by the DM example is 
included. Through the use of these processes, the exemplar practice has been able to meet all the 
demands of Stage 2 Meaningful Use Menu Objectives. Interested parties are able to use these 
documents for replication purposes with the goal of Stage 2 attainment.    
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How the IT Nurse Creates a Report: A1c as an Example in the Allscripts EHR 
Patients with diabetes mellitus (DM) are closely monitored regarding the control of their A1c 
levels. This document provides step-by-step instructions regarding the creation of a population 
report (Objective 11) in the Allscripts EHR. This list enables close monitoring of patients with 
DM and a way to identify patients in need of follow-up care based on uncontrolled A1c levels. 
 
1. Open the Reporting Module in Allscripts 
2. Login as System Manager 
3. Click on the Green Plus Sign with symbolizes “Add Report” 
4. A new screen will open entitled “Report Properties” 
5. Fill in the Appropriate Sections 
a. Title: Diabetes Mellitus with A1C >= 7 within the past year 
b. Status: Enabled (active – working, usable report) 
c. Keep for:  365 days (Enables you to see trends on a chart) 
d. Segment: All active patients, non-occupational, not deceased (segment = 
denominator of report) 
e. Criterion: Diagnosis ICD-9 250. 
f. Encounter: Not needed if within so many days  or Within the past year 
g. Labs:  
 
Lab Result Value Days Most Recent 
 365 Not Needed If Using 
Most Recent 
i. Lab Test:  
1. Search Term: “A1c” include appropriate lab tests 
2. Search Term (LOINC): “4548-4” include appropriate lab tests 
3. Search Term (CPT Code): “83036” include appropriate lab tests 
6. If “Lab Result Value, Days” was selected, remove “Last Year” from the report as it is 
now imbedded within the report. If “Within the Past Year” was selected for the 
encounter, keep “Last Year” in the report as this is where the time frame comes from. 
7. Assign Action: Potential Actions Include 
a. Send Web Message to let Patient Know of Abnormal Lab (Not generally done but  
can help qualify for Meaningful Use sending medically relevant messages if 
patient responds) 
b. Display in Patient Manager (Lets whoever opens the chart that the patient has  
been identified as having an A1c out of range in the past year. This can help meet 
the clinical decision support tool MUO) 
c. Send Messages (To whatever staff is involved in addressing the issue, ie. quality 
department) 
8. Click on Schedule 
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a. Schedule report to be run (Most reports are run on the first of each month and sent 
to quality to address those that are not sent to quality are often quarterly) 
9. Click Execute to run report for the first initial time (after that it runs automatically) 
a. Execute with actions (will create reminders, messages, patient manager) 
10. Click Results to view Report  
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Quality Department Decision Tree: A1c as an Example 
From this point on, each team member who comes in contact with the EHR of a patient who has 
been identified by the report as needing a repeat A1c has a responsibility in assuring this is done. 
However, after the report runs, it is automatically sent to the quality team. The quality team 
examines the report and each patient identified as having an elevated A1c to determine if a 
patient-visit is necessary. 
 
 
 
 
 
 
  
CMA in Quality Department 
receives report in CERT for 
those not meeting goal of an A1c 
below 7% in the past 12 months 
Was the Last A1c below 7%? 
No Further Action Required 
Is the last A1c greater than 10%? 
 
Yes  
Does the patient have an upcoming 
office visit of lab work scheduled?  
 
 
Quality department member creates 
an action reminder to follow up 
regarding the outcome of the patient 
appointment 
Continue on to 
scheduled 
appointment  
Was the patient successfully 
contacted? 
Was the patient 
successfully 
scheduled?  
Attempt to contact 
patient again using 
preferred method or 
alternative method  
No  
No  
No  
No  
Yes  
Yes  
Yes  Clinical staff sees need for 
A1c based on timeframe of 
last A1c and puts in a CPOE 
for this to be completed  
A1c Normal  A1c Abnormal  
Contact patient regarding 
elevated A1c and the 
process begins again 
Process complete until 
next report is run 
No  
Attempt to contact patient 
again using preferred method 
or alternative method  
Was the patient 
successfully scheduled?  No  
Send message to provider explaining issue with contacting patient. Question whether 
discharging patient should be considered. Put a compliance note in the chart.  
Scheduler or quality department 
member attempts to contact patient 
using the patient’s preferred contact 
method to schedule an appointment 
Yes  
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Phone Nurse Decision Tree: A1c as an Example 
Simultaneously, the phone nurses remain cognizant of patient needs. When a patient calls the 
office, the phone nurse is not only addressing the patient’s reason for calling, but is also looking 
at the patient’s EHR for notes produced by the report and/or identified by the quality team 
pointing to outcome measures that are outside of normal limits, requiring follow up.  
   
  
Patient calls the office to speak with the phone nurse or the 
phone nurse contacts the patient regarding an issue 
Phone nurse opens the patient’s chart 
Does the Patient Manager show the 
patient is in need of an updated A1c? 
Yes  No  
Notify patient while on the phone that 
he/she is due for an A1c.  
Is the patient scheduled for an 
appointment? 
Yes  
Has a future order already been 
created for an A1c to be drawn at that 
time? 
Continue phone call addressing the 
initial reason for the phone call 
No  
Does the patient agree to schedule an 
appointment? 
Yes  No  
No further 
action is 
required 
The phone 
nurse utilizes 
protocols and 
orders the 
A1c through 
the CPOE 
Yes  
No  
The phone nurse makes a note of 
this interaction in the patient’s 
chart 
The phone nurse 
utilizes protocols and 
orders the A1c 
through the CPOE 
After the reason for the phone 
call is addressed, the patient 
phone call is transferred to the 
scheduler who will assist the 
patient in making an appointment 
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Point of Care Nurse Decision Tree: A1c as an Example 
When a patient does come to the office for a visit, regardless of the reason, the point of care 
nurses are the make sure an up-to-date A1c level is available for the provider for all diabetic 
patients. 
 
  
Patient comes into the office for a 
scheduled appointment 
Is the patient a diabetic? 
Does the Patient Manager 
Clinical Decision Support 
Tool show a need for an 
A1c to be drawn during 
this visit? 
No  Yes  
No need to continue 
Yes  
No  
Is there a future order for 
an A1c? 
Did the patient have an A1c 
greater than 7% between 3 and 
6 months ago? 
No  
No need to continue 
Yes  
Utilizing protocols, the 
clinical staff member 
orders the A1c through the 
CPOE 
An A1c is drawn by the clinical staff 
member when rooming the patient. The 
new A1c is then available to the provider 
at the beginning of the patient visit. 
Yes  No  
No need to 
continue 
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An Interdisciplinary Team Approach to meeting Stage 2 Meaningful Use Requirements: 
A1c as an Example 
The following provides an example of how visit for a patient with diabetes progresses in terms of 
meeting Meaningful Use Stage 2 objectives. Please Note: Not all of the Stage 2 Meaningful Use 
Objectives (MUOs) are addressed by this example.  
 
1. A report is created by the Project Manager LPN to run at the first of each month to 
identify patients active within the practice who have an A1c greater than or equal to 7% 
in the past year (Information Technology Nurse) (MUO 11) 
2. This list identifying patients who have had an A1c greater than or equal to 7% in the past 
year is sent to the quality department (MUO 12) 
3. The quality team identifies patients on this list who do not have an upcoming 
appointment or blood work ordered (MUO 12) 
4. Through the CPOE system, based on standing protocols, a future order for an A1c is 
created for patients in in need of a repeat A1c blood draw that is not yet ordered (Quality 
Team Member, Point of Care Nurse, or Point of Care CMA) (MUO 1) 
5. Those who do not have an upcoming office visit or lab appointment scheduled are 
contacted via their preferred method (phone, secure message, etc.) as deemed appropriate 
regarding the need for follow up care by scheduling or the quality team (MUO 12) 
6. Patient contacted and agrees to schedule an appointment 
7. Patient comes in for an office visit 
8. Demographic info is recorded/updated (Front Desk) (MUO 3) 
9. The patient is brought back to a room (Point of Care Nurse or Point of Care CMA) 
10. Vital signs are charted (Point of Care Nurse or Point of Care CMA) (MUO 4) 
11. An A1c is run (Point of Care Nurse or Point of Care CMA) 
12. The result of the A1c is documented in the EHR for the provider to view upon entering 
the room (Point of Care Nurse or Point of Care CMA) (MUO 10) 
13. Smoking status for patients greater than 13 years or older is updated/documented (Point 
of Care Nurse, CMA, or Provider) (MUO 5) 
14. Medication reconciliation is completed (Point of Care Nurse, Point of Care CMA, or 
Provider) (MUO 14) 
15. Visit is conducted (Provider) 
16. Orders for new prescriptions or adjustments in medications are transmitted via e-
prescribe to the patient’s pharmacy (Provider) (MUO 2) 
17. Additional lab work is ordered as deemed appropriate via CPOE (Provider) (MUO 1) 
18. The patient is encouraged to sign up for the patient portal (Point of Care Nurse, Point of 
Care CMA, Provider, or Clerical Staff) (MUO 7) 
19. The patient agrees to sign up for the patient portal and provides their email  
20. Patient-specific educational resources are identified through the EHR and given to patient 
upon discharge (Point of Care Nurse, Point of Care CMA, or Provider) (MUO 13) 
21. The patient is offered a clinical summary of the visit during checkout. This is 
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automatically sent to the patient via the portal if the patient has one. A printed copy is 
provided if the patient would like a clinical summary but does not have a portal. If the 
patient does not wish to receive a clinical summary, the summary is saved to the log and 
a note placed in the patient’s chart regarding this (Checkout Desk) (MUO 8)  
22. The patient leaves the office 
23. The patient is sent an invitation to sign up for the patient portal via the email address 
provided during the appointment (Patient Service Representative) (MUO 7) 
24. The patient signs up for the portal and has the ability to view, download, and transmit 
their health information (MUO 7) 
25. The patient receives a secure message in the portal from the Patient Service 
Representative notifying patient of lab results and further instruction as necessary. The 
patient is asked to send a secure message back to the provider (MUO 17)   
26. Patient sends secure message back (MUO 17) 
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Meeting the Remaining Meaningful Use Stage 2 Objectives 
 
Objectives 9 and 15: Protect Electronic Health Information and Provide a Summary Care 
Record for Each Care Transition or Referral  
 
When the referral specialist makes a referral, if the receiving facility has the capability to 
receive the electronically protected health information (ePHI) (MUO 9), a patient summary 
regarding what prompted the referral is electronically sent via Consolidated-Clinical Data 
Architecture (C-CDA) for practices that have the capability to receive such data or sent through 
eFax by the referral specialist to the receiving facility (MUO 15). The receiving office then 
contacts the patient regarding the referral if the patient has been accepted and an appointment is 
set. A confirmation receipt of the referral and acceptance or decline of the request is then sent 
back to the referral specialist from the receiving facility via phone, fax, or, occasionally, via eFax 
or C-CDA. A comment regarding this appointment is then attached to the referral order. After 
the date of the set appointment, the referral specialist confirms that a consultation note has been 
received and makes a note of this, completing the referral process. In this way, pertinent 
information is efficiently communicated between facilities and the referral loop is closed.  
The health information exchange is also enhancing the referral process and, more 
broadly, interoperability (MUOs 9 and 15). Through a health information exchange, the secure 
transfer of electronic information across organizations within a particular geographical location 
or healthcare system is made possible. Referrals can be made through the health information 
exchange used by organizations within the same geographical vicinity. To do so, the referral 
specialist sends pertinent patient’s information to the receiving facility through the EHR. Using a 
secure login, the referral specialist then accesses the exchange. A referral form is then completed 
containing additional information and notifying the receiving facility they have access to patient 
information through the EHR. The referral specialist and receiving facility are then able to 
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communicate via secure messaging through the health information exchange as needed. Clinic 
team members then have access to the patient note after the referral visit is complete through the 
EHR to close the loop.    
Objectives 9 and 16: Protect Electronic Health Information and Submit Electronic Data 
Regarding Immunizations to Registries 
The MCIR for immunizations is currently being utilized to communicate data in a one-
way fashion (MUO 16) (MCIR, 2015). When an individual is immunized or an immunization is 
updated, clinical staff accesses the MCIR through a secure login and, from the EHR, enters the 
immunization information. Because the Clinic has an HL7 interface that enables communication 
to the registry, this information is automatically transferred from the EHR and recorded in the 
MCIR to meet the requirement of core objective 16 in Stage 2 Meaningful Use. As technology 
and software continues to advance, communication between healthcare entities and registries will 
continue to move toward true interoperability where two-way communication will be possible, a 
goal of Stage 3 Meaningful Use.  
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Model Replication Guidelines 
For practices interested in model replication, a phased-in approach to model replication 
may be financially advisable. Users interested in such an approach may consider adding, based 
on the potential return-on-investment, an information technology nurse first, followed by a 
quality nurse, and then add to the quality team with certified medical assistants (CMAs). A 
phone nurse or phone nurses (versus the use of CMAs on the phone) and point of care nurses 
may then also be considered. Such a phased-in approach would ease the initial financial burden 
inherited with this model and aid users in tailoring the model to meet the needs of a particular 
practice.  
When examining the investment of diversifying the interdisciplinary team with these staff 
members, toolkit users must take note that FTEs and wages should be adjusted when replicating 
this model to remain effective and competitive in the market. Therefore, geographical location, 
demand, and the size of the practice should be considered. Following such guidelines are 
presumed to smooth the transition to this interdisciplinary team model of primary care delivery.  
 
 
For questions pertaining to this model and its replication, the author of this toolkit, Katie 
Alfredson, can be contacted via email: alfredsk@mail.gvsu.edu 
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Appendix 
The Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs: Stage 2 
Toolkit 
Please Note: The following document was created by the Centers for Medicare & Medicaid 
Services (2013) and can be found on the website http://www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage2_Toolkit_EHR_0313.pdf  
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About this Toolkit 
 
This Stage 2 Toolkit is an interactive document that provides users with resources 
and information about Stage 2 of the EHR Incentive Programs and 2014 Clinical 
Quality Measure requirements. The toolkit includes materials for eligible 
professionals (EPs), eligible hospitals, and critical access hospitals (CAHs). 
 
Table of Contents 
 
The table of contents is interactive and includes bookmarks. Users can click on a 
resource to be directed to that section of the PDF. By clicking on the title of the 
resource, users can return to the table of contents. 
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The Basics 
 Stage 2 Overview Tipsheet – provides an overview of the major provisions 
included in the Stage 2 rule 
 Stage 1 Changes Tipsheet – focuses on the changes that were made to Stage 1 
of meaningful use in the Stage 2 rule 
 2014 Clinical Quality Measures Tipsheet – provides information on the next 
phase of Clinical Quality Measures (CQMs) and how to report them to meet 
meaningful use in 2014 and beyond 
 Stage 2 FAQs – provides answers to questions about the Stage 2 rule and how 
it affects hospitals and EPs 
 2014 eCQM Resources – lists all of the 2014 CQM webpages and resources 
 
Resources  for Eligible  Professionals (EPs) 
 
Stage 2 Details 
 Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible 
Professionals – lists all the core and menu objectives for EPs, with direct links  
to each individual measure specification sheet (requires internet access to view 
spec sheets) 
 Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals – compares core 
and menu measures from Stage 1 with measures for Stage 2 of meaningful use 
for EPs 
 Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Professionals 
– provides an overview of the payment adjustment and hardship exceptions 
included in the Stage 2 rule for EPs 
 
  
 
 
EHR Incentive Programs 
Stage 2  
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– contains information about changes made to 2011 CQMs for the measures 
that were kept as part of the 2014 CQMs for EPs 
 Full Table of Recommended Adult Measures – lists the 9 CQMs in the 
recommended core set for the adult population 
 Full Table of Recommended Pediatric Measures – lists the 9 CQMs in the 
recommended core set for the pediatric population 
Resources for Eligible Hospitals & Critical Access Hospitals (CAHs) 
 
Stage 2 Details 
 Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible 
Hospitals and CAHs – lists all the core and menu objectives for eligible hospitals 
and CAHs, with direct links to each individual measure specification sheet 
(requires internet access to view spec sheets) 
 Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs – 
compares core and menu measures from Stage 1 with measures for Stage 2 of 
meaningful use for eligible hospitals and CAHs 
 Payment Adjustments & Hardship Exceptions Tipsheet for Eligible Hospitals and 
CAHs – provides an overview of the payment adjustment and hardship 
exceptions included in the Stage 2 rule for eligible hospitals and CAHs 
 
2014 CQMs 
 2014 CQMs for Eligible Hospitals [PDF, 377KB] – provides the description and 
definition statements for the 64 CQMs for use by eligible hospitals in the EHR 
Incentive Programs beginning in 2014 
 Technical Release Note 2014 eCQMs for Eligible Hospitals [PDF, 362KB] – 
contains information about changes made to 2011 CQMs for the measures 
that were kept as part of the 2014 CQMs for eligible hospitals 
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Stage 2 Overview Tipsheet 
Last Updated: August, 2012 
Overview 
CMS recently published a final rule that specifies the Stage 2 criteria that eligible professionals (EPs), 
eligible hospitals, and critical access hospitals (CAHs) must meet in order to continue to participate in 
the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs. 
 
If you have not participated in the Medicare or Medicaid EHR Incentive Programs previously, or if you 
have never achieved meaningful use under the Stage 1 criteria, please visit the CMS EHR Incentive 
Programs website (www.cms.gov/EHRIncentivePrograms) for more information about how to take part 
in the program. 
 
Stage 2 Timeline 
 
In the Stage 1 meaningful use regulations, CMS had established a timeline that required providers to 
progress to Stage 2 criteria after two program years under the Stage 1 criteria. This original timeline 
would have required Medicare providers who first demonstrated meaningful use in 2011 to meet the 
Stage 2 criteria in 2013. 
 
However, we have delayed the onset of Stage 2 criteria. The earliest that the Stage 2 criteria will be 
effective is in fiscal year 2014 for eligible hospitals and CAHs or calendar year 2014 for EPs. The table 
below illustrates the progression of meaningful use stages from when a Medicare provider begins 
participation in the program. 
 
 
 
1st Year 
 
Stage of Meaningful Use 
 
2011 
 
2012 
 
2013 
 
2014 
 
2015 
 
2016 
 
2017 
 
2018 
 
2019 
 
2020 
 
2021 
2011 1 1 1 2 2 3 3 TBD TBD TBD TBD 
2012 
 1 1 2 2 3 3 TBD TBD TBD TBD 
2013 
  1 1 2 2 3 3 TBD TBD TBD 
2014 
   1 1 2 2 3 3 TBD TBD 
2015 
    1 1 2 2 3 3 TBD 
2016 
     1 1 2 2 3 3 
2017 
      1 1 2 2 3 
Note that providers who were early demonstrators of meaningful use in 2011 will meet three 
consecutive years of meaningful use under the Stage 1 criteria before advancing to the Stage 2 criteria in 
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2014. All other providers would meet two years of meaningful use under the Stage 1 criteria before advancing to 
the Stage 2 criteria in their third year. 
 
In the first year of participation, providers must demonstrate meaningful use for a 90-day EHR reporting 
period; in subsequent years, providers will demonstrate meaningful use for a full year EHR reporting 
period (an entire fiscal year for hospitals or an entire calendar year for EPs) except in 2014, which is 
described below. Providers who participate in the Medicaid EHR Incentive Programs are not required to 
demonstrate meaningful use in consecutive years as described by the table above, but their progression 
through the stages of meaningful use would follow the same overall structure of two years meeting the 
criteria of each stage, with the first year of meaningful use participation consisting of a 90-day EHR 
reporting period. 
 
For 2014 only 
All providers regardless of their stage of meaningful use are only required to demonstrate meaningful 
use for a three-month EHR reporting period. 
 
o For Medicare providers, this 3-month reporting period is fixed to the quarter of either the 
fiscal (for eligible hospitals and CAHs) or calendar (for EPs) year in order to align with 
existing CMS quality measurement programs, such as the Physician Quality Reporting 
System (PQRS) and Hospital Inpatient Quality Reporting (IQR). 
o For Medicaid providers only eligible to receive Medicaid EHR incentives, the 3-month 
reporting period is not fixed, where providers do not have the same alignment needs. 
 
CMS is permitting this one-time three-month reporting period in 2014 only so that all providers who 
must upgrade to 2014 Certified EHR Technology will have adequate time to implement their new 
Certified EHR systems. 
 
Core and Menu Objectives 
 
Stage 1 established a core and menu structure for objectives that providers had to achieve in order to 
demonstrate meaningful use. Core objectives are objectives that all providers must meet. There are also 
a predetermined number of menu objectives that providers must select from a list and meet in order to 
demonstrate meaningful use. 
 
For many of the core and menu objectives, exclusions were provided that would allow providers to 
achieve meaningful use without having to meet those objectives that were outside of their normal 
scope of clinical practice. Under the Stage 1 criteria, EPs had to meet 15 core objectives and 5 menu 
objectives that they selected from a total list of 10. Eligible hospitals and CAHs had to meet 14 core 
objectives and 5 menu objectives that they selected from a total list of 10. 
 
Stage 2 retains this core and menu structure for meaningful use objectives. Although some Stage 1 
objectives were either combined or eliminated, most of the Stage 1 objectives are now core objectives 
under the Stage 2 criteria. For many of these Stage 2 objectives, the threshold that providers must meet 
for the objective has been raised. We expect that providers who reach Stage 2 in the EHR Incentive 
Programs will be able to demonstrate meaningful use of their Certified EHR Technology for an even 
larger portion of their patient populations. 
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 EPs must meet 17 core objectives and 3 menu objectives that they select from a total list of 6, 
or a total of 20 core objectives. 
 
 Eligible hospitals and CAHs must meet 16 core objectives and 3 menu objectives that they 
select from a total list of 6, or a total of 19 core objectives. 
 
The end of this tipsheet contains a complete list of the Stage 2 core and menu objectives for both EPs 
and eligible hospitals and CAHs. Providers can also download a table of the Stage 2 core and menu 
objectives and measures by clicking on the links below: 
 
 Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals 
 Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs 
 
New Objectives & New Measures 
Though most of the new objectives introduced for Stage 2 are menu objectives, EPs and eligible 
hospitals each have a new core objective that they must achieve. CMS believes that both of these 
objectives will have a positive impact on patient care and safety and are therefore requiring all providers 
to meet the objectives in Stage 2. 
 
New Stage 2 Core Objectives: 
 
  
Use secure electronic messaging to communicate with patients on relevant health 
information (for EPs only) 
 
Automatically track medications from order to administration using assistive technologies in 
conjunction with an electronic medication administration record (eMAR) (for Eligible 
Hospitals/CAHs only) 
 
 
Some new objectives were also introduced for Stage 2, and most of these were introduced as menu 
objectives for Stage 2. As with the previous stage, many of the Stage 2 objectives have exclusions that 
allow providers to achieve meaningful use without having to meet objectives outside their normal scope 
of clinical practice. 
To demonstrate meaningful use under Stage 2 criteria— 
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In addition, the Stage 2 criteria place an emphasis on health information exchange between providers to 
improve care coordination for patients. One of the core objectives for both EPs and eligible hospitals and 
CAHs requires providers who transition or refer a patient to another setting of care or provider of care to 
provide a summary of care record for more than 50% of those transitions of care and referrals. 
Additionally, there are new requirements for the electronic exchange of summary of care documents: 
 For more than 10% of transitions and referrals, EPs, eligible hospitals, and CAHs that transition or 
refer their patient to another setting of care or provider of care must provide a summary of care 
record electronically. 
 The EP, eligible hospital, or CAH that transitions or refers their patient to another setting of care 
or provider of care must either a) conduct one or more successful electronic exchanges of a 
summary of care record with a recipient using technology that was designed by a different EHR 
developer than the sender's, or b) conduct one or more successful tests with the CMS- 
designated test EHR during the EHR reporting period. 
 
 
 
 
 
 
 
  
Provide patients the ability to view online, download and transmit their health information 
within four business days of the information being available to the EP (for EPs only) 
 
 
Provide patients the ability to view online, download and transmit their health information 
within 36 hours after discharge from the hospital (for Eligible Hospitals/CAHs only) 
 
 
 
Stage 2 also replaces the previous Stage 1 objectives to provide electronic copies of health information 
or discharge instructions and provide timely access to health information with objectives that allow 
patients to access their health information online. 
Stage 2 Patient Access Objectives: 
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Finally, there are new Stage 2 measures for several objectives that require patients to use health 
information technology in order for providers to achieve meaningful use. CMS believes that EPs, eligible 
hospitals, and CAHs are in the best position to encourage the use of health IT by patients to further their 
own health care. 
 
Under the Stage 2 core objectives to provide patients the ability to view online, download and transmit 
their health information, more than 5 percent of patients seen by the EP or admitted to an inpatient 
(Place of Service 21) or emergency department (Place of Service 23) of an eligible hospital or CAH view, 
download, or transmit to a third party their health information. 
 
Under the Stage 2 core objective to use secure electronic messaging to communicate with patients on 
relevant health information, a secure message must be sent using the electronic messaging function of 
Certified EHR Technology by more than 5 percent of unique patients seen by an EP during the EHR 
reporting period. 
 
 
  
 
Record electronic notes in patient records 
 
 
 
Imaging results accessible through CEHRT 
 
Record patient family health history 
 
 
Identify and report cancer cases to a State cancer registry (for EPs only) 
 
 
Identify and report specific cases to a specialized registry (other than a cancer registry) (for 
EPs only) 
 
 
Generate and transmit permissible discharge prescriptions electronically (eRx) (new for 
eligible hospitals and CAHs only) 
 
Provide structured electronic lab results to ambulatory providers (for eligible hospitals 
and CAHs only) 
 
There are also new Stage 2 menu objectives for EPs, eligible hospitals, and CAHs: 
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Overview 
Stage 1 Changes Tipsheet 
Last Updated: August, 2012 
 
CMS recently announced some changes to the Stage 1 meaningful use objectives, measures, and 
exclusions for eligible professionals (EPs), eligible hospitals, and critical access hospitals (CAHs). Some of 
these changes will take effect as early as October 1, 2012, for eligible hospitals and CAHs, or January 1, 
2013, for EPs. Other Stage 1 changes will not take effect until the 2014 fiscal or calendar year and will be 
optional in 2013. The table at the end of this publication summarizes the changes to the Stage 1 
meaningful use objectives. 
 
Exclusions for Menu Objectives 
Beginning in 2014, EPs, eligible hospitals, and CAHs will no longer be permitted to count an exclusion 
toward the minimum of 5 menu objectives on which they must report if there are other menu objectives 
which they can select. In other words, a provider cannot select a menu objective and claim an exclusion 
for it if there are other menu objectives they can meet. 
 
EPs, eligible hospitals, and CAHs will not be penalized for selecting a menu objective and claiming the 
exclusion if they would also qualify for the exclusions for all the remaining menu objectives. For 
example, EPs who must select to test the capability to submit data to either an immunization registry or 
a syndromic surveillance database as one of their menu objectives can select the menu objective for 
submitting data to an immunization registry and claim the exclusion if they would also be able to claim 
the exclusion for submitting data to a syndromic surveillance database. They would not be penalized for 
claiming this exclusion. 
 
Computerized Provider Order Entry (CPOE) 
Beginning in 2013, CMS is adding an optional alternate measure to the objective for computerized 
provider order entry (CPOE). The current measure for CPOE is based on the number of unique patients 
with a medication in their medication list that was entered using CPOE. The new, alternate measure is 
based on the total number of medication orders created during the EHR reporting period. An EP, eligible 
hospital, or CAH may select either measure for this objective in Stage 1 in order to achieve meaningful 
use. (Note that this alternative measure will be required for all providers in Stage 2.) 
 
 
 
Electronic Prescribing 
Beginning in 2013, CMS is adding an additional exclusion to the objective for electronic prescribing for 
providers who are not within a 10 mile radius of a pharmacy that accepts electronic prescriptions. 
 
  
Alternate Measure: More than 30 percent of medication orders created by the EP or authorized 
providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) 
during the EHR reporting period are recorded using CPOE. 
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CMS is changing the measure of the objective for recording and charting changes in vital signs for EPs, 
eligible hospitals, and CAHs. The current measure specifies that vital signs must be recorded for more 
than 50 percent of all unique patients ages 2 and over. The new measure amends that age limit to 
recording blood pressure for patients ages 3 and over and height and weight for patients of all ages. 
 
The exclusions for this objective for EPs are also changing. The current exclusions only allow an EP to 
claim the exclusion if all three vital signs (height, weight, blood pressure) are not relevant to their scope 
of practice or if the EP sees no patients 2 years or older. However, under the new Stage 1 changes, an EP 
can claim an exclusion if the EP sees no patients 3 years or older (the EP would not have to record blood 
pressure), if all three vital signs are not relevant to their scope of practice (the EP would not record any 
vital signs), if height and weight are not relevant to their scope of practice (the EP would still record 
blood pressure), or if blood pressure is not relevant to their scope of practice (the EP would still record 
height and weight). 
 
This new measure and these new exclusions are optional in 2013 but will be required in 2014 and 
beyond. 
 
 
 
  
New Measure: More than 50 percent of all unique patients seen by the EP or admitted to the 
eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR 
reporting period have blood pressure (for patients age 3 and over only) and height and weight (for 
all ages) recorded as structured data. 
New Exclusion: Any EP who 
1. Sees no patients 3 years or older is excluded from recording blood pressure; 
 
2. Believes that all three vital signs of height, weight, and blood pressure have no relevance 
to their scope of practice is excluded from recording them; 
 
3. Believes that height and weight are relevant to their scope of practice, but blood pressure 
is not, is excluded from recording blood pressure; or 
 
4. Believes that blood pressure is relevant to their scope of practice, but height and weight 
are not, is excluded from recording height and weight. 
           i i   i i  
      l i  i  i i   il     
        i  
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Electronic Exchange of Key Clinical Information 
Beginning in 2013, the objective for electronic exchange of key clinical information will no longer be 
required for Stage 1 for EPs, eligible hospitals, and CAHs. Providers faced numerous challenges in 
understanding the requirements for this objective, so we are moving instead to a more robust 
requirement for electronic health information exchange as a part of the Stage 2 objective for providing a 
summary of care record following a transition of care or referral. 
 
Report Clinical Quality Measures 
Beginning in 2013, there will no longer be a separate objective for reporting ambulatory or hospital 
clinical quality measures as a part of meaningful use. It is important to note, however, that EPs, eligible 
hospitals, and CAHs will still be required to report on clinical quality measures in order to achieve 
meaningful use. CMS is simply removing the standalone objective that requires providers to attest that 
they plan to report on clinical quality measures because it is redundant. 
 
Electronic Copy of and Electronic Access to Health Information 
In order to better align Stage 1 objectives with the new 2014 capabilities of Certified EHR Technology, 
CMS is replacing several Stage 1 objectives for providing electronic copies of and electronic access to 
health information with objectives to provide patients the ability to view, download, or transmit their 
health information or hospital admission information online. The capability to provide patients online 
access to this information will be a part of Certified EHR Technology beginning in 2014, therefore the 
new Stage 1 objectives will be required beginning in 2014. 
The following current Stage 1 objectives will be replaced beginning in 2014: 
 
 EPs/Hospital Stage 1 Core Objective: Provide patients with an electronic copy of their health 
information (including diagnostics test results, problem list, medication lists, medication 
allergies, discharge summary, procedures) upon request. 
 Hospital Stage 1 Core Objective: Provide patients with an electronic copy of their discharge 
instructions at time of discharge, upon request. 
 EP Stage 1 Menu Objective: Provide patients with timely electronic access to their health 
information (including lab results, problem list, medication lists, and allergies) within 4 business 
days of the information being available to the EP. 
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Public Health Reporting Objectives 
 
Beginning in 2013, all of the Stage 1 public health objectives (submitting data to an immunization 
registry, submitting data to a syndromic surveillance database, or submitting reportable lab results to a 
public health agency) will require that providers perform at least one test of their Certified EHR 
Technology’s capability to send data to public health agencies, except where prohibited. The intent of 
this modification is to encourage all EPs, eligible hospitals, and CAHs to submit public health data, even 
when not required by State/local law. Therefore, if providers are authorized to submit the data, they 
should do so even if it is not required by either law or practice. If the test of submission is successful, 
provider should institute regular reporting with the entity with whom the successful test was conducted. 
 
Stage 1 Objective Changes to Objective Effective 
Year 
(CY/FY) 
Use CPOE for medication orders 
directly entered by any licensed 
healthcare professional who 
can enter orders into the 
medical record per State, local 
and professional guidelines 
Change:  Addition of an alternative measure 
 
More than 30 percent of medication orders created by the 
EP or authorized providers of the eligible hospital's or CAH's 
inpatient or emergency department (POS 21 or 23) during 
the EHR reporting period are recorded using CPOE 
2013 - Onward 
(Optional) 
Generate and transmit 
permissible prescriptions 
electronically (eRx) 
Change: Addition of an additional exclusion 
 
Any EP who: does not have a pharmacy within their 
organization and there are no pharmacies that accept 
electronic prescriptions within 10 miles of the EP's practice 
location at the start of his/her EHR reporting period. 
2013 – 
Onward 
(Required) 
  
New Objectives and Measures 
New EP Objective: Provide patients the ability to view online, download and transmit their 
health information within 4 business days of the information being available to the EP. 
New EP Measure: More than 50 percent of all unique patients seen by the EP during the 
EHR reporting period are provided timely (within 4 business days after the information is 
available to the EP) online access to their health information subject to the EP's discretion 
to withhold certain information. 
New Hospital Objective: Provide patients the ability to view online, download and 
transmit information about a hospital admission. 
New Hospital Measure: More than 50 percent of all patients who are discharged from 
the inpatient or emergency department (POS 21 or 23) of an eligible hospital or CAH 
have their information available online within 36 hours of discharge. 
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Stage 1 Objective Changes to Objective Effectiv
e Year 
(CY/FY
) 
Record and chart changes in Change: Age Limitations on Growth Charts and 
Blood Pressure 
 
More than 50 percent of all unique patients seen by the EP 
or admitted to the eligible hospital's or CAH's inpatient or 
emergency department (POS 21 or 23) during the EHR 
reporting period have blood pressure (for patients age 3 
and over only) and height and weight (for all ages) 
recorded as structured data 
2013 Only 
vital signs (Optional) 
 
2014 – 
Onward 
(Required) 
Public Health Objectives: Change: Addition of "except where prohibited" to the 
objective regulation text for the public health 
objectives under § 495.6 
2013 – 
Onward 
(Require
d) 
Record and chart changes in Change: Changing the age and splitting the EP 
exclusion Any EP who 
(1) Sees no patients 3 years or older is excluded 
from recording blood pressure; 
 
(2) Believes that all three vital signs of height, weight, 
and blood pressure have no relevance to their scope of 
practice is excluded from recording them; 
 
(3) Believes that height and weight are relevant to 
their scope of practice, but blood pressure is not, is 
excluded from recording blood pressure; or 
 
(4) Believes that blood pressure is relevant to their 
scope of practice, but height and weight are not, is 
excluded from recording height and weight. 
2013 Only 
vital signs (Optional) 
2014 – 
Onward 
(Required) 
Capability to exchange key 
clinical information (for 
example, problem list, 
medication list, medication 
allergies, and diagnostic test 
results), among providers of 
care and patient authorized 
entities electronically 
Change:  Objective is no longer required 2013 – 
Onward 
(Require
d) 
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Stage 1 Objective Changes to Objective Effective 
Year 
(CY/FY) 
Report ambulatory/hospital 
clinical quality measures to 
CMS or the States 
Change: Objective is incorporated directly into the 
definition of a meaningful EHR user and eliminated as an 
objective 
2013 – 
Onward 
(Required) 
EP and Hospital Objectives: 
Provide patients with an 
electronic copy of their health 
information (including 
diagnostics test results, 
problem list, medication lists, 
medication allergies, discharge 
summary, procedures) upon 
request. 
 
EP Objective: Provide patients 
with timely electronic access to 
their health information 
(including lab results, problem 
list, medication lists, and 
allergies) within 4business days 
of the information being 
available to the EP. 
 
 
 
 
Hospital Objective: Provide 
patients with an electronic copy 
of their discharge instructions 
at time of discharge, upon 
request. 
Change: Replace these four objectives with the Stage 2 
objective and one of the two Stage 2 measures. 
 
 
 
 
 
 
 
 
 
 
EP Objective: Provide patients the ability to view online, 
download and transmit their health information within 4 
business days of the information being available to the EP. 
 
EP Measure: More than 50 percent of all unique patients 
seen by the EP during the EHR reporting period are 
provided timely (within 4 business days after the 
information is available to the EP) online access to their 
health information subject to the EP's discretion to 
withhold certain information. 
 
 
Hospital Objective: Provide patients the ability to view 
online, download and transmit information about a 
hospital admission. 
 
Hospital Measure: More than 50 percent of all patients 
who are discharged from the inpatient or emergency 
department (POS 21 or 23) of an eligible hospital or CAH 
have their information available online within 36 hours of 
discharge. 
2014 – 
Onward 
(Required) 
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Beginning in 2014, the reporting of clinical quality measures (CQMs) will change for all providers. EHR 
technology that has been certified to the 2014 standards and capabilities will contain new CQM criteria, 
and eligible professionals (EPs), eligible hospitals, and critical access hospitals (CAHs) will report using 
the new 2014 criteria regardless of whether they are participating in Stage 1 or Stage 2 of the Medicare 
and Medicaid Electronic Health Record (EHR) Incentive Programs. Although clinical quality measure 
(CQM) reporting has been removed as a core objective for both EPs and eligible hospitals and CAHs, all 
providers are required to report on CQMs in order to demonstrate meaningful use. 
 
2013 
 Eligible Professionals (EPs), will continue to report from the 44 measures finalized for Stage 1 in the 
same schema laid out for Stage 1 
 3 core/alternate core 
 3 additional measures for EPs 
 Eligible hospitals and CAHs will continue to report the 15 measures finalized for Stage 1 
 Beginning in 2012 and continuing in 2013, there are two reporting methods available for reporting 
the Stage 1 measures: 
 Attestation (https://ehrincentives.cms.gov/) 
 eReporting Pilots: 
o Physician Quality Reporting System EHR Incentive Program Pilot for EPs 
o eReporting Pilot for eligible hospitals and CAHs 
 
2014 and Beyond 
 EPs must report on 9 of the 64 approved CQMs 
 Recommended core CQMs – encouraged but not required 
o 9 CQMs for the adult population 
o 9 CQMs for the pediatric population 
o NQF 0018 strongly encouraged since controlling blood pressure is high priority goal 
in many national health initiatives, including the Million Hearts campaign 
 Selected CQMs must cover at least 3 of the National Quality Strategy domains (See 
“Measure Selection Process” below.) 
 Eligible Hospitals and CAHs must report on 16 of the 29 approved CQMs 
 Selected CQMs must cover at least 3 of the National Quality Strategy domains (See 
“Measure Selection Process” below.) 
 Beginning in 2014, all Medicare-eligible providers beyond their first year of demonstrating 
meaningful use must electronically report their CQM data to CMS. (Medicaid EPs and hospitals that 
are eligible only for the Medicaid EHR Incentive Program will electronically report their CQM data to 
their state.) See “Reporting Options for EPs” and “Reporting Options for Eligible Hospitals and C!Hs” 
below for more information. 
  
 
   
 
Las  pda   2012 
Criteria for Reporting Clinical Quality Measures 
  Medicare EHR Incentive Program 
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Measure Selection Process 
CMS selected the recommended core set of CQMs for EPs based on analysis of several factors: 
 Conditions that contribute to the morbidity and mortality of the most Medicare and 
Medicaid beneficiaries 
 Conditions that represent national public health priorities 
 Conditions that are common to health disparities 
 Conditions that disproportionately drive healthcare costs and could improve with better 
quality measurement 
 Measures that would enable CMS, States, and the provider community to measure quality 
of care in new dimensions, with a stronger focus on parsimonious measurement 
 Measures that include patient and/or caregiver engagement 
In addition, CMS selected all CQMs to align with the Department of Health and Human Services’ 
National Quality Strategy priorities for health care quality improvement.  These domains include: 
 Patient and Family Engagement 
 Patient Safety 
 Care Coordination 
 Population and Public Health 
 Efficient Use of Healthcare Resources 
 Clinical Processes/Effectiveness 
When selecting their CQMs to report, EPs, eligible hospitals, and CAHs must select CQMs that cover at 
least three of these six domains. A complete list of 2014 CQMs and their associated National Quality 
Strategy domains will be posted on the CMS EHR Incentive Programs website 
(www.cms.gov/EHRIncentivePrograms) in the future. CMS will also post the recommended core set of 
CQMs for EPs. 
Reporting and submission periods for EPs, Eligible Hospitals, and CAHs in their first year of Meaningful 
Use submitting CQMs via attestation beginning with CY/FY 2014 
Provider 
Type 
Reporting Period for First Year of 
Meaningful Use (Stage 1) 
Submission Period for First Year of 
Meaningful Use (Stage 1)* 
EP 90 consecutive days Anytime immediately following the end of the 
90-day reporting period, but no later than 
February 28 of the following calendar year. 
Eligible 
Hospital/CAH 
90 consecutive days Anytime immediately following the end of the 
90-day reporting period, but no later than 
November 30 of the following fiscal year. 
*For purposes of avoiding a payment adjustment, Medicare EPs and eligible hospitals that are in their first year of 
demonstrating meaningful use in the year immediately preceding a payment adjustment year must submit their CQM data no 
later than October 1 (EPs) or July 1 (eligible hospitals) of such preceding year. 
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Reporting and submission periods for EPs, Eligible Hospitals, and CAHs beyond their first year of Meaningful 
Use submitting CQMs electronically beginning with CY/FY 2014 
For 2014 only, all providers regardless of their stage of meaningful use are only required to demonstrate 
meaningful use for a three-month EHR reporting period. Medicare providers can either report their 
CQMs for the entire year or select an optional three-month reporting period for CQMs that is identical 
to their three-month reporting period for meaningful use. 
 
For Medicare providers, this 3-month reporting period is fixed to the quarter of either the fiscal (for 
eligible hospitals and CAHs) or calendar (for EPs) year in order to align with existing CMS quality 
measurement programs, such as the Physician Quality Reporting System (PQRS) and Hospital Inpatient 
Quality Reporting (IQR). CMS is permitting this one-time three-month reporting period in 2014 only so 
that all providers who must upgrade to 2014 Certified EHR Technology will have adequate time to 
implement their new Certified EHR systems. 
 
In subsequent years, the reporting period for clinical quality measures would be the entire calendar year 
(for EPs) or fiscal year (for eligible hospitals and CAHs). 
 
Provider 
Type 
Optional Reporting Period in 
2014* 
Reporting Period for 
Subsequent Years of 
Meaningful Use (Stage 
1 and Subsequent 
Stages) 
Submission Period for 
Subsequent Years of 
Meaningful Use (Stage 
1 and Subsequent 
Stages) 
EP Calendar year quarter: 
January 1 – March 31 
April 1 – June 30 
July 1 – September 30 
October 1 – December 31 
1 calendar year 
(January 1 - December 
31) 
2 months following the 
end of the reporting 
period 
(January 1 - February 28) 
Eligible Fiscal year quarter: 1 fiscal year 2 months following the 
Hospital/CAH October 1 – December 31 (October 1 - September end of the reporting 
January 1 – March 31 30) period 
April 1 – June 30 (October 1 - November 
July 1 – September 30 30) 
*NOTE: The optional quarter reporting periods have the same submission period as a full year reporting period for electronic 
submission. 
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Reporting Options for EPs 
 
 
 
 
 
 
 
 
*Attestation is required for EPs in their first year of demonstrating meaningful use because it is the only reporting method that 
would allow them to meet the submission deadline of October 1 to avoid a payment adjustment. 
**Groups with EPs in their first year of demonstrating meaningful use can report as a group, however individual EPs who are in 
their first year must attest to their CQM results by October 1 to avoid a payment adjustment. 
 
 
 
 
 
 
  
Category Data 
Leve
l 
Paye
r 
Level 
Submission 
Type 
Reporting Schema 
EPs in First 
Year of 
Demonstrating 
Meaningful 
Use* 
Aggregate All payer Attestation Submit 9 CQMs (includes adult and 
pediatric recommended core CQMs), 
covering at least 3 NQS domains 
EPs Beyond the First Year of Demonstrating Meaningful Use 
Option 1 Aggregate All payer Electronic Submit 9 CQMs (includes adult and 
pediatric recommended core CQMs), 
covering at least 3 NQS domains 
Option 2 Patient Medicare 
Only 
Electronic Satisfy requirements of PQRS 
reporting options using CEHRT 
Group Reporting (only EPs Beyond the First Year of Demonstrating Meaningful Use)** 
EPs in an ACO 
(Medicare 
Shared Savings 
Program or 
Pioneer ACOs) 
Patient Medicare 
Only 
Electronic Satisfy requirements of Medicare Shared 
Savings Program of Pioneer ACOs using 
CEHRT 
EPs 
satisfactorily 
reporting via 
PQRS group 
reporting 
options 
Patient Medicare 
Only 
Electronic Satisfy requirements of PQRS group 
reporting options using CEHRT 
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Reporting Options for Eligible Hospitals and Critical Access Hospitals 
 
 
 
 
 
 
 
 
*Attestation is required for eligible hospitals in their first year of demonstrating meaningful use because it is the only reporting 
method that would allow them to meet the submission deadline of July 1 to avoid a payment adjustment. 
 
2. Medicaid EHR Incentive Program 
2013 and Beyond 
 EPs, eligible hospitals, and CAHs participating only in a Medicaid EHR Incentive Program will submit 
their CQM data directly to their State. 
 Each State is responsible for sharing the details on the process for electronic reporting with its 
provider community. 
 Subject to CMS’s prior approval, the process and the timeline are within the States’ purview. 
 
 
 
 
 
 
  
Category Data 
Leve
l 
Paye
r 
Level 
Submission 
Type 
Reporting Schema 
Eligible 
Hospitals in 
First Year of 
Demonstrating 
Meaningful 
Use* 
Aggregate All pay r Attestation Submit 16 CQMs, covering at least 3 NQS 
domains 
Eligible Hospitals/CAHs Beyond the First Year of Demonstrating Meaningful Use 
Option 1 Aggregate All payer Electronic Submit 16 CQMs, covering at least 3 NQS 
domains 
Option 2 Patient Sample - 
all payer 
Electronic Submit 16 CQMs, covering at least 3 NQS 
domains 
 Manner similar to the 2012 
Medicare EHR Incentive Program 
Electronic Reporting Pilot 
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II. Questions about Stage 2 Meaningful Use Measures & 
Objectives 
 
III. Questions about changes to the Medicare EHR Incentive 
Program from Stage 2 
 
IV. Questions about changes to the Medicaid EHR Incentive 
Program from Stage 2 
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Please see the full FAQ online to see a chart of the changes to specific objectives, 
measures and policies: https://questions.cms.gov/faq.php?id=5005&faqId=7527 
Date Updated: 8/23/2012 
New ID #7527 
2) What is Stage 2 for the Medicare and Medicaid EHR Incentive Programs? 
 
In August 2012, CMS published a final rule that specifies the Stage 2 meaningful use 
criteria that eligible professionals, eligible hospitals, and critical access hospitals must 
meet to continue to participate in the Medicare and Medicaid Electronic Health 
Record (EHR) Incentive Programs and avoid payment adjustments. 
Stage 2 retains the core and menu structure for meaningful use objectives. Although 
some Stage 1 objectives were either combined or eliminated, most of the Stage 1 
objectives are now core objectives under the Stage 2 criteria. For many of these 
Stage 2 objectives, the threshold that providers must meet for the objective has 
been raised. 
New objectives are also introduced for Stage 2, and most of these are introduced as 
menu objectives. As with the previous stage, many of the Stage 2 objectives have 
exclusions that allow providers to achieve meaningful use without having to meet 
objectives outside of their normal scope of clinical practice. 
To demonstrate meaningful use under Stage 2 criteria— 
• Eligible professionals must meet 17 core objectives and 3 menu objectives they 
select from a list of 6, for a total of 20 core objectives (the same number of 
objectives that had to be met in Stage 1). 
• Eligible hospitals and critical access hospitals must meet 16 core objectives and 3 
menu objectives they select from a list of 6, for a total of 19 core objectives (the 
same number of objectives that had to be met in Stage 1). 
 
Please note, providers who were early demonstrators of meaningful use in 2011 will 
meet three consecutive years of meaningful use under the Stage 1 criteria before 
advancing to the Stage 2 criteria in 2014. All other providers would meet two years 
  
      
              
             
The August 23, 2012, final rule includes some changes to the Stage 1 
meaningful use objectives, measures, and exclusions for eligible 
professionals, eligible hospitals, and critical access hospitals. Some of 
these changes will take effect as early as October 1, 2012, for eligible 
hospitals and critical access hospitals, or January 1, 2013, for eligible 
prof ssionals. Other Stage 1 changes will not tak  effect until the 2014 
fiscal or c lendar y ar, and will be ptional in 2013. 
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of meaningful use under the Stage 1 criteria before advancing to the Stage 2 criteria 
in their third year, regardless of the year in which you begin participation. 
The Stage 2 final rule also includes some changes to the Stage 1 meaningful use 
objectives, measures, and exclusions. Some of the changes to Stage 1 will take  
effect as early as October 1, 2012, for eligible hospitals and critical access hospitals, 
or January 1, 2013, for eligible professionals. Other changes to Stage 1 will not be 
required until FY 2014 (for hospitals) or CY 2014 (for EPs), but will be optional in FY 2013 
(for hospitals) or CY 2013 (for EPs). 
 
Date Updated: 8/23/2012 
New ID #7529 
II. Questions about Stage 2 Meaningful Use Measures & 
Objectives 
 
3) For meaningful use Stage 2's transitions of care and referrals objective, in what ways 
can I meet the second measure that requires more than 10% of the summary care 
records I provide for transitions of care and referrals to be electronically transmitted? 
 
An EP, eligible hospital, or CAH could use 3 distinct approaches (which could also be 
used in combination) to meet this measure. The first two rely solely on the use of 
CEHRT, while the third is slightly different. 
For the first two approaches, this measure can only be met if the EP, eligible hospital, 
or CAH uses the capabilities and standards included as part of its Certified EHR 
Technology (CEHRT) to electronically transmit summary care records for transitions of 
care and referrals  (specifically those capabilities certified to the certification 
criterion adopted by ONC at 45 CFR 170.314(b)(2) “transitions of care – create and 
transmit transition of care/referral summaries,” which specifies standards for data 
content and transport). 
For the third approach, the EP, eligible hospital, or CAH must use its CEHRT to create 
a summary care record for transitions of care and referrals, but instead of using a 
transport standard specified in ONC’s certification criterion at 45 CFR 170.314(b)(2) 
(included as part of its CEHRT) to electronically transmit the summary care record, 
the EP, eligible hospital, or CAH may use a NwHIN Exchange participant to facilitate 
the electronic transmission to the recipient. The NwHIN Exchange is now known as 
“eHealth Exchange” and a list of participants can be found here. 
The following are more detailed explanations of each permitted approach. We also 
emphasize that regardless of the way an EP, eligible hospital, or CAH chooses to 
transmit the summary of care record, such a transmission will only count in the 
numerator if it is received by the provider to whom the sending provider is referring or 
transferring the patient. 
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1. Use of the transport standard capability required for certification. As required by 
ONC to meet the CEHRT definition, every EP, eligible hospital, and CAH, must have 
EHR technology that is capable of electronically transmitting a summary care record 
for transitions of care and referrals according to the primary Direct Project 
specification (the Applicability Statement for Secure Health Transport). Thus, EPs, 
eligible hospitals, or CAHs that electronically transmit summary care records using 
their CEHRT’s “Direct” capability (natively or combined with an intermediary) would 
be able to count all such electronic transmissions in their numerator. 
 
2. Use of the SOAP-based optional transport standard capability permitted for 
certification. As part of certification, ONC permits EHR technology developers to 
voluntarily seek certification for their EHR technology’s capability to perform SOAP- 
based electronic transmissions. EHR technology developers who take this approach 
would enable their customers to also use this approach to meet the measure. Thus, 
EPs, eligible hospitals, or CAHs that electronically transmit summary care records 
using their CEHRT’s “SOAP-based” capability (natively or combined with an 
intermediary) would be able to count all of those transmissions in their numerator. 
 
3. Use of CEHRT to create a summary care record in accordance with the required 
standard (i.e., Consolidated CDA as specified in 45 CFR 170.314(b)(2)), and the 
electronic transmission is accomplished through the use of an eHealth Exchange 
participant who enables the electronic transmission of the summary care record to 
its intended recipient. Thus, EPs, eligible hospitals, or CAHs who create standardized 
summary care records using their CEHRT and then use an eHealth Exchange 
participant to electronically transmit the summary care record would be able to 
count all of those transmissions in their numerator. 
 
We note that for this third approach, the regulation also permits an EP, eligible 
hospital, or CAH to count in their numerator instances where a summary care record 
for transitions of care or referrals was received via electronic exchange facilitated in 
a manner consistent with the governance mechanism ONC establishes for the 
nationwide health information network. ONC has not yet established a governance 
mechanism for the nationwide health information network. Until ONC establishes 
such a governance mechanism, this specific option will not be available. 
Date Updated: 11/5/2012 
New ID #7697 
4) What are the specific medical specialty codes associated with anesthesiology, 
radiology and pathology for the specialty-based determination for the granting of a 
hardship exception from the payment adjustments in the Medicare Electronic Health 
Record (EHR) Incentive Program? 
 
The included Medicare Specialty Codes are diagnostic radiology (30), nuclear 
medicine (36), interventional radiology (94), anesthesiology (30), and pathology (22). 
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Radiation oncology, together with surgical and medical oncology, is one of the 3 
primary disciplines involved in cancer treatment according to the American College 
of Radiology practice guidelines. Radiation oncologists are therefore specialized 
oncologists as opposed to specialized radiologists and are not eligible for the 
specialty-based exception. If a radiation oncologist believes they meet the hardship 
exception criteria for lack of face-to-face patient interaction and lack of need for 
follow-up care they may apply for that exception, as can any eligible professional 
regardless of specialty. 
Date Updated: 1/2/2013 
New ID #7731 
5) If multiple eligible professionals contribute information to a shared portal or to a 
patient's online personal health record (PHR), how is it counted for meaningful use 
when the patient accesses the information on the portal or PHR? 
 
The answer is relevant to the following meaningful use measure for eligible 
professionals (EPs): “More than 5 percent of all unique patients seen by the EP during 
the EHR reporting period (or their authorized representatives) view, download or 
transmit to a third party their health information.” 
If the patient was seen by the EP during the EHR reporting period, the patient would 
be counted in the EP’s numerator for this measure if the patient (or his/her authorized 
representatives) views online, downloads, or transmits to a third party any of the 
health information from the shared portal or online PHR, regardless of whether the EP 
contributed the particular information that was viewed, downloaded, or transmitted 
by the patient. However, the EP must have contributed at least some of the 
information identified in the Stage 2 final rule to the shared portal or online PHR for 
the patient. 
Date Updated: 1/2/2013 
New ID #7735 
6) To meet the third measure of the objective of providing “a summary of care record 
for each transition of care or referral" for the Medicare and Medicaid Electronic 
Health Record (EHR) Incentive Programs, must the electronic exchange with a 
recipient using technology designed by a different EHR developer occur for each 
provider or can there be one exchange per location? What if the provider chooses 
instead to exchange information with the CMS test EHR? 
 
If a summary of care record used for an actual transition of care or referral is 
electronically exchanged with a recipient who has EHR technology that was 
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developed designed by a different EHR technology developer than the sender's EHR 
technology, then that exchange can be considered to have met the third measure 
of the objective for all providers involved in that transition of care and referral using 
the same Certified EHR Technology. 
If the provider chooses instead to meet this third measure by exchanging with the 
CMS test EHR, we clarify that the use of test information about a fictional patient that 
would be identical in form to what would be sent about an actual patient (e.g., 
"dummy data") must be used for the purposes of conducting the test. Providers that 
use the same EHR technology and share a network for which their organization 
either has operational control of or license to use can conduct one test that covers 
all providers in the organization. For example, if a large group of EPs with multiple 
physical locations use the same EHR technology and those locations are connected 
using a network that the group has either operational control of or license to use, 
then a single test would cover all EPs in that group. Similarly, if a provider uses an EHR 
technology that is hosted (cloud-based) on the developer's network, then a single 
test would allow all EPs, eligible hospitals, and CAHs using the EHR technology that is 
hosted (cloud-based) on the developer's network to meet the measure. 
Date Updated: 1/2/2013 
New ID #7729 
III. Questions about changes to the Medicare EHR Incentive 
Program from Stage 2 
 
7) What are the payment adjustments for eligible professionals who are not 
participating in the Medicare EHR Incentive Program? Are there any hardship 
exceptions? 
 
As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress 
mandated payment adjustments to be applied to Medicare eligible professionals 
(EPs) who are not meaningful users of Certified Electronic Health Record (EHR) 
Technology under the Medicare EHR Incentive Programs. These payment 
adjustments will be applied beginning on January 1, 2015, for Medicare EPs. 
Medicaid EPs who can only participate in the Medicaid EHR Incentive Program and 
do not bill Medicare are not subject to these payment adjustments. 
EPs who can participate in either the Medicare or Medicaid EHR Incentive Programs 
will be subject to the payment adjustments unless they are meaningful users under 
one of the EHR Incentive Programs in the time periods specified below. 
Medicare EPs who are not meaningful users will be subject to a payment adjustment 
beginning on January 1, 2015. 
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8) What are the payment adjustments for eligible hospitals and critical access hospitals 
that are not participating in the Medicare EHR Incentive Program? Are there any 
hardship exceptions? 
 
As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress 
mandated payment adjustments to be applied to Medicare eligible hospitals, and 
critical access hospitals (CAHs) that are not meaningful users of Certified Electronic 
Health Record (EHR) Technology under the Medicare EHR Incentive Programs. These 
payment adjustments will be applied beginning on October 1, 2014, for Medicare 
eligible hospitals. Payment adjustments for CAHs will be applied beginning with the 
fiscal year 2015 cost reporting period. Medicaid eligible hospitals that can only 
participate in the Medicaid EHR Incentive Program and do not bill Medicare are not 
subject to these payment adjustments. 
Eligible hospitals and CAHs that can participate in either the Medicare or Medicaid 
EHR Incentive Programs will be subject to the payment adjustments unless they are 
meaningful users under one of the EHR Incentive Programs in the time periods 
specified below. 
Medicare Subsection (d) eligible hospitals that are not meaningful users will be 
subject to a payment adjustment beginning on October 1, 2014. Critical Access 
Hospitals (CAHs) that are not meaningful users will be subject to a payment 
adjustment for fiscal year 2015. 
For additional information on payment adjustments and hardship exceptions for 
eligible hospitals and CAHs, please review the Payment Adjustments and Hardship 
Exceptions Tip Sheet for Eligible Hospitals and CAHs which will be available on our 
website. 
Date Updated: 8/23/2012 
New ID #7533 
IV. Questions about changes to the Medicaid EHR Incentive 
Program from Stage 2 
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9) The EHR Incentive Programs Stage 1 Rule stated that, in order for a Medicaid 
encounter to count towards the patient volume of an eligible provider, Medicaid had 
to either pay for all or part of the service, or pay all or part of the premium, 
deductible or coinsurance for that encounter. The Stage 2 Rule now states that the 
Medicaid encounter can be counted towards patient volume if the patient is  
enrolled in the state’s Medicaid program (either through the state’s fee-for- 
service programs or the state’s Medicaid managed care programs) at the time of 
service without the requirement of Medicaid payment liability. How will this 
change affect patient volume calculations for Medicaid eligible providers? 
 
Importantly, this change affecting the Medicaid patient volume calculation is 
applicable to all eligible providers, regardless of the stage of the Medicaid EHR 
Incentive Program they are participating in. Billable services provided by an eligible 
provider to a patient enrolled in Medicaid would count toward meeting the 
minimum Medicaid patient volume thresholds. Examples of Medicaid encounters 
under this expanded definition that could be newly eligible might include: 
behavioral health services, HIV/AIDS treatment, or other services that might not be 
billed to Medicaid/managed care for privacy reasons, but where the provider has a 
mechanism to verify eligibility. Also, services to a Medicaid-enrolled patient that 
might not have been reimbursed by Medicaid (or a Medicaid managed care 
organization) may now be included in the Medicaid patient volume calculation 
(e.g., oral health services, immunization, vaccination and women’s health services, , 
telemedicine/telehealth, etc.). 
Providers who are not currently enrolled with their state Medicaid agency who might 
be newly eligible for the incentive payments due to these changes should note that 
they are not necessarily required to fully enroll with Medicaid in order to receive the 
payment. 
In some instances, it may now be appropriate to include services denied by 
Medicaid in calculating patient volume. It will be appropriate to review denial 
reasons. If Medicaid denied the service for timely filing or because another payer’s 
payment exceeded the potential Medicaid payment, it would be appropriate to 
include that encounter in the calculation. If Medicaid denied payment for the 
service because the beneficiary has exceeded service limits established by the 
Medicaid program, it would be appropriate to include that encounter in the 
calculation. If Medicaid denied the service because the patient was ineligible for 
Medicaid at the time of service, it would not be appropriate to include that 
encounter in the calculation. 
Further guidance regarding this change will be distributed to the states as 
appropriate. 
Date Updated: 8/23/2012 
New ID #7535 
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States that have offered CHIP as part of a Medicaid expansion under Title 19 or Title 
21 can include those patients in their provider’s Medicaid patient volume  
calculation as there is cost liability to the Medicaid program in either case (under the 
Stage 1 Rule, only CHIP programs created under a Medicaid expansion via Title 19 
were eligible). Patients in standalone CHIP programs established under Title 21 are 
not to be considered part of the patient volume total (in Stage 1 or Stage 2). This 
change to the patient volume calculation is applicable to all eligible providers, 
regardless of the stage of the Medicaid EHR Incentive Program they are 
participating in. 
 
Date Updated: 8/23/2012 
New ID #7537 
 
11) Are there any changes in the EHR Incentive Programs Stage 2 Rule to the base year 
for the Medicaid hospital incentive payment calculation? 
 
Yes. Previously Medicaid eligible hospitals calculated the base year using a 12 
month period ending in the Federal fiscal year before the hospital's fiscal year that 
serves as the first payment year. In an effort to encourage timely participation in the 
program, §495.310(g)(1)(i)(B) of the Stage 2 Rule was amended to allow hospitals to 
use the most recent continuous 12 month period for which data are available prior 
to the payment year. This change went into effect upon publication of the Stage 2 
Rule. Only hospitals that begin participation in the program after the publication 
date of the Stage 2 Rule (i.e., program years 2013 and later) will be affected by this 
change. Hospitals that began participation in the program prior to the Stage 2 Rule 
will not have to adjust previous calculations. 
 
Date Updated: 8/23/2012 
New ID #7539 
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2014 eCQM Resources 
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2014 Clinical Quality Measures 
(CQMS) & eCQM Resources 
 
Web Pages 
 
Name Description 
Stage 2 EHR Incentive 
Program 
This page provides information about Stage 2 of meaningful use, including 
a wide range of resources, tipsheets, reporting requirements, and an 
overview of the program timeline. 
Clinical Quality Measures This page provides information about CQMs including how they are 
derived, the purposes they serve, reporting requirements for the EHR 
Incentive Programs, and how to access the electronic specifications 
(eCQMs) for electronic reporting through Certified EHR Technology. 
Clinical Quality Measures 
through 2013 
This page provides information about how the program will work and 
what the requirements are for reporting CQMs through 2013. 
2014 Clinical Quality 
Measures 
This page provides information and resources about the CQMs finalized in 
the Stage 2 rule which will be in effect beginning in 2014 for all 
practitioners regardless of what stage of meaningful use they are in. It 
also provides the finalized CQMs, reporting requirements, and access to 
the eCQMs. 
Recommended Core Set This page provides information about the adult and pediatric 
recommended core sets finalized in Stage 2 of meaningful use for 2014. 
Electronic Specifications 
(eCQMs) 
This page provides information about electronic specifications, the 
various formats of the eSpecification files, technical release notes, 
guidance for understanding eCQMs, and access to the electronic 
specifications and value sets. 
Value Set Authority Center 
(VSAC) 
This page is supported by the National Library of Medicine and contains 
the value sets for each of the 64 eCQMs for eligible professional for 2014 
and the 29 eCQMs for eligible hospitals for 2014. A free license is 
required to access the value sets. 
 
 
 
 
October 2012 
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2014 Clinical Quality Measures 
(CQMS) & eCQM Resources 
 
 
Publications 
Name Description 
2014 Clinical Quality 
Measures Tip Sheet 
This document provides an overview of the 2014 CQMs for use in the EHR 
Incentive Programs, including reporting requirements, reporting time 
period, submission options, and background on the measure selection 
process. 
2014 CQMs for Eligible 
Professionals 
This table contains the description and definition statements for the 64 
CQMs for use by eligible professionals in the EHR Incentive Programs 
beginning in 2014. 
2014 CQMs for Eligible 
Hospitals 
This table contains the description and definition statements for the 64 
CQMs for use by eligible hospitals and CAHs in the EHR Incentive 
Programs beginning in 2014. 
Adult Recommended Core 
Set 
This table contains the 9 CQMs in the recommended core set for the adult 
population. 
Pediatric Recommended 
Core Set 
This table contains the 9 CQMs in the recommended core set for the 
pediatric population. 
EP Technical Release Notes This document contains information about changes made to 2011 CQMs 
for the measures that were kept as part of the 2014 CQMs. 
EH Technical Release Notes This document contains information about changes made to 2011 CQMs 
for the measures that were kept as part of the 2014 CQMs. 
eSpecifications for 2014 
eCQMs for Eligible 
Professionals 
This .zip file contains the electronic specifications in a machine readable 
(xml) and human readable (html) format for the 2014 eCQMs for eligible 
professionals.  To obtain the related value sets please visit the VSAC. 
eSpecifications Navigator 
2014 eCQMs for Eligible 
Hospitals 
The eSpec Navigator provides access to the electronic specifications in a 
machine readable (xml) and human readable (html) format for the 2014 
eCQMs for eligible hospitals. To obtain the related value sets please visit 
the VSAC. 
Guide to Reading EP and 
Hospital eCQMs 
This document contains helpful information about understanding and 
implementing eCQMs for the EHR Incentive Program. 
October 2012 
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Stage 2 
  
      
  
Date issued: October, 2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Eligible Professional Core Objectives 
 
(1) 
Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders 
directly entered by any licensed healthcare professional who can enter orders into the medical 
 record per state, local and professional guidelines. 
(2) Generate and transmit permissible prescriptions electronically (eRx). 
(3) Record the following demographics: preferred language, sex, race, ethnicity, date of birth. 
 
(4) 
Record and chart changes in the following vital signs: height/length and weight (no age limit); 
blood pressure (ages 3 and over); calculate and display body mass index (BMI); and plot and 
 display growth charts for patients 0-20 years, including BMI. 
(5) Record smoking status for patients 13 years old or older. 
(6) Use clinical decision support to improve performance on high-priority health conditions. 
(7) 
Provide patients the ability to view online, download and transmit their health information 
within four business days of the information being available to the EP. 
(8) Provide clinical summaries for patients for each office visit. 
(9) 
Protect electronic health information created or maintained by the Certified EHR Technology 
through the implementation of appropriate technical capabilities. 
(10) Incorporate clinical lab-test results into Certified EHR Technology as structured data. 
(11) 
Generate lists of patients by specific conditions to use for quality improvement, reduction of 
disparities, research, or outreach. 
(12) 
Use clinically relevant information to identify patients who should receive reminders for 
preventive/follow-up care and send these patients the reminders, per patient preference. 
(13) 
Use clinically relevant information from Certified EHR Technology to identify patient-specific 
education resources and provide those resources to the patient. 
(14) 
The EP who receives a patient from another setting of care or provider of care or believes an 
encounter is relevant should perform medication reconciliation. 
 
(15) 
The EP who transitions their patient to another setting of care or provider of care or refers their 
patient to another provider of care should provide a summary care record for each transition of 
care or referral. 
(16) 
Capability to submit electronic data to immunization registries or immunization information 
systems except where prohibited, and in accordance with applicable law and practice. 
(17) Use secure electronic messaging to communicate with patients on relevant health information. 
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View or download all of the EP Stage 2 Core and Menu Objectives for Stage 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Eligible Professional Menu Objectives 
(1) 
 
(2) 
Capability to submit electronic syndromic surveillance data to public health agencies except 
where prohibited, and in accordance with applicable law and practice. 
Record electronic notes in patient records. 
(3) 
 
(4) 
Imaging results consisting of the image itself and any explanation or other accompanying 
information are accessible through CEHRT. 
Record patient family health history as structured data. 
(5) 
Capability to identify and report cancer cases to a public health central cancer registry, except 
where prohibited, and in accordance with applicable law and practice. 
(6) 
Capability to identify and report specific cases to a specialized registry (other than a cancer 
registry), except where prohibited, and in accordance with applicable law and practice. 
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Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure 
Use CPOE for medication 
orders directly entered 
by any licensed 
healthcare professional 
who can enter orders 
into the medical record 
per state, local and 
professional guidelines 
More than 30% of unique 
patients with at least one 
medication in their 
medication list seen by 
the EP have at least one 
medication order 
entered using CPOE 
Use computerized 
provider order entry 
(CPOE) for medication, 
laboratory and radiology 
orders directly entered by 
any licensed healthcare 
professional who can 
enter orders into the 
medical record per state, 
local and professional 
guidelines 
More than 60% of 
medication, 30% of 
laboratory, and 30% of 
radiology orders created by 
the EP during the EHR 
reporting period are recorded 
using CPOE 
Implement drug-drug 
and drug-allergy 
interaction checks 
The EP has enabled 
this functionality for 
the entire EHR 
reporting period 
No longer a separate 
objective for Stage 2 
This measure is incorporated 
into the Stage 2 Clinical 
Decision Support measure 
Generate and transmit 
permissible 
prescriptions 
electronically (eRx) 
More than 40% of all 
permissible 
prescriptions written 
by the EP are 
transmitted 
electronically using 
certified EHR 
technology 
Generate and transmit 
permissible prescriptions 
electronically (eRx) 
More than 50% of all 
permissible prescriptions 
written by the EP are 
compared to at least one 
drug formulary and 
transmitted electronically 
using Certified EHR 
Technology 
Record demographics 
 Preferred language 
 Gender 
 Race 
 Ethnicity 
 Date of birth 
More than 50% of all 
unique patients seen by 
the EP have 
demographics recorded 
as structured data 
Record the following 
demographics 
 Preferred 
language 
 Gender 
 Race 
 Ethnicity 
 Date of birth 
More than 80% of all unique 
patients seen by the EP have 
demographics recorded as 
structured data 
Maintain an up-to-date 
problem list of current 
More than 80% of all 
unique patients seen 
No longer a separate 
objective for Stage 2 
This measure is incorporated 
into the Stage 
Stage 1 vs. Stage 2 Comparison 
Table for Eligible Professionals 
CORE OBJECTIVES (17 total) 
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and active diagnoses by the EP have at least 
one entry or an 
indication that no 
problems are known 
for the patient 
recorded as structured 
data 
 2 measure of Summary of 
Care Document at 
Transitions of Care and 
Referrals 
Maintain 
active 
medication list 
More than 80% of all 
unique patients seen 
by the EP have at least 
one entry (or an 
indication that the 
patient is not currently 
prescribed any 
medication) recorded 
as structured data 
No longer a separate 
objective for Stage 2 
This measure is 
incorporated into the Stage 
2 measure of Summary of 
Care Document at 
Transitions of Care and 
Referrals 
Maintain active 
medication allergy list 
More than 80% of all 
unique patients seen 
by the EP have at least 
one entry (or an 
indication that the 
patient has no known 
medication allergies) 
recorded as structured 
data 
No longer a separate 
objective for Stage 2 
This measure is 
incorporated into the Stage 
2 measure of Summary of 
Care Document at 
Transitions of Care and 
Referrals 
Record and chart 
changes in vital signs: 
 Height 
 Weight 
 Blood pressure 
 Calculate 
and display 
BMI 
 Plot and display 
growth charts for 
children 2-20 years, 
including BMI 
For more than 50% of 
all unique patients age 
2 and over seen by the 
EP, blood pressure, 
height and weight are 
recorded as structured 
data 
Record and chart 
changes in vital signs: 
 Height 
 Weight 
 Blood pressure (age 
3 and over) 
 Calculate and display 
BMI 
 Plot and display 
growth charts for 
patients 0-20 years, 
including BMI 
More than 80% of all unique 
patients seen by the EP have 
blood pressure (for patients 
age 3 and over only) and 
height and weight (for all 
ages) recorded as structured 
data 
Record smoking status More than 50% of all Record smoking status More than 80% of all unique 
for patients 13 years old unique patients 13 for patients 13 years old patients 13 years old or 
or older years old or older seen or older older seen by the EP have 
by the EP have smoking status recorded as 
smoking status structured data 
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 recorded as structured 
data 
  
Implement one clinical 
decision support rule 
relevant to specialty or 
high clinical priority along 
with the ability to track 
compliance that rule 
Implement one clinical 
decision support rule 
Use clinical decision 
support to improve 
performance on high- 
priority health conditions 
1. Implement 5 clinical 
decision support 
interventions related to 4 
or more clinical  quality 
measures, if applicable, at 
a relevant point in patient 
care for the entire EHR 
reporting period. 
2. The EP, eligible hospital, or 
CAH has enabled the 
functionality for drug- 
drug and drug-allergy 
interaction checks for the 
entire EHR reporting 
period 
Report clinical quality 
measures (CQMs) to 
CMS or the States 
Provide aggregate 
numerator, 
denominator, and 
exclusions through 
attestation or through 
the PQRS Electronic 
Reporting Pilot 
No longer a separate 
objective for Stage 2, but 
providers must still 
submit CQMs to CMS or 
the States in order to 
achieve meaningful use 
Starting in 2014, all CQMs 
will be submitted 
electronically to CMS 
Provide patients with an 
electronic copy of their 
health information 
(including diagnostic test 
results, problem list, 
medication lists, 
medication allergies), 
upon request 
More than 50% of all 
patients of the EP who 
request an electronic 
copy of their health 
information are 
provided it within 3 
business days 
Provide patients the ability 
to view online, download 
and transmit their health 
information within four 
business days of the 
information being available 
to the EP 
i. More than 50% of all 
unique patients seen by 
the EP during the EHR 
reporting period are 
provided timely (available 
to the patient within 4 
business days after the 
information is available to 
the EP) online access to 
their health information 
ii. More than 5% of all 
unique patients seen by 
the EP during the EHR 
reporting period (or their 
authorized 
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   representatives) 
view, download, or 
transmit to a third 
party their health 
information 
Provide clinical 
summaries for 
patients for each 
office visit 
Clinical summaries 
provided to patients 
for more than 50% of 
all office visits within 
3 business days 
Provide clinical 
summaries for 
patients for each 
office visit 
Clinical summaries 
provided to patients within 
one business day for more 
than 50% of office visits 
Capability to exchange Performed at least one This objective is This measure is eliminated 
key clinical information test of certified EHR eliminated from Stage 1 from Stage 1 in 2013 and is 
(for example, problem technology's capacity in 2013 and is no longer no longer a measure for 
list, medication list, to electronically an objective for Stage 2 Stage 2 
medication allergies, exchange key clinical 
diagnostic test results), information 
among providers of 
care and patient 
authorized entities 
electronically 
Protect electronic Conduct or review a Protect electronic health Conduct or review a 
health information security risk analysis information created or security risk analysis in 
created or maintained per 45 CFR 164.308 maintained by the accordance with the 
by the certified EHR (a)(1) and implement Certified EHR Technology requirements under 45 CFR 
technology through the security updates as through the 164.308 (a)(1), including 
implementation of necessary and correct implementation of addressing the 
appropriate technical identified security appropriate technical encryption/security of data 
capabilities deficiencies as part of capabilities. at rest and implement 
its risk management security updates as 
process necessary and correct 
identified security 
deficiencies as part of its 
risk management process 
Implement drug- The EP has enabled No longer a separate This measure is 
formulary checks this functionality and objective for Stage 2 incorporated into the e- 
has access to at least Prescribing measure for 
one internal or Stage 2 
external drug 
formulary for the 
entire EHR reporting 
period 
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Incorporate clinical lab- More than 40% of all Incorporate clinical lab- More than 55% of all clinical 
test results into certified clinical lab tests results test results into Certified lab tests results ordered by 
EHR technology as ordered by the EP EHR Technology as the EP during the EHR 
structured data during the EHR structured data reporting period whose 
reporting period results are either in a 
whose results are positive/negative or 
either in a numerical format are 
positive/negative or incorporated in Certified 
numerical format are EHR Technology as 
incorporated in structured data 
certified EHR 
technology as 
structured data 
Generate lists of Generate at least one Generate lists of patients Generate at least one 
patients by specific report listing patients by specific conditions to report listing patients of the 
conditions to use for of the EP with a use for quality EP with a specific condition 
quality improvement, specific condition improvement, reduction 
reduction of disparities, of disparities, research, 
research or outreach or outreach 
Send reminders to More than 20% of all Use clinically relevant Use EHR to identify and 
patients per patient unique patients 65 information to identify provide reminders for 
preference for years or older or 5 patients who should preventive/follow-up care 
preventive/ follow up years old or younger receive reminders for for more than 10% of 
care were sent an preventive/follow-up patients with two or more 
appropriate reminder care office visits in the last 2 
during the EHR years 
reporting period 
Provide patients with More than 10% of all This objective is This measure is eliminated 
timely electronic access unique patients seen eliminated from Stage 1 from Stage 1 in 2014 and is 
to their health by the EP are provided in 2014 and is no longer no longer a measure for 
information (including timely (available to the an objective for Stage 2 Stage 2 
lab results, problem list, patient within four 
medication lists, business days of being 
medication allergies) updated in the 
within four business certified EHR 
days of the information technology) electronic 
being available to the EP access to their health 
information subject to 
the EP’s discretion to 
withhold certain 
information 
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Use certified EHR 
technology to identify 
patient-specific 
education resources and 
provide those resources 
to the patient if 
appropriate 
More than 10% of all 
unique patients seen 
by the EP are provided 
patient-specific 
education resources 
Use certified EHR 
technology to identify 
patient-specific 
education resources and 
provide those resources 
to the patient if 
appropriate 
Patient-specific education 
resources identified by 
CEHRT are provided to 
patients for more than 10% 
of all unique patients with 
office visits seen by the EP 
during the EHR reporting 
period 
The EP who receives a 
patient from another 
setting of care or 
provider of care or 
believes an encounter is 
relevant should perform 
medication 
reconciliation 
The EP performs 
medication 
reconciliation for more 
than 50% of transitions 
of care in which the 
patient is transitioned 
into the care of the EP 
The EP who receives a 
patient from another 
setting of care or 
provider of care or 
believes an encounter is 
relevant should perform 
medication reconciliation 
The EP performs medication 
reconciliation for more than 
50% of transitions of care in 
which the patient is 
transitioned into the care of 
the EP 
The EP who transitions 
their patient to another 
setting of care or 
provider of care or 
refers their patient to 
another provider of care 
should provide 
summary of care record 
for each transition of 
care or referral 
The EP who transitions 
or refers their patient 
to another setting of 
care or provider of 
care provides a 
summary of care 
record for more than 
50% of transitions of 
care and referrals 
The EP who transitions 
their patient to another 
setting of care or 
provider of care or refers 
their patient to another 
provider of care should 
provide summary of care 
record for each 
transition of care or 
referral 
1. The EP who transitions 
or refers their patient to 
another setting of care 
or provider of care 
provides a summary of 
care record for more 
than 50% of transitions 
of care and referrals 
2. The EP who transitions 
or refers their patient to 
another setting of care 
or provider of care 
provides a summary of 
care record either a) 
electronically 
transmitted to a 
recipient using CEHRT 
or b) where the 
recipient receives the 
summary of care record 
via exchange facilitated 
by an organization that 
is a NwHIN Exchange 
participant or is 
validated through an 
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   ONC‑established 
governance mechanism 
to facilitate exchange for 
10% of transitions and 
referrals 
3.    The EP who transitions or 
refers their patient to 
another setting of care or 
provider of care must 
either a) conduct one or 
more successful electronic 
exchanges of a summary 
of care record with a 
recipient using technology 
that was designed by a 
different EHR developer 
than the sender's, or b) 
conduct one or more 
successful tests with the 
CMS-designated test EHR 
during the EHR reporting 
period 
Capability to submit 
electronic data to 
immunization registries 
or Immunization 
Information Systems and 
actual submission except 
where prohibited and in 
accordance with 
applicable law and 
practice 
Performed at least one 
test of certified EHR 
technology's capacity to 
submit electronic data to 
immunization registries 
and follow up 
submission if the test is 
successful (unless none 
of the immunization 
registries to which the EP 
submits such 
information have the 
capacity to receive the 
information 
electronically) 
Capability to submit 
electronic data to 
immunization registries or 
Immunization Information 
Systems and actual 
submission except where 
prohibited and in 
accordance with applicable 
law and practice 
Successful ongoing submission 
of electronic immunization 
data from Certified EHR 
Technology to an 
immunization registry or 
immunization information 
system for the entire EHR 
reporting period 
NEW NEW Use secure electronic 
messaging to 
A secure message was sent 
using the electronic 
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  communicate with 
patients on relevant 
health information 
messaging function of 
Certified EHR Technology by 
more than 5% of unique 
patients seen during the 
EHR reporting period 
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MENU OBJECTIVES (EPs must select 3 of 6 menu objectives) 
 
 
 
 
 
 
 
 
 
  
Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure 
Capability to submit 
electronic syndromic 
surveillance data to public 
health agencies and actual 
submission except where 
prohibited and in 
accordance with applicable 
law and practice 
Performed at least one 
test of certified EHR 
technology's capacity to 
provide electronic 
syndromic surveillance 
data to public health 
agencies and follow-up 
submission if the test is 
successful (unless none 
of the public health 
agencies to which an EP, 
eligible hospital or CAH 
submits such 
information have the 
capacity to receive the 
information 
electronically) 
Capability to submit 
electronic syndromic 
surveillance data to public 
health agencies and actual 
submission except where 
prohibited and in 
accordance with applicable 
law and practice 
Successful ongoing submission of 
electronic syndromic surveillance 
data from Certified EHR 
Technology to a public health 
agency for the entire EHR 
reporting period 
NEW NEW Record electronic notes in 
patient records 
Enter at least one electronic 
progress note created, edited 
and signed by an EP for more 
than 30% of unique patients 
NEW NEW Imaging results 
consisting of the image 
itself and any 
explanation or other 
accompanying 
information are 
accessible through 
CEHRT 
More than 10% of all scans and 
tests whose result is an image 
ordered by the EP for patients 
seen during the EHR reporting 
period are incorporated into or 
accessible through Certified EHR 
Technology 
NEW NEW Record patient family 
health history as 
structured data 
More than 20% of all unique 
patients seen by the EP during 
the EHR reporting period have a 
structured data entry for one or 
more first-degree relatives or an 
indication that family health 
history has been 
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   reviewed 
NEW NEW Capability to identify and 
report cancer cases to a 
State cancer registry, 
except where prohibited, 
and in accordance with 
applicable law and 
practice 
Successful ongoing submission 
of cancer case information 
from Certified EHR Technology 
to a cancer registry for the 
entire  EHR reporting period 
NEW NEW Capability to identify and 
report specific cases to a 
specialized registry 
(other than a cancer 
registry), except where 
prohibited, and in 
accordance with 
applicable law and 
practice 
Successful ongoing submission 
of specific case information 
from Certified EHR Technology 
to a specialized registry for the 
entire EHR reporting period 
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% ADJUSTMENT ASSUMING LESS THAN 75 PERCENT OF EPs ARE MEANINGFUL USERS 
 
 
 
 
 
 
Overview 
Payment Adjustments & Hardship 
Exceptions Tipsheet for Eligible 
Professionals 
Last Updated: August, 2012 
 
As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress mandated payment 
adjustments to be applied to Medicare eligible professionals (EPs) who are not meaningful users of 
Certified Electronic Health Record (EHR) Technology under the Medicare EHR Incentive Programs. These 
payment adjustments will be applied beginning on January 1, 2015, for Medicare EPs. Medicaid EPs who 
can only participate in the Medicaid EHR Incentive Program and do not bill Medicare are not subject to 
these payment adjustments. 
 
EPs who can participate in either the Medicare or Medicaid EHR Incentive Programs will be subject to 
the payment adjustments unless they are meaningful users under one of the EHR Incentive Programs in 
the time periods specified below. 
Payment Adjustments for Medicare EPs 
Medicare EPs who are not meaningful users will be subject to a payment adjustment beginning on 
January 1, 2015. 
 
This payment adjustment will be applied to the Medicare physician fee schedule (PFS) amount for 
covered professional services furnished by the EP during the year (including the fee schedule amount for 
purposes of determining a payment based on the fee schedule amount). The payment adjustment is 1% 
per year and is cumulative for every year that an EP is not a meaningful user. Depending on the total 
number of Medicare EPs who are meaningful users under the EHR Incentive Programs after 2018, the 
maximum cumulative payment adjustment can reach as high as 5%. The table below illustrates the 
potential application of payment adjustments to covered professional services for a Medicare EP who is 
not a meaningful user beginning in 2014. 
 
 
 
 
 
 
 
  
  
2015 
 
2016 
 
2017 
 
2018 
 
2019 
 
2020+ 
EP is not subject to the payment adjustment for the e 
Rx in 2014 
99% 98% 97% 96% 95% 95% 
EP is subject to the payment adjustment for the e Rx in 
2014 
 
98% 
 
98% 
 
97% 
 
96% 
 
95% 
 
95% 
90 
 
 
 
 
 
 
 
 
 
Because payment adjustments are mandated to begin on the first day of the 2015 calendar year, CMS 
will apply a prospective determination for payment adjustments. Therefore Medicare EPs must 
demonstrate meaningful use prior to the 2015 calendar year in order to avoid the adjustments. 
 
EPs who first demonstrated meaningful use in 2011 or 2012 must demonstrate meaningful use for a full 
year in 2013 to avoid payment adjustments in 2015. They must continue to demonstrate meaningful use 
every year to avoid payment adjustments in subsequent years. The table below illustrates the timeline  
to avoid payment adjustments for EPs who must demonstrate meaningful use for a full year in 2013. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
Full Year EHR Reporting Period 
 
2013 
 
2014 
 
2015 
 
2016 
 
2017 
 
2019 
 
EPs who first demonstrate meaningful use in 2013 must demonstrate meaningful use for a 90-day 
reporting period in 2013 to avoid payment adjustments in 2015. They must continue to demonstrate 
meaningful use every year to avoid payment adjustments in subsequent years. The table below 
illustrates the timeline to avoid payment adjustments for EPs who demonstrate meaningful use for a 90- 
day reporting period in 2013. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
90 day EHR Reporting Period 
 
2013 
     
 
Full Year EHR Reporting Period 
  
2014 
 
2015 
 
2016 
 
2017 
 
2019 
 
 
 
 
  
 
% ADJUSTMENT ASSUMING MORE THAN 75 PERCENT OF EPs ARE MEANINGFUL USERS 
  
2015 
 
2016 
 
2017 
 
2018 
 
2019 
 
2020+ 
EP is not subject to the payment adjustment for the e 
Rx in 2014 
99% 98% 97% 97% 97% 97% 
EP is subject to the payment adjustment for the e Rx in 
2014 
 
98% 
 
98% 
 
97% 
 
97% 
 
97% 
 
97% 
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EPs who first demonstrate meaningful use in 2014 must demonstrate meaningful use for a 90-day 
reporting period in 2014 to avoid payment adjustments in 2015. This reporting period must occur in the 
first 9 months of calendar year 2014, and EPs must attest to meaningful use no later than October 1, 
2014, in order to avoid the payment adjustments. EPs must continue to demonstrate meaningful use 
every year to avoid payment adjustments in subsequent years. The table below illustrates the timeline 
to avoid payment adjustments for EPs who first demonstrate meaningful use in 2014. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
90 day EHR Reporting Period 
 
2014* 
 
2014 
    
 
Full Year EHR Reporting Period 
   
2015 
 
2016 
 
2017 
 
2019 
*EPs must attest to meaningful use no later than October 1, 2014. 
 
Hardship Exceptions for Medicare EPs 
EPs may apply for hardship exceptions to avoid the payment adjustments described above. Hardship 
exceptions will be granted only under specific circumstances and only if CMS determines that providers 
have demonstrated that those circumstances pose a significant barrier to their achieving meaningful 
use. Information on how to apply for a hardship exception will be posted on the CMS EHR Incentive 
Programs website (www.cms.gov/EHRIncentiveProgram) in the future. 
 
EPs can apply for hardship exceptions in the following categories: 
 Infrastructure — EPs must demonstrate that they are in an area without sufficient internet 
access or face insurmountable barriers to obtaining infrastructure (e.g., lack of broadband). 
  
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
90 day EHR Reporting Period 
 
2013 
     
 
Full Year EHR Reporting Period 
  
2014 
 
2015 
 
2016 
 
2017 
 
2019 
 
 
  i   i l  i     i l    
i  i  i    i    i  i  i  i    i  
i     l         i l   l    
 i    i      i    i l 
   i        l    i  
i       i   i l  i   
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 New EPs — Newly practicing EPs who would not have had time to become meaningful 
users can apply for a 2-year limited exception to payment adjustments. Thus EPs who 
begin practice in calendar year 2015 would receive an exception to the penalties in 2015 
and 2016, but would have to begin demonstrating meaningful use in calendar year 2016 
to avoid payment adjustments in 2017. 
 Unforeseen Circumstances — Examples may include a natural disaster or other unforeseeable 
barrier. We also solicited comment on a fourth category of hardship exception as follows: 
 By Specialist/Provider Type — EPs must demonstrate that they meet all three of the following 
criteria: 
1. Lack of face-to-face or telemedicine interaction with patients 
2. Lack of follow-up need with patients 
3. Lack of control over the availability of Certified EHR Technology at their practice 
location. (EPs who practice at multiple locations may be granted a hardship exception 
solely for lack of control over the availability of Certified EHR Technology) 
 
Frequently Asked Questions 
Do I have to be a meaningful user each year to avoid the payment adjustments or can I avoid the 
payment adjustments by achieving meaningful use only once? 
You must demonstrate meaningful use every year according to the timelines detailed above in order to 
avoid Medicare payment adjustments. For example, an EP who demonstrates meaningful use for the 
first time in 2013 will avoid the payment adjustment in 2015, but will need to demonstrate meaningful 
use again in 2014 in order to avoid the payment adjustment in 2016. 
 
If I am an EP who is eligible for both the Medicare and Medicaid EHR Incentive Programs, but I register 
to participate in the Medicaid EHR Incentive Program, do I still have to be a meaningful user to avoid 
the payment adjustments? 
Yes. If you are eligible to participate in both the Medicare and Medicaid EHR Incentive Programs, you 
must demonstrate meaningful use according to the timelines detailed above to avoid the payment 
adjustments. You may demonstrate meaningful use under either Medicare or Medicaid. 
 
If I am an EP who is eligible for both the Medicare and Medicaid EHR Incentive Programs, will I avoid 
the payment adjustments during a calendar year when I receive an incentive payment for adopting, 
implementing, or upgrading my Certified EHR Technology? 
No. Congress mandated that an EP must be a meaningful user in order to avoid the payment 
adjustment; therefore receiving a Medicaid EHR incentive payment for adopting, implementing, or 
upgrading your Certified EHR Technology would not exempt you from the payment adjustments. You 
must demonstrate meaningful use according to the timelines detailed above to avoid the payment 
adjustments. You may demonstrate meaningful use under either Medicare or Medicaid. 
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If I am a hospital-based Medicare EP, am I subject to the payment adjustments? 
No. If you perform 90% or more of your covered professional services in either the inpatient (Place of 
Service 21) or emergency department (Place of Service 23) of a hospital, then you will be determined to 
be hospital-based and are not eligible to receive an EHR incentive and will not be subject to the payment 
adjustments. 
 
However, your hospital-based status can change from year to year. For example, an EP who is 
determined to be hospital-based for the 2015 program year would not be subject to the payment 
adjustments in 2017. But if that EP is determined not to be hospital-based for the 2016 and the 2017 
program year, then he or she could be subject to the payment adjustments in 2018 if the EP does not 
demonstrate meaningful use. Therefore it is important to check your hospital-based status at the 
beginning of each year. You can check your hospital-based status by visiting the Medicare EHR Incentive 
Programs Registration System (https://ehrincentives.cms.gov/). 
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ADDITIONAL INFORMATION REGARDING EP CLINICAL QUALITY MEASURES FOR 2014 EHR INCENTIVE PROGRAMS 
 
The table below entitled “Clinical Quality Measures for 2014 CMS EHR Incentive Programs for Eligible Professionals” contains additional up- 
to-date information for the EP clinical quality measures finalized in the Medicare and Medicaid Programs; Electronic Health Record Incentive 
Program; Final Rule. Because measure specifications may need to be updated more frequently than our expected rulemaking cycle will allow for, this 
table provides updates to the specifications. Subsequent updates will be provided in a new version of this table at least 6 months prior to the 
beginning of the calendar year for which the measure will be required, and CMS will maintain and publish an archive of each update. 
 
Please note the titles and descriptions for the clinical quality measures included in this table were updated by the measure stewards and therefore 
may not match the information provided on the NQF website. Measures that do not have an NQF number are measures that are not currently 
endorsed. 
 
 
 
 
 
 
 
 
 
Last updated October 2012 
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CLINICAL QUALITY MEASURES FOR 2014 CMS EHR INCENTIVE PROGRAMS FOR ELIGIBLE PROFESSIONALS 
 
CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward 
 
Link to NQF website 
CMS146v1 0002 Appropriate Percentage of children 2- Children with a group A Children age 2-18 National http://www.qualityforu 
  Testing for 18 years of age who streptococcus test in the 7- years who had an Committee for m.org/MeasureDetails. 
  Children with were diagnosed with day period from 3 days outpatient or Quality Assurance aspx?actid=0&Submis 
  Pharyngitis pharyngitis, ordered an prior through 3 days after emergency department  sionId=370 
   antibiotic and received a the diagnosis of pharyngitis (ED) visit with a   
   group A streptococcus  diagnosis of pharyngitis   
   (strep) test for the  during the   
   episode.  measurement period   
     and an antibiotic   
     ordered on or three   
     days after the visit   
CMS137v1 0004 Initiation and Percentage of patients Numerator 1: Patients who Patients age 13 years National http://www.qualityforu 
  Engagement of 13 years of age and older initiated treatment within 14 of age and older who Committee for m.org/MeasureDetails. 
  Alcohol and Other with a new episode of days of the diagnosis were diagnosed with a Quality Assurance aspx?actid=0&Submis 
Drug Dependence 
Treatment 
alcohol and other drug 
(AOD) dependence who 
received the following. 
Two rates are reported. 
a. Percentage of patients 
who initiated treatment 
within 14 days of the 
diagnosis. 
b. Percentage of patients 
who initiated treatment 
and who had two or more 
additional services with 
an AOD diagnosis within 
30 days of the initiation 
visit.
Numerator 2: Patients who 
initiated treatment and who 
had two or more additional 
services with an AOD 
diagnosis within 30 days of 
the initiation visit 
new episode of alcohol 
or drug dependency 
during a visit in the first 
11 months of the 
measurement period 
sionId=1245 
 
CMS165v1 0018 Controlling High Percentage of patients Patients whose most recent Patients 18-85 years of National http://www.qualityforu 
  Blood Pressure 18-85 years of age who blood pressure is age who had a Committee for m.org/MeasureDetails. 
   had a diagnosis of adequately controlled diagnosis of essential Quality Assurance aspx?actid=0&Submis 
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   hypertension and whose (systolic blood pressure < hypertension within the  sionId=1236#p=- 
   blood pressure was 140 mmHg and diastolic first six months of the  1&s=n&so=a 
   adequately controlled blood pressure < 90 measurement period or   
   (<140/90mmHg) during mmHg) during the any time prior to the   
   the measurement period. measurement period. measurement period   
 
 
 
 
 
 
 
 
 
 
 
 
 
CMS155v1 0024 Weight 
Assessment and 
Counseling for 
Nutrition and 
Physical Activity 
for Children and 
Adolescents 
  rates are reported. 
a. Percentage of patients 
who were ordered at 
least one high-risk 
medication. 
b. Percentage of patients 
who were ordered at 
least two different 
high-risk medications. 
Percentage of patients 3- 
17 years of age who had 
an outpatient visit with a 
Primary Care Physician 
(PCP) or Obstetrician/ 
Gynecologist (OB/GYN) 
and who had evidence of 
the following during the 
measurement period. 
Three rates are reported. 
Numerator 2: Patients 
with an order for at least 
two different high-risk 
medications during the 
measurement period. 
Numerator 1: Patients 
who had a height, weight 
and body mass index 
(BMI) percentile recorded 
during the measurement 
period 
Numerator 2: Patients who 
had counseling for nutrition 
during the measurement 
period 
 
 
 
 
 
 
 
 
 
 
Patients 3-17 years of 
age with at least one 
outpatient visit with a 
primary care physician 
(PCP) or an 
obstetrician/ 
gynecologist (OB/GYN) 
during the 
measurement period 
 
 
 
 
 
 
 
 
 
 
National Committee for 
Quality Assurance 
http://www.qualityforum.org/
MeasureDetails.aspx?actid=
0&amp;SubmissionId=1247
%23p%3D-
1&amp;s=n&amp;so=a
CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward 
 
Link to NQF website 
CMS156v1 0022 Use of High-Risk Percentage of patients Numerator 1: Patients with Patients 66 years and National http://www.qualityforu 
  Medications in the 66 years of age and older an order for at least one older who had a visit Committee for m.org/MeasureDetails. 
  Elderly who were ordered high- 
risk medications. Two  
high-risk medication during 
the measurement period. 
during the 
measurement period 
Quality Assurance aspx?actid=0&Submis 
sionId=273#p=- 
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 Percentage of patients  
 with height, weight, 
and body mass index 
(BMI) with percentile 
documentation 
 Percentage of patients 
with counseling for 
nutrition 
 Percentage of patients 
with counseling for 
physical activity 
Numerator 3: Patients 
who had counseling for 
physical activity during 
the measurement period 
 
 
 
99 
 
 
CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward 
 
Link to NQF website 
CMS138v1 0028 Preventive Care Percentage of patients Patients who were All patients aged 18 American Medical http://www.qualityforu 
  and Screening: aged 18 years and older screened for tobacco use at years and older Association- m.org/MeasureDetails. 
  Tobacco Use: who were screened for least once within 24 months  convened aspx?actid=0&Submis 
  Screening and tobacco use one or more AND who received tobacco  Physician sionId=391#p=- 
  Cessation times within 24 months cessation counseling  Consortium for 1&s=n&so=a 
  Intervention AND who received intervention if identified as a  Performance  
   cessation counseling tobacco user  Improvement®  
   intervention if identified   (AMA-PCPI)  
   as a tobacco user     
CMS125v1 0031 Breast Cancer Percentage of women Women with one or more Women 42-69 years of National http://www.qualityforu 
  Screening 40-69 years of age who mammograms during the age with a visit during Committee for m.org/MeasureDetails. 
   had a mammogram to measurement period or the the measurement Quality Assurance aspx?actid=0&Submis 
   screen for breast cancer. year prior to the period  sionId=392#p=- 
    measurement period   1&s=n&so=a 
CMS124v1 0032 Cervical Cancer Percentage of women Women with one or more Women 24–64 years of National http://www.qualityforu 
  Screening 21-64 years of age, who Pap tests during the age with a visit during Committee for m.org/MeasureDetails. 
   received one or more measurement period or the the measurement Quality Assurance aspx?actid=0&Submis 
   Pap tests to screen for two years prior to the period  sionId=393#p=- 
   cervical cancer. measurement period   1&s=n&so=a 
CMS153v1 0033 Chlamydia Percentage of women Women with at least one Women 16-24 years of National http://www.qualityforu 
  Screening for 16- 24 years of age who chlamydia test during the age who are sexually Committee for m.org/MeasureDetails. 
  Women were identified as measurement period active and who had a Quality Assurance aspx?actid=0&Submis 
   sexually active and who  visit in the  sionId=1253#p=- 
   had at least one test for  measurement period  1&s=n&so=a 
   chlamydia during the     
   measurement period.     
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CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward 
 
Link to NQF website 
CMS130v1 0034 Colorectal Cancer Percentage of adults 50- Patients with one or more Patients 51-75 years of National http://www.qualityforu 
  Screening 75 years of age who had screenings for colorectal age with a visit during Committee for m.org/MeasureDetails. 
   appropriate screening for cancer. Appropriate the measurement Quality Assurance aspx?actid=0&Submis 
   colorectal cancer. screenings are defined by period  sionId=394#p=- 
    any one of the following   1&s=n&so=a 
    criteria below:    
- Fecal occult blood test 
(FOBT) during the 
measurement period 
- Flexible sigmoidoscopy 
during the measurement 
period or the four years 
prior to the measurement 
period 
- Colonoscopy during the 
measurement period or 
the nine years prior to the 
measurement period 
 
CMS126v1 0036 Use of Percentage of patients 5- Patients who were Patients 5-64 years of National http://www.qualityforu 
  Appropriate 64 years of age who dispensed at least one age with persistent Committee for m.org/MeasureDetails. 
  Medications for were identified as having prescription for a preferred asthma and a visit Quality Assurance aspx?actid=0&Submis 
  Asthma persistent asthma and therapy during the during the  sionId=367#p=- 
   were appropriately measurement period measurement period  1&s=n&so=a 
   prescribed medication     
   during the measurement     
   period.     
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CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward 
 
Link to NQF website 
CMS117v1 0038 Childhood Percentage of children 2 Children who have Children who turn 2 National http://www.qualityforu 
  Immunization years of age who had evidence showing they years of age during the Committee for m.org/MeasureDetails. 
  Status four diphtheria, tetanus received recommended measurement period Quality Assurance aspx?actid=0&Submis 
   and acellular pertussis vaccines, had documented and who have a visit  sionId=395#p=- 
   (DTaP); three polio (IPV), history of the illness, had a during the  1&s=n&so=a 
   one measles, mumps seropositive test result, or measurement period   
   and rubella (MMR); three had an allergic reaction to    
   H influenza type B (HiB); the vaccine by their second    
   three hepatitis B (Hep B); birthday    
   one chicken pox (VZV);     
   four pneumococcal     
   conjugate (PCV); one     
   hepatitis A (Hep A); two     
   or three rotavirus (RV);     
   and two influenza (flu)     
   vaccines by their second     
   birthday.     
CMS147v1 0041 Preventive Care Percentage of patients Patients who received an All patients aged 6 American Medical http://www.qualityforu 
  and Screening: aged 6 months and older influenza immunization OR months and older and Association- m.org/MeasureDetails. 
  Influenza seen for a visit between who reported previous seen for a visit between convened aspx?actid=0&Submis 
  Immunization October 1 and March 31 receipt of an influenza October 1 and March Physician sionId=397#p=- 
   who received an immunization 31 Consortium for 1&s=n&so=a 
   influenza immunization   Performance  
   OR who reported   Improvement®  
   previous receipt of an   (AMA-PCPI)  
   influenza immunization     
CMS127v1 0043 Pneumonia Percentage of patients Patients who have ever Patients 65 years of National http://www.qualityforu 
  Vaccination 65 years of age and older received a pneumococcal age and older with a Committee for m.org/MeasureDetails. 
  Status for Older who have ever received vaccination visit during the Quality Assurance aspx?actid=0&Submis 
  Adults a pneumococcal vaccine.  measurement period  sionId=492#p=- 
       1&s=n&so=a 
CMS166v1 0052 Use of Imaging Percentage of patients Patients with an imaging Patients 18-50 years of National http://www.qualityforu 
  Studies for Low 18-50 years of age with a study conducted on the age with a diagnosis of Committee for m.org/MeasureDetails. 
  Back Pain diagnosis of low back date of the outpatient or low back pain during an Quality Assurance aspx?actid=0&Submis 
   pain who did not have an emergency department visit outpatient or  sionId=1220#p=- 
   imaging study (plain X- or in the 28 days following emergency department  1&s=n&so=a 
   ray, MRI, CT scan) within the outpatient or visit   
   28 days of the diagnosis. emergency department visit    
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CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward 
 
Link to NQF website 
CMS131v1 0055 Diabetes: Eye Percentage of patients Patients with an eye Patients 18-75 years of National http://www.qualityforu 
  Exam 18-75 years of age with screening for diabetic age with diabetes with Committee for m.org/MeasureDetails. 
   diabetes who had a retinal disease. This a visit during the Quality Assurance aspx?actid=0&Submis 
   retinal or dilated eye includes diabetics who had measurement period  sionId=1223#p=- 
   exam by an eye care one of the following:   1&s=n&so=a 
professional during the 
measurement period or a 
negative retinal exam (no 
evidence of retinopathy) 
in the 12 months prior to 
the measurement period 
A retinal or dilated eye 
exam by an eye care 
professional in the 
measurement period or a 
negative retinal exam (no 
 evidence of retinopathy) by 
an eye care professional in 
the year prior to the 
measurement period 
 
CMS123v1 0056 Diabetes: Foot Percentage of patients Patients who received a Patients 18-75 years of National http://www.qualityforu 
  Exam aged 18-75 years of age foot exam (visual inspection age with diabetes with Committee for m.org/MeasureDetails. 
   with diabetes who had a with either a sensory exam a visit during the Quality Assurance aspx?actid=0&Submis 
   foot exam during the or pulse exam) during the measurement period  sionId=1224#p=- 
   measurement period. measurement period   1&s=n&so=a 
CMS122v1 0059 Diabetes: Percentage of patients Patients whose most recent Patients 18-75 years of National http://www.qualityforu 
  Hemoglobin A1c 18-75 years of age with HbA1c level (performed age with diabetes with Committee for m.org/MeasureDetails. 
  Poor Control diabetes who had during the measurement a visit during the Quality Assurance aspx?actid=0&Submis 
   hemoglobin A1c > 9.0% period) is >9.0% measurement period  sionId=1225#k=0059& 
   during the measurement    e=1&st=&sd=&mt=&cs 
   period.    =&ss=&s=n&so=a&p= 
       1 
CMS148v1 0060 Hemoglobin A1c Percentage of patients 5- Patients with Patients 5 to17 years of National http://www.qualityforu 
  Test for Pediatric 17 years of age with documentation of date and age with a diagnosis of Committee for m.org/MeasureDetails. 
  Patients diabetes with an HbA1c result for a HbA1c test diabetes and a face-to- Quality Assurance aspx?actid=0&Submis 
   test during the during the measurement face visit for diabetes  sionId=851#k=0060&e 
   measurement period period care between the  =1&st=&sd=&mt=&cs= 
     physician and the  &ss=&s=n&so=a&p=1 
     patient that predates   
     the most recent visit by   
     at least 12 months   
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CMS134v1 0062 Diabetes: Urine The percentage of Patients with a screening Patients 18-75 years of National http://www.qualityforu 
  Protein Screening patients 18-75 years of for nephropathy or age with diabetes with Committee for m.org/MeasureDetails. 
   age with diabetes who evidence of nephropathy a visit during the Quality Assurance aspx?actid=0&Submis 
   had a nephropathy during the measurement measurement period  sionId=1226#k=0062& 
   screening test or period   e=1&st=&sd=&s=n&so 
   evidence of nephropathy    =a&p=1&mt=&cs=&ss 
   during the measurement    = 
   period.     
CMS163v1 0064 Diabetes: Low Percentage of patients Patients whose most recent Patients 18-75 years of National http://www.qualityforu 
  Density 18-75 years of age with LDL-C level performed age with diabetes with Committee for m.org/MeasureDetails. 
  Lipoprotein (LDL) diabetes whose LDL-C during the measurement a visit during the Quality Assurance aspx?actid=0&Submis 
  Management was adequately period is < 100 mg/dL measurement period  sionId=1228#k=0064& 
   controlled (<100 mg/dL)    e=1&st=&sd=&mt=&cs 
   during the measurement    =&ss=&s=n&so=a&p= 
   period.    1 
CMS164v1 0068 Ischemic Vascular Percentage of patients Patients who have Patients 18 years of National http://www.qualityforu 
  Disease (IVD): 18 years of age and older documentation of use of age and older with a Committee for m.org/MeasureDetails. 
  Use of Aspirin or 
Another 
who were discharged 
alive for acute myocardial 
aspirin or another 
antithrombotic during the 
visit during the 
measurement period, 
Quality Assurance aspx?actid=0&Submis 
sionId=1229#k=0068& 
  Antithrombotic infarction (AMI), coronary measurement period and an active diagnosis  e=1&st=&sd=&mt=&cs 
   artery bypass graft  of ischemic vascular  =&ss=&s=n&so=a&p= 
   (CABG) or percutaneous  disease (IVD) or who  1 
   coronary interventions  were discharged alive   
   (PCI) in the 12 months  for acute myocardial   
   prior to the measurement  infarction (AMI),   
   period, or who had an  coronary artery bypass   
   active diagnosis of  graft (CABG) or   
   ischemic vascular  percutaneous coronary   
   disease (IVD) during the  interventions (PCI) in   
   measurement period,  the 12 months prior to   
   and who had  the measurement   
   documentation of use of  period   
   aspirin or another     
   antithrombotic during the     
   measurement period.     
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CMS154v1 0069 Appropriate Percentage of children 3 Children without a Children age 3 months National http://www.qualityforu 
  Treatment for months-18 years of age prescription for antibiotic to 18 years who had an Committee for m.org/MeasureDetails. 
  Children with who were diagnosed with medication on or 3 days outpatient or Quality Assurance aspx?actid=0&Submis 
  Upper Respiratory upper respiratory after the outpatient or ED emergency department  sionId=369#k=0069&e 
  Infection (URI) infection (URI) and were visit for an upper respiratory (ED) visit with a  =1&st=&sd=&s=n&so= 
   not dispensed an infection diagnosis of upper  a&p=1&mt=&cs=&ss= 
   antibiotic prescription on  respiratory infection   
   or three days after the  (URI) during the   
   episode.  measurement period   
CMS145v1 0070 Coronary Artery Percentage of patients Patients who were All patients aged 18 American Medical http://www.qualityforu 
  Disease (CAD): aged 18 years and older prescribed beta blocker years and older with a Association- m.org/MeasureDetails. 
  Beta-Blocker with a diagnosis of therapy diagnosis of coronary convened aspx?actid=0&Submis 
  Therapy—Prior coronary artery disease  artery disease seen Physician sionId=377#k=0070&e 
  Myocardial seen within a 12 month  within a 12 month Consortium for =1&st=&sd=&mt=&cs= 
  Infarction (MI) or period who also have a  period who also have Performance &ss=&s=n&so=a&p=1 
  Left Ventricular prior MI or a current or  prior MI or a current or Improvement ®  
  Systolic prior LVEF <40% who  prior LVEF <40% (AMA-PCPI)  
  Dysfunction were prescribed beta-     
  (LVEF <40%) blocker therapy     
CMS182v1 0075 Ischemic Vascular Percentage of patients Numerator 1: Patients with Patients 18 years of National  
  Disease (IVD): 18 years of age and older a complete lipid profile age and older with a Committee Quality  
  Complete Lipid 
Panel and LDL 
who were discharged alive 
for acute myocardial 
performed during the 
measurement period 
visit during the 
measurement period, 
Assurance  
Control infarction (AMI), coronary 
artery bypass graft (CABG) 
or percutaneous coronary 
interventions (PCI) in the 12 
months prior to the 
measurement period, or 
who had an active diagnosis 
of ischemic vascular 
disease (IVD) during the 
measurement period, and 
who had a complete lipid 
profile performed during the 
measurement period and 
whose LDL-C was 
adequately controlled(< 100 
mg/dL). 
Numerator 2: Patients whose 
most recent LDL-C level 
performed during the 
measurement period is <100 
mg/dL 
and an active diagnosis of 
ischemic vascular disease 
(IVD) during the 
measurement period, or 
who were discharged alive 
for acute myocardial 
infarction (AMI), coronary 
artery bypass graft (CABG) 
or percutaneous coronary 
intervensions (PCI) in the 
12 months prior to the 
measurement period 
http://www.qualityforu
m.org/MeasureDetails.
aspx?actid=0&amp;Su
bmissionId=1232%23k
%3D0075&amp;e=1&a
mp;st&amp;sd&amp;m
t&amp;cs&amp;ss&am
p;s=n&amp;so=a&amp
;p=1 
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CMS135v1 0081 Heart Failure Percentage of patients Patients who were All patients aged 18 American Medical http://www.qualityforu 
  (HF): Angiotensin- aged 18 years and older prescribed ACE inhibitor or years and older with a Association- m.org/MeasureDetails. 
  Converting with a diagnosis of heart ARB therapy either within a diagnosis of heart convened aspx?actid=0&Submis 
  Enzyme (ACE) failure (HF) with a current 12 month period when seen failure with a current or Physician sionId=383#k=0081&e 
  Inhibitor or or prior left ventricular in the outpatient setting or prior LVEF < 40% Consortium for =1&s=n&so=a&p=1&st 
  Angiotensin ejection fraction (LVEF) < at hospital discharge  Performance =&sd=&mt=&cs=&ss= 
  Receptor Blocker 40% who were   Improvement ®  
  (ARB) Therapy for prescribed ACE inhibitor   (AMA-PCPI)  
  Left Ventricular or ARB therapy either     
  Systolic within a 12 month period     
  Dysfunction when seen in the     
  (LVSD) outpatient setting OR at     
   each hospital discharge     
CMS144v1 0083 Heart Failure Percentage of patients Patients who were All patients aged 18 American Medical http://www.qualityforu 
  (HF): Beta- aged 18 years and older prescribed beta-blocker years and older with a Association- m.org/MeasureDetails. 
  Blocker Therapy with a diagnosis of heart therapy either within a 12 diagnosis of heart convened aspx?actid=0&Submis 
  for Left Ventricular failure (HF) with a current month period when seen in failure with a current or Physician sionId=384#k=0083&e 
  Systolic or prior left ventricular the outpatient setting or at prior LVEF < 40% Consortium for =1&st=&sd=&mt=&cs= 
  Dysfunction ejection fraction (LVEF) < hospital discharge  Performance &ss=&s=n&so=a&p=1 
  (LVSD) 40% who were   Improvement ®  
   prescribed beta-blocker   (AMA-PCPI)  
   therapy either within a 12     
   month period when seen     
   in the outpatient setting     
   OR at each hospital     
   discharge     
CMS143v1 0086 Primary Open Percentage of patients Patients who have an optic All patients aged 18 American Medical http://www.qualityforu 
  Angle Glaucoma aged 18 years and older nerve head evaluation years and older with a Association- m.org/MeasureDetails. 
  (POAG): Optic with a diagnosis of during one or more office diagnosis of primary convened aspx?actid=0&Submis 
  Nerve Evaluation POAG who have an optic visits within 12 months open-angle glaucoma Physician sionId=436#k=0086&e 
   nerve head evaluation   Consortium for =1&st=&sd=&mt=&cs= 
   during one or more office   Performance &ss=&s=n&so=a&p=1 
   visits within 12 months   Improvement ®  
      (AMA-PCPI)  
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CMS167v1 0088 Diabetic Percentage of patients Patients who had a dilated All patients aged 18 American Medical http://www.qualityforu 
  Retinopathy: aged 18 years and older macular or fundus exam years and older with a Association- m.org/MeasureDetails. 
  Documentation of with a diagnosis of performed which included diagnosis of diabetic convened aspx?actid=0&Submis 
  Presence or diabetic retinopathy who documentation of the level retinopathy Physician sionId=438#k=0088&e 
  Absence of had a dilated macular or of severity of retinopathy  Consortium for =1&st=&sd=&mt=&cs= 
  Macular Edema fundus exam performed AND the presence or  Performance &ss=&s=n&so=a&p=1 
  and Level of which included absence of macular edema  Improvement ®  
  Severity of documentation of the during one or more office  (AMA-PCPI)  
  Retinopathy level of severity of visits within 12 months    
   retinopathy and the     
   presence or absence of     
   macular edema during     
   one or more office visits     
   within 12 months     
CMS142v1 0089 Diabetic Percentage of patients Patients with All patients aged 18 American Medical http://www.qualityforu 
  Retinopathy: aged 18 years and older documentation, at least years and older with a Association- m.org/MeasureDetails. 
  Communication with a diagnosis of once within 12 months, of diagnosis of diabetic convened aspx?actid=0&Submis 
  with the Physician diabetic retinopathy who the findings of the dilated retinopathy who had a Physician sionId=439#k=0089&e 
  Managing had a dilated macular or macular or fundus exam via dilated macular or Consortium for =1&st=&sd=&mt=&cs= 
  Ongoing Diabetes 
Care 
fundus exam performed 
with documented 
communication to the 
physician who manages the 
fundus exam 
performed 
Performance 
Improvement ® 
&ss=&s=n&so=a&p=1 
   communication to the patient’s diabetic care  (AMA-PCPI)  
   physician who manages     
   the ongoing care of the     
   patient with diabetes     
   mellitus regarding the     
   findings of the macular or     
   fundus exam at least     
   once within 12 months     
CMS139v1 0101 Falls: Screening Percentage of patients Patients who were Patients aged 65 years National http://www.qualityforu 
  for Future Fall 65 years of age and older screened for future fall risk and older with a visit Committee for m.org/MeasureDetails. 
  Risk who were screened for at least once within the during the Quality Assurance aspx?actid=0&Submis 
   future fall risk during the measurement period measurement period  sionId=445#k=0101&e 
   measurement period.    =1&st=&sd=&mt=&cs= 
       &ss=&s=n&so=a&p=1 
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CMS161v1 0104 Major Depressive Percentage of patients Patients who had suicide All patients aged 18 American Medical http://www.qualityforu 
  Disorder (MDD): aged 18 years and older risk assessment completed years and older with a Association- m.org/MeasureDetails. 
  Suicide Risk with a new diagnosis or at each visit new diagnosis or convened aspx?actid=0&Submis 
  Assessment recurrent episode of  recurrent episode of Physician sionId=1238#k=0104& 
   MDD who had a suicide  MDD Consortium for e=1&st=&sd=&mt=&cs 
   risk assessment   Performance =&ss=&s=n&so=a&p= 
   completed at each visit   Improvement ® 1 
   during the measurement   (AMA-PCPI)  
   period.     
CMS128v1 0105 Anti-depressant Percentage of patients Numerator 1: Patients who Patients 18 years of National http://www.qualityforu 
  Medication 18 years of age and older have received age and older with a Committee for m.org/MeasureDetails. 
  Management who were diagnosed with 
major depression and 
treated with 
antidepressant medication 
for at least 84 days (12 
weeks) of continuous 
diagnosis of major 
depression in the 180 
days (6 months) prior 
Quality Assurance aspx?actid=0&Submis 
sionId=855#k=0105&e 
=1&st=&sd=&mt=&cs= 
   antidepressant 
medication, and who 
remained on 
antidepressant 
treatment during the 114- 
day period following the 
Index Prescription Start 
Date 
to the measurement 
period or the first 180 
days (6 months) of the 
measurement period, 
 &ss=&s=n&so=a&p=1 
medication treatment. 
Two rates are reported. 
a. Percentage of patients 
who remained on an 
antidepressant 
medication for at least 
84 days (12 weeks). 
b. Percentage of patients 
who remained on an 
antidepressant 
medication for at least 
180 days (6 months). 
Numerator 2: Patients who 
have received 
antidepressant medications 
for at least 180 days (6 
months) of continuous 
treatment during the 231- 
day period following the 
Index Prescription Start 
Date 
who were treated with 
antidepressant 
medication, and with a 
visit during the 
measurement period 
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CMS136v1 0108 ADHD: Follow-Up Percentage of children 6- Numerator 1: Patients who Denominator 1: National http://www.qualityforu 
Care for Children 12 years of age and had at least one face-to- Children 6-12 years of Committee for m.org/MeasureDetails. 
Prescribed 
Attention- 
Deficit/Hyperactivi 
ty Disorder 
newly dispensed a 
medication for attention- 
deficit/ hyperactivity 
disorder (ADHD) who 
face visit with a practitioner 
with prescribing authority 
within 30 days after the 
IPSD 
age who were 
dispensed an ADHD 
medication during the 
Intake Period and who 
Quality Assurance aspx?actid=0&Submis 
sionId=857#k=0108&e 
=1&st=&sd=&mt=&cs= 
&ss=&s=n&so=a&p=1 
(ADHD) 
Medication 
had appropriate follow-up 
care. Two rates are 
reported. 
a. Percentage of children 
who had one follow-up 
visit with a practitioner 
with prescribing 
authority during the 
30-Day Initiation 
Phase. 
b. Percentage of children 
who remained on 
ADHD medication for 
at least 210 days and 
who, in addition to the 
visit in the Initiation 
Phase, had at least 
two additional follow- 
up visits with a 
practitioner within 270 
days (9 months) after 
the Initiation Phase 
ended. 
Numerator 2: Patients who 
had at least one face-to- 
face visit with a practitioner 
with prescribing authority 
during the Initiation Phase, 
and at least two follow-up 
visits during the 
Continuation and 
Maintenance Phase. One of 
the two visits during the 
Continuation and 
Maintenance Phase may be 
a telephone visit with a 
practitioner. 
had a visit during the 
measurement period 
Denominator 2: 
Children 6-12 years of 
age who were 
dispensed an ADHD 
medication during the 
Intake Period and who 
remained on the 
medication for at least 
210 days out of the 300 
days following the 
IPSD, and who had a 
visit during the 
measurement period. 
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CMS169v1 0110 Bipolar Disorder Percentage of patients Patients in the denominator Patients 18 years of Center for Quality http://www.qualityforu 
and Major with depression or with evidence of an age or older at the start Assessment & m.org/MeasureDetails. 
Depression: bipolar disorder with assessment for alcohol or of the measurement Improvement in aspx?actid=0&Submis 
Appraisal for evidence of an initial other substance use period with a new Mental Health sionId=1241#k=0110& 
alcohol or 
chemical 
assessment that includes 
an appraisal for alcohol 
following or concurrent with 
the new diagnosis, and 
diagnosis of unipolar 
depression or bipolar 
(CQAIMH) e=1&st=&sd=&mt=&cs 
=&ss=&s=n&so=a&p= 
substance use or chemical substance 
use. 
prior to or concurrent with 
the initiation of treatment for 
that diagnosis. 
 
(Note: the endorsed 
measure calls for the 
assessment to be 
performed prior to 
discussion of the treatment 
plan with the patient, but 
the current approach was 
considered more feasible in 
an EHR setting. The 
"Assessment for Alcohol or 
Other Drug Use" required in 
the numerator is meant to 
capture a provider's 
assessment of the patient's 
symptoms of substance 
use. The essence of the 
measure is to avoid treating 
the patient for unipolar 
depression or bipolar 
disorder without an 
assessment of their use of 
alcohol or other drugs.) 
disorder during the first 
323 days of the 
measurement period, 
and evidence of 
treatment for unipolar 
depression or bipolar 
depression within 42 
days of diagnosis. The 
existence of a 'new 
diagnosis' is 
established by the 
absence of diagnoses 
and treatments of 
unipolar depression or 
bipolar disorder during 
the 180 days prior to 
the diagnosis. 
 1 
 
The intent of the measure is 
that the appraisal be 
performed at each and 
every initial assessment. It 
is possible for there to be 
one or two initial 
assessments during the 
measurement period. Due 
to limitations in the current 
measurement frameworks, 
the numerator in the current 
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    measure definition can be    
    satisfied if the appraisal is    
    performed at ANY single    
    initial assessment. Future    
    versions, implemented with    
    ever improving    
    measurement logic    
    frameworks, should close    
    this loophole.    
CMS157v1 0384 Oncology: Percentage of patient Patient visits in which pain All patient visits, American Medical http://www.qualityforu 
  Medical and visits, regardless of intensity is quantified regardless of patient Association- m.org/MeasureDetails. 
  Radiation – Pain patient age, with a  age,  with a diagnosis convened aspx?actid=0&Submis 
  Intensity diagnosis of cancer  of cancer currently Physician sionId=621#k=0384&e 
  Quantified currently receiving  receiving Consortium for =1&st=&sd=&mt=&cs= 
   chemotherapy or  chemotherapy or Performance &ss=&s=n&so=a&p=1 
   radiation therapy in which  radiation therapy Improvement ®  
   pain intensity is   (AMA-PCPI)  
   quantified     
CMS141v1 0385 Colon Cancer: Percentage of patients Patients who are referred All patients aged 18 American Medical http://www.qualityforu 
  Chemotherapy for aged 18 through 80 for chemotherapy, through 80 years with Association- m.org/MeasureDetails. 
  AJCC Stage III years with AJCC Stage prescribed chemotherapy, AJCC Stage III colon convened aspx?actid=0&Submis 
  Colon Cancer III colon cancer who are or who have previously cancer Physician sionId=628#k=0385&e 
  Patients referred for adjuvant received adjuvant  Consortium for =1&st=&sd=&mt=&cs= 
   chemotherapy, chemotherapy within the  Performance &ss=&s=n&so=a&p=1 
   prescribed adjuvant 12- month reporting period  Improvement ®  
   chemotherapy, or have   (AMA-PCPI)  
   previously received     
   adjuvant chemotherapy     
   within the 12-month     
   reporting period     
CMS140v1 0387 Breast Cancer: Percentage of female Patients who were All female patients American Medical http://www.qualityforu 
  Hormonal patients aged 18 years prescribed tamoxifen or aged 18 years and Association- m.org/MeasureDetails. 
  Therapy for Stage and older with Stage IC aromatase inhibitor (AI) older with a diagnosis convened aspx?actid=0&Submis 
  IC-IIIC Estrogen through IIIC, ER or PR during the 12-month of stage IC through Physician sionId=631#k=0387&e 
  Receptor/ positive breast cancer reporting period IIIC, estrogen receptor Consortium for =1&st=&sd=&mt=&cs= 
  Progesterone who were prescribed  (ER) or progesterone Performance &ss=&s=n&so=a&p=1 
  Receptor (ER/PR) tamoxifen or aromatase  receptor (PR) positive Improvement ®  
  Positive Breast inhibitor (AI) during the  breast cancer (AMA-PCPI)  
  Cancer 12-month reporting period     
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CMS129v1 0389 Prostate Cancer: Percentage of patients, Patients who did not have a All patients, regardless American Medical http://www.qualityforu 
  Avoidance of regardless of age, with a bone scan performed at of age, with a diagnosis Association- m.org/MeasureDetails. 
  Overuse of Bone diagnosis of prostate any time since diagnosis of of prostate cancer at convened aspx?actid=0&Submis 
  Scan for Staging cancer at low risk of prostate cancer low risk of recurrence Physician sionId=624#k=0389&e 
  Low Risk Prostate recurrence receiving  receiving interstitial Consortium for =1&st=&sd=&mt=&cs= 
  Cancer Patients interstitial prostate  prostate brachytherapy, Performance &ss=&s=n&so=a&p=1 
   brachytherapy, OR  OR external beam Improvement ®  
   external beam  radiotherapy to the (AMA-PCPI)  
   radiotherapy to the  prostate, OR radical   
   prostate, OR radical  prostatectomy, OR   
   prostatectomy, OR  cryotherapy   
   cryotherapy who did not     
   have a bone scan     
   performed at any time     
   since diagnosis of     
   prostate cancer     
CMS62v1 0403 HIV/AIDS: Percentage of patients, Patients with at least two All patients, regardless National http://www.qualityforu 
  Medical Visit regardless of age, with a medical visits during the of age, with a diagnosis Committee for m.org/MeasureDetails. 
   diagnosis of HIV/AIDS measurement year with a of HIV/AIDS seen Quality Assurance aspx?actid=0&Submis 
   with at least two medical minimum of 90 days within a 12 month  sionId=580#k=0403&e 
   visits during the between each visit period  =1&st=&sd=&mt=&cs= 
   measurement year with a    &ss=&s=n&so=a&p=1 
   minimum of 90 days     
   between each visit.     
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CMS52v1 0405 HIV/AIDS: Percentage of patients Numerator 1: Patients who Denominator 1: All National http://www.qualityforu 
  Pneumocystis aged 6 weeks and older were prescribed patients aged 6 years Committee for m.org/MeasureDetails. 
  jiroveci with a diagnosis of pneumocystis jiroveci and older with a Quality Assurance aspx?actid=0&Submis 
  pneumonia (PCP) HIV/AIDS who were pneumonia (PCP) diagnosis of HIV/AIDS  sionId=582#k=0405&e 
  Prophylaxis prescribed Pneumocystis prophylaxis within 3 months and a CD4 count below  =1&st=&sd=&mt=&cs= 
   jiroveci pneumonia (PCP) 
prophylaxis 
of CD4 count below 200 
cells/mm
3 
Numerator 2: Patients who 
were prescribed 
pneumocystic jiroveci 
pneumonia (PCP) 
prophylaxis within 3 months 
of CD4 count below 500 
cells/ mm
3 
or a CD4 
percentage below 15% 
Numerator 3: Patients who 
were prescribed 
Pneumocystic jiroveci 
pneumonia (PCP) 
prophylaxis at the time of 
diagnosis of HIV 
 
 
200 cells/mm3 who had 
at least two visits during 
the measurement year, 
with at least 90 days in 
between each visit 
Denominator 2: All 
patients aged 1-5 years 
of age with a diagnosis of 
HIV/AIDS and a CD4 
count below 500 
cells/mm3 or a CD4 
percentage below 15% 
who had at least two 
visits during the 
measurement year, with 
at least 90 days in 
between each visit 
Denominator 3: All 
patients aged 6 weeks to 
12 months with a 
diagnosis of HIV who 
had at least two visits 
during the measurement 
year, with at least 90 
days in between each 
visit 
 &ss=&s=n&so=a&p=1 
 
 
 
CMS77v1 TBD 
(Proposed 
as 
NQF0407 
HIV/AIDS: RNA 
control for 
Patients with HIV 
Percentage of 13 years 
and older with a diagnosis 
of HIV/AIDS, with at least 
two visits during the 
measurement year, with at 
least 90 days between 
each visit, whose most 
recent HIV RNA level is 
<200 copies/mL. 
 
Patients whose most 
recent HIV RNA level is 
<200 copies/mL. 
 
All patients aged 13 
years and older with a 
diagnosis of HIV/AIDS 
with at least two visits 
during the measurement 
year, with at least 90 
days between each visit. 
 
National 
Committee for 
Quality Assurance 
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Cc  cCMS2v1 0418 Preventive Care Percentage of patients Patients screened for All patients aged 12 Quality Insights of http://www.qualityforu 
  and Screening: aged 12 years and older clinical depression on the years and older before Pennsylvania/ m.org/MeasureDetails. 
  Screening for screened for clinical date of the encounter using the beginning of the Centers for aspx?actid=0&Submis 
  Clinical depression on the date of an age appropriate measurement period Medicare & sionId=522#k=0418&e 
  Depression and the encounter using an standardized tool AND if with at least one Medicaid Services =1&st=&sd=&mt=&cs= 
  Follow-Up Plan age appropriate positive,  a follow-up plan is eligible encounter  &ss=&s=n&so=a&p=1 
   standardized depression documented on the date of during the   
   screening tool AND if the positive screen measurement period.   
   positive, a follow up plan     
   is documented on the     
   date of the positive     
   screen.     
CMS68v1 0419 Documentation of Percentage of specified Eligible professional attests All visits occurring Quality Insights of http://www.qualityforu 
  Current visits for patients aged 18 to documenting a list of during the 12 month Pennsylvania/ m.org/MeasureDetails. 
  Medications in the years and older for which current medications to the reporting period for Centers for aspx?actid=0&Submis 
  Medical Record the eligible professional best of his/her knowledge patients aged 18 years Medicare & sionId=524#k=0419&e 
   attests to documenting a and ability. This list must and older before the Medicaid Services =1&st=&sd=&mt=&cs= 
   list of current medications include ALL prescriptions, start of the  &ss=&s=n&so=a&p=1 
   to the best of his/her over-the-counters, herbals measurement period   
   knowledge and ability. and vitamin/mineral/dietary    
   This list must include ALL (nutritional) supplements    
   prescriptions, over-the- AND must contain the    
   counters, herbals, and medications’ name,    
   vitamin/mineral/dietary dosages, frequency and    
   (nutritional) supplements route of administration.    
   AND must contain the     
   medications’ name,     
   dosage, frequency and     
   route of administration.     
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CMS69v1 0421 Preventive Care Percentage of patients Patients with a documented Initial Patient Quality Insights of http://www.qualityforu 
and Screening: aged 18 years and older calculated BMI during the Population 1: All Pennsylvania/ m.org/MeasureDetails. 
Body Mass Index with an encounter during encounter or during the patients 65 years of Centers for aspx?actid=0&Submis 
(BMI) Screening the reporting period with previous six months, AND age and older before Medicare & sionId=526#k=0421&e 
and Follow-Up a documented calculated 
BMI during the encounter 
when the BMI is outside of 
normal parameters, follow- 
the beginning of the 
measurement period 
Medicaid Services =1&st=&sd=&mt=&cs= 
&ss=&s=n&so=a&p=1 
 or during the previous six up is documented during with at least one   
 months AND when the the encounter or during the eligible encounter   
 BMI is outside of normal previous six months of the during the   
 parameters, follow-up encounter with the BMI measurement period   
 plan is documented outside of normal NOT INCLUDING   
 during the encounter or parameters encounters where the   
 during the previous 6  patient is receiving   
 months of the encounter  palliative care, refuses   
 with the BMI outside of  BMI measurement, the   
 normal parameters.  patient is in an urgent   
Normal Parameters: Age 
65 years and older BMI ≥ 
23 and < 30 Age 18-64 
years BMI ≥18.5 and < 25 
or emergent medical 
situation where time is of 
the essence and to delay 
treatment would 
jeopardize the patient’s 
health status, or there is 
any other reason 
documented in the 
medical record by the 
provider explaining why 
BMI measurement was 
not appropriate. Initial 
Patient Population 2: All 
patients 18 through 64 
years before the 
beginning of the 
measurement period with 
at least one eligible 
encounter during the 
measurement period NOT 
INCLUDING encounters 
where the patient is 
receiving palliative care, 
refuses BMI 
measurement, the 
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     the patient is in an   
     urgent or emergent   
     medical situation where   
     time is of the essence   
     and to delay treatment   
     would jeopardize the   
     patient’s health status,   
     or there is any other   
     reason documented in   
     the medical record by   
     the provider explaining   
     why BMI measurement   
     was not appropriate.   
CMS132v1 0564 Cataracts: Percentage of patients Patients who had one or All patients aged 18 American Medical http://www.qualityforu 
  Complications aged 18 years and older more specified operative years and older who Association- m.org/MeasureDetails. 
  within 30 Days with a diagnosis of procedures for any of the had cataract surgery convened aspx?actid=0&Submis 
  Following uncomplicated cataract following major and no significant pre- Physician sionId=898#k=0564&e 
  Cataract Surgery who had cataract surgery complications within 30 operative ocular Consortium for =1&st=&sd=&mt=&cs= 
  Requiring 
Additional 
Surgical 
Procedures 
and had any of a 
specified list of surgical 
procedures in the 30 
days following cataract 
days following cataract 
surgery: retained nuclear 
fragments, endophthalmitis, 
dislocated or wrong power 
conditions impacting 
the surgical 
complication rate 
Performance 
Improvement ® 
(AMA-PCPI) 
&ss=&s=n&so=a&p=1 
   surgery which would IOL, retinal detachment, or    
   indicate the occurrence wound dehiscence    
   of any of the following     
   major complications:     
   retained nuclear     
   fragments,     
   endophthalmitis,     
   dislocated or wrong     
   power IOL, retinal     
   detachment, or wound     
   dehiscence.     
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CMS133v1 0565 Cataracts: 20/40 Percentage of patients Patients who had best- All patients aged 18 American Medical http://www.qualityforu 
  or Better Visual aged 18 years and older corrected visual acuity of years and older who Association- m.org/MeasureDetails. 
  Acuity within 90 with a diagnosis of 20/40 or better (distance or had cataract surgery convened aspx?actid=0&Submis 
  Days Following uncomplicated cataract near) achieved within 90  Physician sionId=899#k=0565&e 
  Cataract Surgery who had cataract surgery days following cataract  Consortium for =1&st=&sd=&mt=&cs= 
   and no significant ocular surgery  Performance &ss=&s=n&so=a&p=1 
   conditions impacting the   Improvement ®  
   visual outcome of   (AMA-PCPI)  
   surgery and had best-     
   corrected visual acuity of     
   20/40 or better (distance     
   or near) achieved within     
   90 days following the     
   cataract surgery.     
CMS158v1 0608 Pregnant women This measure identifies Patients who were tested All female patients OptumInsight http://www.qualityforu 
  that had HBsAg pregnant women who for Hepatitis B surface aged 12 and older who  m.org/MeasureDetails. 
  testing had a HBsAg (hepatitis antigen (HBsAg) during had a full term delivery  aspx?actid=0&Submis 
   B) test during their pregnancy within 280 days during the  sionId=1018#k=0608& 
   pregnancy. prior to delivery. measurement period.  e=1&st=&sd=&mt=&cs 
       =&ss=&s=n&so=a&p= 
       1 
CMS159v1 0710 Depression Adult patients age 18 and Adults who achieved Adults age 18 and MN Community http://www.qualityforu 
  Remission at older with major remission at twelve months older with a diagnosis Measurement m.org/MeasureDetails. 
  Twelve Months depression or dysthymia as demonstrated by a of major depression or  aspx?actid=0&Submis 
   and an initial PHQ-9 twelve month (+/- 30 days) dysthymia and an initial  sionId=55#k=0710&e= 
   score > 9 who PHQ-9 score of less than PHQ-9 score greater  1&st=&sd=&mt=&cs=& 
   demonstrate remission at five. than nine during an  ss=&s=n&so=a&p=1 
   twelve months defined as  outpatient encounter.   
   PHQ-9 score less than 5.     
   This measure applies to     
   both patients with newly     
   diagnosed and existing     
   depression whose     
   current PHQ-9 score     
   indicates a need for     
   treatment.     
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CMS160v1 0712 Depression Adult patients age 18 and Adult patients who have a Adult patients age 18 MN Community http://www.qualityforu 
  Utilization of the older with the diagnosis PHQ-9 tool administered at and older with an office Measurement m.org/MeasureDetails. 
  PHQ-9 Tool of major depression or least once during the four- visit and the diagnosis  aspx?actid=0&Submis 
   dysthymia who have a month period. of major depression or  sionId=56#k=0712&e= 
   PHQ-9 tool administered  dysthymia during each  1&st=&sd=&mt=&cs=& 
   at least once during a 4  four month period  ss=&s=n&so=a&p=1 
   month period in which     
   there was a qualifying     
   visit.     
CMS75v1 TBD Children who Percentage of children, Children who had cavities Children, age 0-20 Maternal and Child  
  have dental decay ages 0-20 years, who or decayed teeth. years, with a visit Health Bureau,  
  or cavities have had tooth decay or  during the Health Resources  
   cavities during the  measurement period. & Services  
   measurement period.   Administration  
CMS177v1 1365 Child and Percentage of patient Patient visits with an All patient visits for American Medical http://www.qualityforu 
  Adolescent Major visits for those patients assessment for suicide risk those patients aged 6 Association- m.org/MeasureDetails. 
  Depressive aged 6 through 17 years  through 17 years with a Physician aspx?actid=0&Submis 
  Disorder: Suicide with a diagnosis of major  diagnosis of major Consortium for sionId=1365#k=1365& 
  Risk Assessment depressive disorder with  depressive disorder Performance e=1&st=&sd=&mt=&cs 
   an assessment for   Improvement =&ss=&s=n&so=a&p= 
   suicide risk.   (AMA-PCPI) 1 
CMS82v1 1401 Maternal The percentage of Children with Children with a visit National http://www.qualityforu 
  depression children who turned 6 documentation of maternal who turned 6 months of Committee for m.org/MeasureDetails. 
  screening months of age during the screening or treatment for age in the Quality Assurance aspx?actid=0&Submis 
   measurement year, who postpartum depression for measurement period.  sionId=1401#k=1401& 
   had a face-to-face visit the mother.   e=1&st=&sd=&mt=&cs 
   between the clinician and    =&ss=&s=n&so=a&p= 
   the child during child’s    1 
   first 6 months, and who     
   had a maternal     
   depression screening for     
   the mother at least once     
   between 0 and 6 months     
   of life.     
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CMS74v1 TBD Primary Caries Percentage of children, Children who receive a Children, age 0-20 University of  
  Prevention age 0-20 years, who fluoride varnish application years, with a visit Minnesota  
  Intervention as received a fluoride  during the   
  Offered by varnish application during  measurement period.   
  Primary Care the measurement period.     
  Providers,      
  including Dentists      
CMS61v1 TBD Preventive Care Percentage of patients Numerator 1: (High Risk) Denominator 1: (High Quality Insights of  
  and Screening: 
Cholesterol – 
Fasting Low 
Density 
aged 20 through 79 years 
whose risk factors have 
been assessed and a 
fasting LDL-C test has 
Patients who had a fasting 
LDL-C test performed or a 
calculated LDL-C during the 
measurement period 
Risk) All patients aged 20 
through 79 years who 
have CHD or CHD Risk 
Equivalent 
Pennsylvania/ 
Centers for 
Medicare & 
Medicaid Services 
 
Lipoprotein (LDL- 
C) Test Performed 
been performed. Numerator 2: (Moderate 
Risk) Patients who had a 
fasting LDL-C test 
performed or a calculated 
LDL-C during the 
measurement period 
Numerator 3: (Low Risk) 
Patients who had a fasting 
LDL-C test performed or a 
calculated LDL-C during the 
measurement period or up to 
four (4) years prior to the 
current measurement period 
Denominator 2: 
(Moderate Risk) All 
patients aged 20 through 
79 years who have 
Multiple Risk Factors (2+) 
of the following: Cigarette 
Smoking, Hypertension, 
Low High Density 
Lipoprotein (HDL-C)**, 
Family History of 
Premature CHD, or Age 
(men >= 45; women >= 
55) 
Denominator 3: (Low Risk) 
All patients aged 20 
through 79 years who 
have risk factors 0 or 1 of 
the following risk factors: 
Cigarette Smoking, 
Hypertension, Low High 
Density Lipoprotein (HDL-
C)**, Family History of 
Premature CHD, or 
119 
 
 
CMS 
eMeasure ID 
 
NQF # 
 
Measure Title 
 
Measure Description 
 
Numerator Statement 
Denominator 
Statement 
 
Measure Steward Link to NQF website 
     Age (men >= 45;  
     women >= 55)  
     **For Denominator 2  
     and Denominator 3,  
     HDL-C > or equal to 60  
     mg/dL subtracts 1 risk  
     from the above (This is  
     a negative risk factor.)  
CMS64v1 TBD Preventive Care Percentage of patients Numerator 1: Patients Denominator 1: (High Quality Insights of 
  and Screening: 
Risk-Stratified 
aged 20 through 79 years 
who had a fasting 
whose most recent fasting 
LDL-C test is <100 mg/dL 
Risk) All patients aged 
20 through 79 years 
Pennsylvania/ 
Centers for 
Cholesterol – 
Fasting Low 
Density Lipoprotein 
(LDL- C) 
LDL-C test performed and 
whose risk-stratified fasting 
LDL-C is at or below the 
recommended LDL-C goal. 
Numerator 2: Patients whose 
most recent fasting LDL-C 
test is <130 mg/dL 
Numerator 3: Patients whose 
most recent fasting LDL-C 
test is <160 mg/dL 
who had a fasting LDL- C 
or a calculated LDL- C test 
performed during the 
measurement period and 
have CHD or CHD Risk 
Equivalent OR Have 
Multiple Risk Factors (2+) 
of the following: Cigarette 
Smoking, Hypertension, 
Low High Density 
Lipoprotein (HDL-C)**, 
Family History of 
Premature CHD, or Age 
(men >= 45; women >= 
55) AND a 10-year 
Framingham risk >20% 
Denominator 2: (Moderate 
Risk) All patients aged 20 
through 79 years who had 
a fasting LDL-C or a 
calculated LDL-C test 
performed during the 
measurement period and 
have Multiple Risk 
Medicare & 
Medicaid Services 
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Factors (2+) of the 
following: Cigarette 
Smoking, 
Hypertension, Low 
High Density 
Lipoprotein (HDL-C)**, 
Family History of 
Premature CHD, or 
Age (men >= 45; 
women >= 55) and 
AND 10-year 
Framingham risk 
<=20% Denominator 3: 
(Low Risk) All patients 
aged 20 through 79 
years who have had a 
fasting LDL-C or a 
calculated LDL-C test 
performed up to 4 
years prior to the 
current measurement 
period and have 0 or 1 
of the following risk 
factors: Cigarette 
Smoking, 
Hypertension, Low 
High Density 
Lipoprotein (HDL-C)**, 
Family History of 
Premature CHD, or 
Age (men >= 45; 
women >= 55) 
**HDL-C > or equal to 
60 mg/dL subtracts 1 
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risk from the above 
(This is a negative risk 
factor) 
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CMS149v1 TBD Dementia: Percentage of patients, Patients for whom an All patients, regardless American Medical 
  Cognitive regardless of age, with a assessment of cognition is of age, with a diagnosis Association- 
  Assessment diagnosis of dementia for performed and the results of dementia. convened 
   whom an assessment of reviewed at least once  Physician 
   cognition is performed within a 12-month period  Consortium for 
   and the results reviewed   Performance 
   at least once within a 12   Improvement ® 
   month period.   (AMA-PCPI) 
CMS65v1 TBD Hypertension: Percentage of patients Patients whose follow-up All patients aged 18-85 Centers for 
  Improvement in aged 18-85 years of age blood pressure is at least years of age, who had Medicare & 
  blood pressure with a diagnosis of 10 mmHg less than their at least one outpatient Medicaid Services 
   hypertension whose baseline blood pressure or visit in the first six  
   blood pressure improved is adequately controlled. months of the  
during the measurement 
period. 
If a follow-up blood 
pressure reading is not 
recorded during the 
measurement year, the 
patient’s blood pressure is 
assumed not improved 
measurement year, 
who have a diagnosis 
of hypertension 
documented during that 
outpatient visit, and 
who have uncontrolled
 
 baseline blood 
pressure at the time of 
that visit 
 
CMS50v1 TBD Closing the Percentage of patients Number of patients with a Number of patients, Centers for 
  referral loop: with referrals, regardless referral, for which the regardless of age, who Medicare & 
  receipt of of age, for which the referring provider received were referred by one Medicaid Services 
  specialist report referring provider a report from the provider to provider to another  
   receives a report from whom the patient was provider, and who had  
   the provider to whom the referred. a visit during the  
   patient was referred.  measurement period.  
CMS66v1 TBD Functional status Percentage of patients Patients with patient Adults, aged 18 and Centers for 
  assessment for aged 18 years and older reported functional status older, with a primary Medicare & 
  knee replacement with primary total knee assessment results (e.g., total knee arthroplasty Medicaid Services 
 arthroplasty (TKA) who VR-12, VR-36, PROMIS-10 (TKA) and who had an  
completed baseline and Global Health; PROMIS-29, outpatient encounter  
follow-up (patient- KOOS) not more than 180 not more than 180 days  
reported) functional days prior to the primary prior to procedure, and  
status assessments. TKA procedure, and at at least 60 days and  
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 least 60 days and not more not more than 180 days  
 than 180 days after TKA after TKA procedure.  
 procedure   
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CMS56v1 TBD Functional status Percentage of patients Patients with patient Adults aged 18 and Centers for 
  assessment for aged 18 years and older reported functional status older with a primary Medicare & 
  hip replacement with primary total hip assessment results (e.g., total hip arthroplasty Medicaid Services 
   arthroplasty (THA) who VR-12, VR-36, PROMIS- (THA) and who had an  
   completed baseline and 10-Global Health, PROMIS- outpatient encounter  
   follow-up (patient- 29, HOOS) not more than not more than 180 days  
   reported) functional 180 days prior to the prior to procedure, and  
   status assessments. primary THA procedure, at least 60 days and  
    and at least 60 days and not more than 180 days  
    not more than 180 days after THA procedure.  
    after THA procedure.   
CMS90v1 TBD Functional status Percentage of patients Patients with patient Adults aged 65 years Centers for 
  assessment for aged 65 years and older reported functional status and older who had two Medicare & 
  complex chronic with heart failure who assessment results (e.g., outpatient encounters Medicaid Services 
  conditions completed initial and VR-12; VR-36; MLHF-Q; during the  
   follow-up patient-reported KCCQ; PROMIS-10 Global measurement year and  
   functional status Health, PROMIS-29) an active diagnosis of  
   assessments present in the EHR at least heart failure.  
    two weeks before or during   
    the initial encounter and the   
    follow-up encounter during   
    the measurement year.   
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CMS179v1 TBD ADE Prevention 
and Monitoring: 
Average percentage of 
time in which patients 
Average percentage of time 
that patients in the measure 
Initial Patient 
Population statement: 
National 
Committee for 
  Warfarin Time in 
Therapeutic 
aged 18 and older with 
atrial fibrillation who are 
population have INR results 
within the therapeutic range 
Patients aged 18 and 
older with atrial 
Quality Assurance 
  Range on chronic warfarin (i.e., TTR) fibrillation without  
   therapy have  valvular heart disease  
   International Normalized  who had been on  
   Ratio (INR) test results  chronic warfarin  
   within the therapeutic  therapy for at least 180  
   range (i.e., TTR) during  days before the start of  
   the measurement period.  and during the  
     measurement period.  
     Patient should have at  
     least one outpatient  
     visit during the  
     measurement period  
     Equals All in Initial  
     Patient Population with  
     sufficient international  
     normalized ratio (INR)  
     results to calculate a  
     warfarin time in  
     therapeutic range  
     (TTR)  
CMS22v1 TBD Preventive Care Percentage of patients Patients who were Percentage of patients Quality Insights of 
  and Screening: aged 18 years and older screened for high blood aged 18 years and Pennsylvania/ 
  Screening for seen during the reporting pressure AND a older before the start of Centers for 
  High Blood period who were recommended follow-up the measurement Medicare & 
  Pressure and screened for high blood plan is documented as period Medicaid Services 
  Follow-Up pressure AND a indicated if the blood   
  Documented recommended follow-up pressure is pre-   
   plan is documented hypertensive or   
   based on the current hypertensive   
   blood pressure (BP)    
   reading as indicated    
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CPT only copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the 
American Medical Association. Applicable FARS/DFARS apply to government use. Fee schedules, relative value 
units, conversion factors, and/or related components are not assigned by the AMA, are not part of CPT, and the AMA 
is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical 
services.  The AMA assumes no liability for data contained or not contained herein. 
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CLINICAL QUALITY MEASURES FOR CMS’S 2014 EHR INCENTIVE PROGRAM 
FOR ELIGIBLE PROFESSIONALS 
RELEASE NOTES 
In August 2012, the Centers for Medicare & Medicaid Services (CMS) finalized the clinical 
quality measures (CQMs) for the 2014 Medicare and Medicaid Electronic Health Record (EHR) 
Incentive Program for Eligible Professionals, also known as Meaningful Use Stage 2 (MU2) for 
Eligible Professionals.
1 
This list of CQMs for MU2 includes measures retained  from Meaningful 
Use Stage 1 (MU1) for use in MU2. All retained MU1 measures have been updated based on 
advances in technology and tools for eMeasure development, comments from stakeholders, 
changes initiated by measure developers, and CMS’s standards as defined in the agency’s 
Measures Management System Blueprint, Version 8 (Blueprint).
2
 
CMS recognizes the importance of providing support, training, and information to MU 
stakeholders, particularly as the EHR Incentive Programs transition to MU2. The purpose of this 
document is to inform eligible providers and the vendor community about updated program 
requirements related to the CQMs. T his update includes information about global changes 
incorporated across all measures as well as specific changes to the measures retained in MU2. 
Global changes are listed first and include structural modifications; updates to value sets; and 
data elements and standards revised in accordance with the Blueprint. Specific changes to 
measures   include   changes   to   measure   components,   such   as   initial   patient populations, 
 
1 CMS. “Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 2.” 2012. 
Available at [http://www.ofr.gov/(X(1)S(uzclbwrx5fwqm2w2mipkysrh))/OFRUpload/OFRData/2012- 
21050_PI.pdf].  Accessed August 28, 2012. 
2 
CMS. “CMS Measure Management System Blueprint, Version 8.” Available at 
[http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment- 
Instruments/MMS/MeasuresManagementSystemBlueprint.html]. Accessed August 28, 2012. 
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denominators, numerators, exclusions, and exceptions, as well as logic changes that affect how 
data elements interrelate during the measurement period. 
This document is intended for readers who are familiar with eMeasure components and the 
current standards for constructing an eMeasure. For more information on eMeasures, please visit 
the CMS website (http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment- 
Instruments/QualityMeasures/Downloads/QMGuideForReadingEHR.pdf) and download the 
Guide for Reading the EHR Incentive Program EP Measures. 
Global Edits 
 Introduced a new measure-identification scheme that combines the eMeasure 
identifier, National Quality Forum (NQF) number (if applicable), and eMeasure 
version number. 
 Updated the rationale, clinical recommendation statements, and references to 
include the latest clinical guidance related to the measures. 
 Provided additional guidance to help implementers interpret the calculation 
requirements for the measures. 
 Updated the eMeasure header to reflect Blueprint requirements (such as using the 
initial patient population to define the denominator and including stratification 
variables in the header) and modified other fields, such as population criteria, to 
reflect these changes. 
 Changed the standardization of the measurement period from “year” to “period.” 
 Updated the measure logic to reflect the changes to the Quality Data Model (QDM), 
to reflect consistent use of relative timing across measures (including age 
calculation), occurencing, and denominator exclusions. 
 Assigned data elements based on version 2.1.1.1 of the QDM3 to each clinical 
concept, adding attributes as needed to precisely define QDM elements. 
 For measures using the QDM of “Medication, Active,” added the AND / AND 
NOT construct to compensate for varying interpretations of the relative timing 
“during.” The ‘“Medication, Active” period can start at any time but cannot end 
before “Occurrence A of Encounter, Performed.” 
 
 
3 
For more on the Quality Data Model, visit the NQF website at 
http://www.qualityforum.org/Projects/h/QDS_Model/QDS_Version_2_1.aspx. 
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 Incorporated supplemental data elements (race, ethnicity, sex, and payer)  as 
required by the Blueprint. 
 Reorganized and retitled the encounter value sets to standardize them across 
developers. Also incorporated encounter value sets using SNOMED-CT to align 
with the Health Information Technology Standards Committee’s (HITSC’s) 
vocabulary recommendations for the QDM data type “Encounter.” 
 Updated existing value sets and added new value sets to align with the transitional 
and final vocabularies, based on the HITSC recommendations and required by the 
Blueprint. 
 Fully specified ICD-9-CM and ICD-10-CM codes and, as applicable, ensured 
consistency with the 2012 Physician Quality Reporting Program (PQRS) measures. 
 Provided grouping object identifiers for each data element. 
 
NQF 0002: Appropriate Testing for Children with Pharyngitis 
 Clarified the initial patient population to only include the review the first episode of 
tonsillitis or pharyngitis per patient. 
 Included only ordered medications as a criteria for the initial patient population. 
 Modified the denominator exclusions to only include active antibiotic medications 
 Added the restriction that antibiotic medication in the denominator exclusions must 
be active 30 da ys before the diagnosis because the encounter is linked to the 
diagnosis through the initial patient population criteria. 
 Required the laboratory test to have a result present to ensure that the test has been 
completed. 
 Updated the numerator criteria to require the laboratory test for Streptococcus to 
occur within three days of the episode. 
 
NQF 0004: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment 
 Updated the measure title for consistency with the measure titles used in other 
programs, such as the PQRS. 
 Updated the measure description to define “adolescent and adult patients” as 
patients age 13 or older. 
 Modified the structure of the measure so that it is a single measure with reporting 
stratified by age group. 
 Changed the time window for the first diagnosis of alcohol or drug dependency in 
the initial patient population to the first 11 months of the measurement period. 
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 Updated the specifications to require use of diagnosis criteria to determine if the 
patient has the condition, and to require use of encounter criteria to identify the 
beginning of the episode by requiring the diagnosis to start during the encounter. 
 Removed acute and nonacute inpatient encounters for numerator 1. 
 Clarified that, to be compliant for numerator 2, the patient must meet the criteria for 
both numerator 1 and 2. 
 
NQF 0018: Controlling High Blood Pressure 
 Clarified that the diagnosis of hypertension could occur any time between the first 
part of the measurement period to before the measurement period. 
 Changed the age range from age 17–84 to age 18–85. 
 Clarified that the denominator exclusion of pregnancy had to be in the measurement 
period. 
 Clarified that the systolic and diastolic blood pressure reading must come from the 
most recent visit. 
 
NQF 0024: Weight Assessment and Counseling for Nutrition and Physical Activity for 
Children and Adolescents 
 Modified the structure of the measure so it is a single measure with reporting 
stratified by age groups. 
 Changed the age criteria of the initial patient population from patients age 2–17 to 
age 3–17. 
 Clarified that the eligible encounter in the initial patient population should be with a 
primary care physician or obstetrician/gynecologist. 
 Changed the denominator exclusion to only include a diagnosis of pregnancy. 
 Added the patient’s height and weight to numerator criteria, in addition to body 
mass index. 
 
NQF 0028: Preventive Care and Screening: Tobacco Use: Screening and Cessation 
Intervention 
 Combined the measure pair a and b into one measure, and updated the title to reflect 
this modification. 
 Expanded the definition of “eligible encounters” in the initial patient population. 
 Combined the numerator criteria from the previously paired measures. 
 Updated the QDM data type for “Procedure, Performed: Tobacco Use Cessation 
Counseling to “Intervention, Performed: Tobacco Use Cessation Counseling.” 
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 Added denominator exceptions for medical reasons. 
NQF 0031: Breast Cancer Screening 
 Added “female” sex criteria to the initial patient population. 
 Changed the age criteria  of  the  initial  patient  population  from  age  41–68  to 
age 42–69. 
 Changed the eligible time period for an encounter in the initial patient population 
from two years to during the one-year measurement period. 
 Clarified that because we are only looking for complete mastectomies, a patient that 
had two unilateral mastectomies should be excluded. 
 Changed the numerator criterion from “performed” to requiring a “result” to be 
present. 
 
NQF 0032: Cervical Cancer Screening 
 Added “female” sex criteria to the initial patient population. 
 Changed the eligible time period for an encounter in the initial patient population 
from three years to during the one-year measurement period. 
 Changed the age criteria  of  the  initial  patient  population  from  age  23–63  to 
age 24–63. 
 
NQF 0033: Chlamydia Screening for Women 
 Modified the structure of the measure so it is a single measure with reporting 
stratified by age group. 
 Changed the age criteria  of  the  initial  patient  population  from  age  15–24  to 
age 16–24. 
 Added “female” sex criteria to the initial patient population. 
 Updated the categories of events that identify women as sexually active. 
 Removed active and dispensed medications and performed procedures from the list 
of exclusions, requiring only that the procedure or medication be ordered. 
 
NQF 0034: Colorectal Cancer Screening 
 Changed the eligible time period for an encounter in the initial patient population 
from two years to during the one-year measurement period. 
 Changed the age criteria  of  the  initial  patient  population  from  age  50–74  to 
age 51–75. 
 Added exclusion for malignant neoplasm of the colon. 
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NQF 0036: Use of Appropriate Medications for Asthma 
 Changed the age criteria of the initial patient population from age 5–50 to age 5–64. 
 Modified the structure of the measure so it is a single measure with reporting 
stratified by age groups. 
 Clarified the eligible time window for a diagnosis of persistent asthma to any time 
before or during the measurement period, with a requirement of only one encounter. 
 Modified the criteria for the initial patient population to require a diagnosis of 
asthma (medication alone will not suffice). 
 Removed active and dispensed medications from the list of numerator criteria, 
requiring only that the medication be ordered. 
 
NQF 0038: Childhood Immunization Status 
 Modified the measure to report only one combined rate; separate rates for each 
vaccine or a combination of vaccines will no longer be calculated. 
 Clarified that the encounter criteria for the initial patient population does not need 
to be with a primary care or OB/GYN provider. 
 Expanded the numerator criteria to include both medication administered and the 
procedure for administering the vaccine. 
 Changed the exclusion for “medication allergy” to be defined by an anaphylactic 
reaction to the vaccine and allowed this reaction to count as numerator compliance 
for each vaccine. 
 Combined the separate measles, mumps, and rubella (MMR) administered vaccines 
into one numerator criterion. Also updated the time window for MMR vaccine 
administration to occur any time before the patient’s second birthday in the 
numerator. 
 Allowed past diagnoses of disease to count for the appropriate vaccine. 
 Added a laboratory test for the hepatitis A antigen to the numerator criteria for the 
hepatitis A vaccine. Also updated hepatitis A medication criteria to allow only one 
vaccination to count for numerator compliance. 
 Updated the HiB vaccine medication criteria to require three vaccinations for 
compliance. 
 Separated two- and three-dose rotavirus vaccines to ensure the proper number of 
doses is administered. 
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NQF 0041: Preventive Care and Screening: Influenza Immunization 
 Updated the measure title to reflect the updated measure specifications. 
 Expanded the age group to include all patients age 6 months or older in the initial 
patient population. 
 Changed the time window of the denominator for which the encounters must occur 
to reflect the new time period for the flu season recommended by the Centers for 
Disease Control and Prevention. 
 Added “peritoneal dialysis procedure” and “hemodialysis procedure” to the 
denominator criteria. 
 Added to the numerator any communication from patient to provider regarding the 
previous receipt of a vaccine. 
 
NQF 0043: Pneumonia Vaccination Status for Older Adults 
 Restricted the time window for an encounter in the initial patient population to only 
during the measurement period. 
 Changed the age criteria of the initial patient population from age 64 and older to 
age 65 and older. 
 Added pneumococcal vaccine administered and history of a pneumococcal vaccine 
to the numerator criteria. 
 
NQF 0052: Use of Imaging Studies for Low-Back Pain 
 Rephrased the measure title. 
 Changed the age criteria  of  the  initial  patient  population  from  age  18–49  to 
age 18–50. 
 Added the eligible age of patients (18–50) to the measure description. 
 Specified that the low-back pain diagnosis must occur during an office or 
emergency-department visit no more than 337 days after the start of the 
measurement period. 
 Moved the exclusion criteria for the denominator to the denominator-exclusion 
section, including a low-back pain diagnosis less than 180 days before occurrence A 
of a low-back pain diagnosis or a diagnosis of cancer, trauma, IV drug abuse, or 
neurologic impairment during the year before the measurement period. 
 Changed the measure to calculate the number of patients with a diagnosis of low- 
back pain who did have an imaging study (e.g., X-ray, MRI, CT scan) within 28 
days of the diagnosis; a lower rate is thus a better score for this measure. 
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NQF 0055: Eye Exam 
 Changed the age criteria  of  the  initial  patient  population  from  age  18–74  to 
age 18–75. 
 Removed from the denominator criteria any dispensed, ordered, or active 
medications indicative of diabetes. 
 Updated the time window for an active diabetes diagnosis to any time before or 
during the measurement period. 
 Modified the encounter criteria in the initial patient population, including limiting 
the time window to the measurement period. 
 Modified the exclusion criteria for the denominator, including removing polycystic 
ovaries diagnosis and medications indicative of diabetes as well as restricting the 
time window for an active gestational-diabetes diagnosis to the  measurement 
period. 
 Limited the eye-exam procedures in the numerator to either a negative retinal exam 
during the year before the measurement period or a retinal or dilated eye exam 
during the measurement period. 
 
NQF 0056: Diabetes: Foot Exam 
 Removed details about the type of diabetes (type 1 or 2) and type of foot exam 
(visual inspection, sensory exam with monofilament, or pulse exam) from the 
measure description. 
 Changed the age criteria  of  the  initial  patient  population  from  age  18–74  to 
age 18–75. 
 Removed from the denominator criteria any dispensed, ordered, or active 
medications indicative of diabetes. 
 Updated the time window for an active diabetes diagnosis to any time before or 
during the measurement period. 
 Modified the encounter criteria in the initial patient population, including limiting 
the time window to the measurement period. 
 Modified the exclusion criteria for the denominator, including removing polycystic 
ovaries and medications indicative of diabetes as well as restricting the  time 
window for an active gestational-diabetes diagnosis to the measurement period. 
 Modified the foot-exam criteria to include the specific components of  the foot 
exam, including a visual exam and either a sensory or pulse exam during the 
measurement period. 
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NQF 0059: Diabetes: Hemoglobin A1c Poor Control 
 Changed the age criteria  of  the  initial  patient  population  from  age  18–74  to 
age 18–75. 
 Removed from the denominator criteria any dispensed, ordered, or active 
medications indicative of diabetes. 
 Updated the time window for a diagnosis of active diabetes to any time before or 
during the measurement period. 
 Modified the encounter criteria in the initial patient population, including limiting 
the time window to the measurement period. 
 Modified the exclusion criteria for the denominator, including removing polycystic 
ovaries and medications indicative of diabetes as well as restricting the  time 
window for an active gestational-diabetes diagnosis to the measurement period. 
 Added the absence of an HbA1c laboratory test results during the measurement 
period for eligible patients as a numerator criterion. 
 
NQF 0062: Diabetes: Urine Protein Screening 
 Updated the measure title to specify protein screening. 
 Removed the details about the type of diabetes (type 1 or 2) from the measure 
description. 
 Changed the age criteria  of  the  initial  patient  population  from  age  18–74  to 
age 18–75. 
 Removed from the denominator criteria any dispensed, ordered, or active 
medications indicative of diabetes. 
 Updated the time window for a diagnosis of active diabetes to any time before or 
during the measurement period. 
 Modified the encounter criteria in the initial patient population, including limiting 
the time window to the measurement period. 
 Modified the exclusion criteria for the denominator, including removing polycystic 
ovaries and medications indicative of diabetes as well as restricting the  time 
window for an active gestational-diabetes diagnosis to the measurement period. 
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NQF 0064: Diabetes: Low-Density Lipoprotein (LDL) Management and Control 
 Removed “and Control” from the measure title. 
 Specified in the measure description that LDL-C under 100 mg/dL is considered 
adequately controlled. 
 Changed the age criteria  of  the  initial  patient  population  from  age  18–74  to 
age 18–75. 
 Removed from the denominator criteria any dispensed, ordered, or active 
medications indicative of diabetes. 
 Updated the time window for an active diabetes diagnosis to any time before or 
during the measurement period. 
 Modified the encounter criteria in the initial patient population, including limiting 
the time window to the measurement period. 
 Modified the exclusion criteria for the denominator, including removing polycystic 
ovaries and medications indicative of diabetes as well as restricting the  time 
window for an active gestational-diabetes diagnosis to the measurement period. 
 Removed the screening indicator. 
 
NQF 0068: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 
 Updated the measure description to reflect the change in the look-back period and 
active-medication requirement. 
 Changed the age criteria of the initial patient population from age 17 and older to 
age 18 and older. 
 Changed the “percutaneous transluminal cardiac angioplasty” category to the 
broader category of “percutaneous coronary interventions” for the initial patient 
population. 
 Changed the eligible time period for diagnoses and procedures for the initial patient 
population from 2 to 12 months before the measurement period to the year before 
the measurement period. 
 Removed the requirement from the initial patient population that the diagnosis and 
procedures of interest needed to occur during an encounter. 
 Limited the numerator criteria to “medication active” (not ordered or dispensed), 
and required that the medication be active at some time during the measurement 
period. 
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NQF 0070: Coronary Artery Disease (CAD): Beta-Blocker Therapy—Prior Myocardial 
Infarction (MI) or Left-Ventricular Systolic Dysfunction (LVEF) < 40% 
 Revised the measure title and description to reflect the most up-to-date information 
from the measure developer/steward. 
 Divided the calculation of the measure into two rates to reflect the two distinct 
denominator populations. It is expected that the implementer will report each 
population score separately and a total score. 
 Expanded the definition of eligible encounter in initial patient populations 1 and 2. 
 Added a denominator population; denominator 1 includes patients with a prior 
(resolved) myocardial infarction, and  denominator  2 i  ncludes  patients  with 
LVEF < 40%. 
 Clarified the recommended type of beta-blocker therapy for each denominator 
population in the guidance statement and logic, in accordance with updated clinical 
recommendations. 
 Added to the denominator exceptions additional methods of capturing allergies and 
intolerances, based on HITSC recommendations 
 
NQF 0075: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control 
 Changed the measure title from “LDL” to “LDL-C.” 
 Specified in the measure description that LDL-C under 100 m g/dL is considered 
adequately controlled. 
 Changed the age criteria of the initial patient population from age 17 and older to 
age 18 and older. 
 Changed “percutaneous transluminal cardiac angioplasty” to the broader category 
of “percutaneous coronary interventions” for the initial patient population. 
 Changed the eligible time period for diagnoses and procedures for the initial patient 
population from 2 to 12 months before the measurement period to the year before 
the measurement period. 
 Removed the requirement from the initial patient population that the diagnosis and 
procedures of interest needed to occur during an encounter. 
 Included a requirement in the numerator 1 criteria that a complete lipid-panel test 
result is present or all the separate components of a complete lipid panel must be 
performed and have a result. 
 Changed numerator 2 criteria to include only a LDL-C lab test result < 100 mg/dL; 
removed the other components needed to calculate the LDL-C for  high 
triglycerides. 
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NQF 0081: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or 
Angiotensin-Receptor Blocker (ARB) Therapy for Left-Ventricular Systolic 
Dysfunction (LVSD) 
 Revised the measure description to reflect the most up-to-date information from the 
measure developer/steward. 
 Removed one denominator option used to capture a patient with LVSD—“LVF 
ASSMT.” 
 Changed all denominator options for capturing a patient with LVSD from a “starts 
before start of…” timing to “starts before or during….” 
 Added to the denominator exception additional methods of capturing allergies and 
intolerances, based on HITSC recommendations. 
 Refined the value sets for the denominator exception. 
 Changed the QDM data type for “Patient reason for ACE inhibitor or ARB decline” 
value set. 
 
NQF 0083: Heart Failure (HF): Beta-Blocker Therapy for Left-Ventricular Systolic 
Dysfunction (LVSD) 
 Revised the measure description to reflect the most up-to-date information from the 
measure developer/steward. 
 Removed one denominator option used to capture a patient with LVSD—“LVF 
ASSMT.” 
 Changed all denominator options for capturing a patient with LVSD from a “starts 
before start of…” timing to “starts before or during….” 
 Refined the value sets for the denominator exception. 
 
NQF 0086: Primary Open-Angle Glaucoma (POAG): Optic-Nerve Evaluation 
 Revised the measure description to reflect the most up-to-date information from the 
measure developer/steward. 
 Expanded the “optic-nerve head evaluation” to capture its two components: cup-to- 
disc ratio and optic-disc exam for structural abnormalities. 
 
NQF 0088: Diabetic Retinopathy: Documentation of Presence or Absence of Macular 
Edema and Level of Severity of Retinopathy 
 Revised the measure logic of the numerator based on t he updated QDM for type 
and category of the numerator criteria. 
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NQF 0089: Diabetic Retinopathy: Communication with the Physician Managing Ongoing 
Diabetes Care 
 Updated the denominator criteria from performing a macular or fundus exam to 
identifying the results of the diagnostic study. 
 Further defined the results of the macular exam in the numerator by separating the 
findings into “present” or “absent.” 
 
NQF 0105: Antidepressant Medication Management 
 Shortened the measure title. 
 Updated the measure description to specify the two calculated rates. 
 Changed the age criteria of the initial patient population from patients age 18 and 
older 245 days into the measurement period to age 18 and older at the start of the 
measurement period. 
 Changed the eligible time period for a diagnosis of major depression in the initial 
patient population. The original time period was less than 245 d ays before the 
measurement period starts to no more than 245 days before the measurement period 
ends. The revised time period is less than 180 days before the measurement period 
starts to no more than 180 days after the measurement period ends. 
 Removed the criterion that the depression diagnosis must occur during an 
encounter. 
 Limited the criteria for the initial patient population to “antidepressant medication 
active” (not ordered or dispensed). 
 Removed a denominator criterion that another diagnosis of depression not occur 
sooner than 120 days before the diagnosis of depression for the episode of interest. 
 Added a denominator exclusion that another antidepressant medication not  be 
active less than 90 days before the antidepressant medication of interest. 
 Changed the numerator criteria for numerator 1 and 2 to focus on the cumulative 
amount of medication dispensed. 
 
NQF 0385: Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients 
 Revised the measure title and description to reflect the most up-to-date information 
from the measure developer/steward. 
 Added “AJCC” to the measure title. 
 Revised the measure description to include an upper limit of 80 years of age. Also 
revised the initial patient population to include all patients age 18 through 80 with 
colon cancer. 
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 Removed an inactive diagnosis of colon cancer (history of colon cancer) from the 
criteria for the initial patient population, as the measure is limited to patients with a 
first-recorded diagnosis of colon cancer during the 12-month reporting period (that 
is, during an eligible encounter between the patient and provider). 
 Excluded patients whose clinical-staging procedure started before the active 
diagnosis of colon cancer. 
 Excluded patients whose diagnosis of colon cancer was more than two years before 
the measurement end date. 
 Specified that the patient’s clinical-staging procedure resulting in “colon distant 
metastasis status MO” started before the eligible encounter. 
 Specified the tumor sizes and lymph-node statuses following the clinical-staging 
procedure that are eligible for inclusion in the denominator. 
 Specified the timing of ordering or administering chemotherapy eligible for 
inclusion in the numerator. 
 Alternate methods of capturing allergies and intolerances added to denominator 
exceptions to align with HITSC recommendations. 
 
NQF 0387:  Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen 
Receptor/Progesterone Receptor (ER/PR)-Positive Breast Cancer 
 Revised the measure title by deleting the term “oncology” to reflect the most up-to- 
date information from the measure developer/steward. 
 Specified that an active diagnosis of breast cancer took place less than five years 
before the patient-provider encounter for the initial patient population. 
 Removed an inactive diagnosis of breast cancer (history of breast cancer) from the 
criteria for the initial patient population, as the measure is limited to patients with a 
first-recorded diagnosis of breast cancer within the past five years. 
 Excluded patients whose clinical-staging procedure started before the active 
diagnosis of breast cancer. 
 Specified that the patient’s clinical-staging procedure resulting in “breast distant 
metastasis status MO” started before the eligible encounter. 
 Removed the breast cancer Stage IC-IIIC procedure from the denominator criteria 
and added the clinical-staging procedure. 
 Specified the tumor sizes and lymph-node statuses following the clinical-staging 
procedure that are eligible for inclusion in the denominator. 
 Specified the eligible timing of the ordering and dispensing of tamoxifen or 
aromatase inhibitor therapy for numerator inclusion. 
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 Revised the denominator exceptions to capture clinical-trial participants and 
removed adverse medication events to align with HITSC recommendations. 
 
NQF 0389: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low-Risk 
Prostate Cancer Patients 
 Corrected prostate-specific criterion for antigen test results from <= 10 mg/dL to 
<= 10 ng/mL. 
 Removed “Procedure result: AJCC cancer stage low-risk recurrence  prostate 
cancer” from denominator criteria. 
 Added performance of a “clinical staging procedure” with result of prostate cancer 
primary tumor size T1c or T2a to denominator criteria. 
 Added “Diagnostic Study, Order: Bone Scan (Source: ‘Other provider’)” to list of 
denominator exceptions (note: MU1 denominator exclusions are now considered 
denominator exceptions in MU2). 
 
NQF 0421: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-
Up 
 Updated the description and numerator to include timing guidance for follow-up of 
“BMI outside of normal parameters” to include “in the past six months or during 
the current visit.” 
 Added definitions for Body Mass Index (BMI), Calculated BMI, and Follow-Up 
Plan. 
 Revised Denominator Exclusion by deleting “terminal illness” and system reasons 
for not calculating BMI, added “patients receiving palliative care,” and moved 
patient and medical reason for not calculating BMI to Denominator Exceptions. 
 Clarified patient reason for not calculating BMI to include “The patient refuses 
BMI measurement.” 
 Clarified medical or other reason for not calculating BMI to include “If there is any 
other reason documented in the medical record by the provider explaining why BMI 
measurement was not appropriate” OR “If the patient is in an urgent or emergent 
medical situation where time is of the essence and to delay treatment would 
jeopardize the patient’s health status.” 
 Added Care Goal and Communication follow-up to applicable above and below 
normal BMI follow-up interventions. 
 Added BMI interventions for “Above Normal Follow-up,” “Above Normal 
Referrals,” “Above Normal Medications,” “Below Normal Follow-up,” “Below 
Normal Referrals,” and “Below Normal Medications.” 
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2014 Clinical Quality Measures (CQMs) 
Adult Recommended Core Measures 
Please note, in Stage 2 of meaningful use, the core set requirement has been removed. Instead, the Centers for 
Medicare & Medicaid Services (CMS) proposed a recommended core which includes measures aligned with high priority 
health care improvement goals. If one or more of these measures are not relevant for your organization, please utilize 
other measures from the approved 2014 CQM set to meet the reporting requirement. 
 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
CMS165v1 
NQF 0018 
Controlling High Blood Pressure 
 
Percentage of patients 18-85 years of age who 
had a diagnosis of hypertension and whose 
blood pressure was adequately controlled 
(<140/90mmHg) during the measurement 
period. 
National 
Committee for 
Quality 
Assurance 
(NCQA): 
www.ncqa.org 
 EHR PQRS 
 ACO 
 Group 
Reporting 
PQRS 
 UDS 
Clinical 
Process/ 
Effectiveness 
NEW: CMS156v1 
NQF 0022 
Use of High-Risk Medications in the Elderly 
 
Percentage of patients 66 years of age and older 
who were ordered high-risk medications. Two 
rates are reported. 
 
a. Percentage of patients who were ordered at 
least one high-risk medication. 
b. Percentage of patients who were ordered at 
least two different high-risk medications. 
NCQA: 
www.ncqa.org 
PQRS Patient Safety 
CMS138v1 
NQF 0028 
Preventive Care and Screening: Tobacco Use: 
Screening and Cessation Intervention 
 
Percentage of patients aged 18 years and older 
who were screened for tobacco use one or more 
times within 24 months AND who received 
cessation counseling intervention if identified as 
a tobacco user. 
AMA Physician 
Consortium for 
Performance 
Improvement 
(AMA-PCPI): 
cpe@ama
- assn.org 
 EHR PQRS 
 ACO 
 Group 
Reporting 
PQRS 
 UDS 
Population/ 
Public Health 
 
 
 
 
 
October 2012 
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Adult Recommended Core Measures 
 
 
 
 
 
October 2012 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
CMS166v1 
NQF 0052 
Use of Imaging Studies for Low Back Pain 
 
Percentage of patients 18-50 years of age with a 
diagnosis of low back pain who did not have an 
imaging study (plain X-ray, MRI, CT scan) within 28 
days of the diagnosis. 
NCQA: 
www.ncqa.org 
 Efficient Use 
of Healthcare 
Resources 
NEW: CMS2v1 
NQF 0418 
Preventive Care and Screening: Screening for 
Clinical Depression and Follow-Up Plan 
 
Percentage of patients aged 12 years and older 
screened for clinical depression on the date of the 
encounter using an age appropriate standardized 
depression screening tool AND if positive, a follow- 
up plan is documented on the date of the positive 
screen. 
CMS: 
1-888-734-6433, 
or 
http://questions
. 
cms.hhs.gov/app 
/ask/p/21,26,11 
39 
 
Quality Insights 
of Pennsylvania 
(QIP): 
www.usqualitym 
easures.org 
 EHR PQRS 
 ACO 
 Group 
Reporting 
PQRS 
Population/ 
Public Health 
NEW: CMS68v1 Documentation of Current Medications in the CMS:  PQRS Patient Safety 
 Medical Record 1-888-734-6433,  EHR PQRS 
NQF 0419  or 
Percentage of specified visits for patients aged 18 http://questions. 
years and older for which the eligible professional cms.hhs.gov/app 
attests to documenting a list of current /ask/p/21,26,11 
medications to the best of his/her knowledge and 39 
ability. This list must include ALL prescriptions,  
over-the-counters, herbals, and QIP: 
vitamin/mineral/dietary (nutritional) supplements www.usqualitym 
AND must contain the medications' name, dosage, easures.org 
frequency and route of administration. 
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Adult Recommended Core Measures 
 
 
 
 
 
 
 
 
 
 
October 2012 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
CMS69v1 Preventive Care and Screening: Body Mass Index CMS:  EHR PQRS Population/ 
 (BMI) Screening and Follow-Up 1-888-734-6433,  ACO Public Health 
NQF 0421  or  Group 
Percentage of patients aged 18 years and older with http://questions. Reporting 
a calculated BMI in the past six months or during the cms.hhs.gov/app PQRS 
current reporting period documented in the medical /ask/p/21,26,11  UDS 
record AND if the most recent BMI is outside of 39 
normal parameters, a follow-up plan is documented  
within the past six months or during the current QIP: 
reporting period. www.usquality 
 measures.org 
Normal Parameters: 
 Age 65 years and older BMI ≥ 23 and < 30 
 Age 18-64 years BMI ≥ 18.5 and < 25 
New: CMS50v1 Closing the referral loop: receipt of specialist CMS:  Care 
report 1-888-734-6433, Coordination 
 or 
Percentage of patients with referrals, regardless of http://questions. 
age, for which the referring provider receives a cms.hhs.gov/app 
report from the provider to whom the patient was /ask/p/21,26,11 
referred. 39 
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2014 Clinical Quality Measures (CQMs) 
Pediatric Recommended Core Measures 
 
Please note, in Stage 2 of meaningful use, the core set requirement has been removed. Instead, the Centers for 
Medicare & Medicaid Services (CMS) proposed a recommended core which includes measures aligned with high priority 
health care improvement goals. If one or more of these measures are not relevant for your organization, please utilize 
other measures from the approved 2014 CQM set to meet the reporting requirement. 
 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
CMS146v1 
NQF 0002 
Appropriate Testing for Children with Pharyngitis 
 
Percentage of children 2-18 years of age, who 
were diagnosed with pharyngitis, ordered an 
antibiotic and received a group A streptococcus 
(strep) test for the episode. 
National 
Committee for 
Quality 
Assurance 
(NCQA): 
www.ncqa.org 
 EHR PQRS 
 CHIPRA 
Efficient Use 
of Healthcare 
Resources 
CMS155v1 
NQF 0024 
Weight Assessment and Counseling for Nutrition 
and Physical Activity for Children and 
Adolescents 
 
Percentage of patients 3-17 years of age who had 
an outpatient visit with a Primary Care Physician 
(PCP) or Obstetrician/Gynecologist (OB/GYN) and 
who had evidence of the following during the 
measurement period. Three rates are reported. 
 
 Percentage of patients with height, weight, 
and body mass index (BMI) percentile 
documentation. 
 Percentage of patients with counseling for 
nutrition. 
 Percentage of patients with counseling for 
physical activity. 
NCQA: 
www.ncqa.org 
 EHR PQRS 
 UDS 
Population/ 
Public Health 
CMS153v1 
NQF 0033 
Chlamydia Screening for Women 
 
Percentage of women 16-24 years of age who 
were identified as sexually active and who had at 
least one test for Chlamydia during the 
measurement period. 
NCQA: 
www.ncqa.org 
 EHR PQRS 
 CHIPRA 
 ACA 2701 
 HEDIS 
 State Use 
 NCQA-
PCMH 
Recognition 
Population/ 
Public Health 
 
 
October 2012 
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October 2012 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
CMS126v1 
NQF 0036 
Use of Appropriate Medications for 
Asthma 
 
Percentage of patients 5-64 years of age who 
were identified as having persistent asthma and 
were appropriately prescribed medication during 
the measurement period. 
NCQA: 
www.ncqa.org 
EHR PQRS Clinical 
Process/ 
Effectiveness 
CMS117v1 
NQF 0038 
Childhood Immunization Status 
 
Percentage of children 2 years of age who had 
four diphtheria, tetanus and acellular pertussis 
(DTaP); three polio (IPV), one measles, mumps 
and rubella (MMR); three H influenza type B (HiB); 
three hepatitis B (Hep B); one chicken pox (VZV); 
four pneumococcal conjugate (PCV); one hepatitis 
A (Hep A); two or three rotavirus (RV); and two 
influenza (flu) vaccines by their second birthday. 
NCQA: 
www.ncqa.org 
 EHR PQRS 
 UDS 
Population/ 
Public Health 
NEW: CMS154v1 
NQF 0069 
Appropriate Treatment for Children with Upper 
Respiratory Infection (URI) 
 
Percentage of children 3 months-18 years of age 
who were diagnosed with upper respiratory 
infection (URI) and were not dispensed an 
antibiotic prescription on or three days after the 
episode. 
NCQA: 
www.ncqa.org 
 PQRS 
 NCQA-
PCMH 
Recognition 
Efficient Use 
of Healthcare 
Resources 
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October 2012 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
NEW: CMS136v1 
NQF 0108 
ADHD: Follow-Up Care for Children Prescribed 
Attention Deficit/Hyperactivity Disorder (ADHD) 
Medication 
 
Percentage of children 6-12 years of age and 
newly dispensed a medication for attention- 
deficit/hyperactivity disorder (ADHD) who had 
appropriate follow-up care. Two rates are 
reported. 
 
a. Percentage of children who had one follow- 
up visit with a practitioner with prescribing 
authority during the 30-Day Initiation Phase. 
b. Percentage of children who remained on 
ADHD medication for at least 210 days and 
who, in addition to the visit in the Initiation 
Phase, had at least two additional follow-up 
visits with a practitioner within 270 days (9 
months) after the Initiation Phase ended. 
NCQA: 
www.ncqa.org 
 Clinical 
Process/ 
Effectiveness 
NEW: CMS2v1 Preventive Care and Screening: Screening for Centers for  EHR PQRS Population/ 
 Clinical Depression and Follow-Up Plan Medicare &  ACO Public Health 
NQF 0418  Medicaid  Group 
Percentage of patients aged 12 years and older Services (CMS): Reporting 
screened for clinical depression on the date of 1-888-734- PQRS 
the encounter using an age appropriate 6433, or 
standardized depression screening tool AND if http://question 
positive, a follow-up plan is documented on the s.cms.hhs.gov/a 
date of the positive screen. pp/ask/p/21,26 
,1139 
Quality Insights 
of Pennsylvania 
(QIP): 
www.usquality 
measures.org 
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October 2012 
CMS 
eMeasure ID & 
CQM Number 
 
CQM Title & Description 
Measure 
Steward & 
Contact 
Information 
Other Quality 
Measure 
Programs that 
use the Same 
CQM 
 
 
Domain 
NEW: CMS75v1 Children who have dental decay or cavities 
 
Percentage of children ages 0-20, who have had 
tooth decay or cavities during the measurement 
period. 
Maternal and 
Child Health 
Bureau, Health 
Resources and 
Services 
Administratio
n (MCHB-
HRSA): 
http://mchb.hr
s a.gov/ 
 Clinical 
Process/ 
Effectiveness 
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Stage 2 Meaningful Use 
Specification Sheet Table of 
Contents for Eligible Hospitals 
and CAHs 
RESOURCES FOR 
ELIGIBLE HOSPITALS & 
CRITICAL ACCESS 
HOSPITALS 
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Stage 2 
      
      
Eligible Hospital Core Objectives 
 
(1) 
Use computerized provider order entry (CPOE) for medication, laboratory, and radiology orders 
directly entered by any licensed healthcare professional who can enter orders into the medical 
record per state, local, and professional guidelines. 
(2) 
Record all of the following demographics: preferred language, sex, race, ethnicity, date of birth, date 
and preliminary cause of death in the event of mortality in the eligible hospital or CAH. 
 
(3) 
Record and chart changes in the following vital signs: height/length and weight (no age limit); 
blood pressure (ages 3 and over); calculate and display body mass index (BMI); and plot and 
 display growth charts for patients 0-20 years, including BMI. 
(4) Record smoking status for patients 13 years old or older. 
(5) Use clinical decision support to improve performance on high-priority health conditions. 
(6) 
Provide patients the ability to view online, download, and transmit information about a hospital 
admission. 
(7) 
Protect electronic health information created or maintained by the Certified EHR Technology 
through the implementation of appropriate technical capabilities. 
(8) Incorporate clinical lab test results into Certified EHR Technology as structured data. 
(9) 
Generate lists of patients by specific conditions to use for quality improvement, reduction of 
disparities, research, or outreach. 
(10) 
Use clinically relevant information from Certified EHR Technology to identify patient-specific 
education resources and provide those resources to the patient. 
(11) 
The eligible hospital or CAH who receives a patient from another setting of care or provider of care 
or believes an encounter is relevant should perform medication reconciliation. 
 
(12) 
The eligible hospital or CAH who transitions their patient to another setting of care or provider of 
care or refers their patient to another provider of care provides a summary care record for each 
transition of care or referral. 
(13) 
Capability to submit electronic data to immunization registries or immunization information 
systems except where prohibited, and in accordance with applicable law and practice. 
(14) 
Capability to submit electronic reportable laboratory results to public health agencies, where 
except where prohibited, and in accordance with applicable law and practice. 
(15) 
Capability to submit electronic syndromic surveillance data to public health agencies, except 
where prohibited, and in accordance with applicable law and practice. 
(16) 
Automatically track medications from order to administration using assistive technologies in 
conjunction with an electronic medication administration record (eMAR). 
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View or download all of the eligible hospital and CAH Stage 2 Core and Menu Objectives for Stage 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Eligible Hospital Menu Objectives 
(1) Record whether a patient 65 years old or older has an advance directive. 
(2) Record electronic notes in patient records. 
(3) 
Imaging results consisting of the image itself and any explanation or other accompanying 
information are accessible through CEHRT. 
(4) Record patient family health history as structured data. 
(5) Generate and transmit permissible discharge prescriptions electronically (eRx). 
Provide structured electronic lab results to ambulatory providers. (6) 
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Stage 1 vs. Stage 2 Comparison 
Table for Eligible Hospitals 
and CAHs 
RESOURCES FOR 
ELIGIBLE HOSPITALS & 
CRITICAL ACCESS 
HOSPITALS 
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Stage 1 vs. Stage 2 
Comparison Table for Eligible 
Hospitals and CAHs 
CORE OBJECTIVES (16 total) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Stage 1 
Objective 
Stage 1 Measure Stage 2 Objective Stage 2 Measure 
Use CPOE for 
medication orders 
directly entered by 
any licensed 
healthcare 
professional who 
can enter orders 
into the medical 
record per state, 
local and 
professional 
guidelines 
More than 30% of 
unique patients with at 
least one medication in 
their medication list 
admitted  to the  
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23) have at least one 
medication order 
entered using CPOE 
Use computerized 
provider order entry 
(CPOE) for medication, 
laboratory and radiology 
orders directly entered by 
any licensed healthcare 
professional who can 
enter orders into the 
medical record per state, 
local and professional 
guidelines 
More than 60% of 
medication, 30% of 
laboratory, and 30% of 
radiology orders created 
by authorized providers of 
the eligible hospital's or 
CAH's inpatient or 
emergency department 
(POS 21 or 23) during the 
EHR reporting period are 
recorded using CPOE 
Implement drug- 
drug and drug- 
allergy interaction 
checks 
The eligible 
hospital/CAH has 
enabled this 
functionality for the 
entire EHR reporting 
period 
No longer a separate 
objective for Stage 2 
This measure is 
incorporated into the 
Stage 2 Clinical Decision 
Support measure 
Record 
demographics 
 Preferred 
language 
 Gender 
 Race 
 Ethnicity 
 Date of birth 
 Date and 
preliminary 
cause of death 
in the event of 
mortality in the 
eligible hospital 
or CAH 
More than 50% of all 
unique patients 
admitted to the 
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23) have demographics 
recorded as structured 
data 
Record the following 
demographics 
 Preferred 
language 
 Gender 
 Race 
 Ethnicity 
 Date of birth 
 Date and 
preliminary cause 
of death in the 
event of mortality 
in the eligible 
hospital or CAH 
More than 80% of all 
unique patients admitted 
to the eligible hospital's or 
CAH's inpatient or 
emergency department 
(POS 21 or 23) have 
demographics recorded as 
structured data 
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Maintain an up-to- 
date problem list of 
current and active 
diagnoses 
More than 80% of all 
unique patients 
admitted to the 
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23) have at least one 
entry or an indication 
that no problems are 
known for the patient 
recorded as structured 
data 
No longer a separate 
objective for Stage 2 
This measure is 
incorporated into the 
Stage 2 measure of 
Summary of Care 
Document at Transitions 
of Care and Referrals 
Maintain active 
medication list 
More than 80% of all 
unique patients 
admitted to the 
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23) have at least one 
entry (or an indication 
that the patient is not 
currently prescribed 
any medication) 
recorded as structured 
data 
No longer a separate 
objective for Stage 2 
This measure is 
incorporated into the 
Stage 2 measure of 
Summary of Care 
Document at Transitions 
of Care and Referrals 
Maintain active More than 80% of all No longer a separate This measure is 
medication allergy unique patients objective for Stage 2 incorporated into the 
list admitted to the Stage 2 measure of 
eligible hospital’s or Summary of Care 
CAH’s inpatient or Document at Transitions 
emergency of Care and Referrals 
department (POS 21 or 
23) have at least one 
entry (or an indication 
that the patient has no 
known medication 
allergies) recorded as 
structured data 
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Record and chart 
changes in vital 
signs: 
 Height 
 Weight 
 Blood pressure 
 Calculate and 
display BMI 
 Plot and display 
growth charts 
for children 2- 
20 years, 
including BMI 
More than 50% of all 
unique patients age 2 
and over admitted to 
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23), blood pressure 
height and weight are 
recorded as structured 
data 
Record and chart changes 
in vital signs: 
 Height 
 Weight 
 Blood pressure (age 3 
and over) 
 Calculate and display 
BMI 
 Plot and display 
growth charts for 
patients 0-20 years, 
including BMI 
More than 80% of all 
unique patients admitted 
to the eligible hospital's or 
CAH's inpatient or 
emergency department 
(POS 21 or 23) have blood 
pressure (for patients age 
3 and over only) and 
height and weight (for all 
ages) recorded as 
structured data 
Record smoking 
status for patients 
13 years old or 
older 
More than 50% of all 
unique patients 13 
years old or older 
admitted to the 
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23) have smoking 
status recorded as 
structured data 
Record smoking status for 
patients 13 years old or 
older 
More than 80% of all 
unique patients 13 years 
old or older admitted to 
the eligible hospital's or 
CAH's inpatient or 
emergency department 
(POS 21 or 23) have 
smoking status recorded 
as structured data 
Implement one 
clinical decision 
support rule 
relevant to 
specialty or high 
clinical priority 
along with the 
ability to track 
compliance that 
rule 
Implement one clinical 
decision support rule 
Use clinical decision 
support to improve 
performance on high- 
priority health conditions 
1. Implement 5 clinical 
decision support 
interventions related 
to 4 or more clinical 
quality measures, if 
applicable, at a 
relevant point in 
patient care for the 
entire EHR reporting 
period. 
2. The eligible hospital or 
CAH has enabled the 
functionality for drug- 
drug and drug-allergy 
interaction checks for 
the entire EHR 
reporting period 
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Report clinical 
quality measures 
(CQMs) to CMS or 
the States 
For 2011, provide 
aggregate numerator, 
denominator, and 
exclusions through 
attestation or 
electronically through 
the Hospital Reporting 
Pilot 
No longer a separate 
objective for Stage 2, but 
providers must still submit 
CQMs to CMS or the 
States in order to achieve 
meaningful use 
Starting in 2014, all CQMs 
will be submitted 
electronically to CMS. 
Provide patients 
with an electronic 
copy of their health 
information 
(including 
diagnostic test 
results, problem 
list, medication 
lists, medication 
allergies), upon 
request 
More than 50% of all 
patients of the 
inpatient or 
emergency 
departments of the 
eligible hospital or CAH 
(POS 21 or 23) who 
request an electronic 
copy of their health 
information are 
provided it within 3 
business days 
Provide patients the ability 
to view online, download 
and transmit their health 
information within 36 
hours after discharge from 
the hospital 
i. More than 50% of all 
unique patients 
discharged from the 
inpatient or  
emergency 
departments of the 
eligible hospital or CAH 
(POS 21 or 23) during 
the EHR reporting 
period are provided 
timely (available to the 
patient  within 36  
hours after discharge 
from the hospital.) 
online access to their 
health information 
ii. More than 5% of all 
unique patients 
discharged from the 
inpatient or  
emergency 
departments of the 
eligible hospital or CAH 
(POS 21 or 23) during 
the EHR reporting 
period (or their 
authorized 
representatives) view, 
download, or transmit 
to a third party their 
health information 
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Provide patients 
with an electronic 
copy of their 
discharge 
instructions at time 
of discharge, upon 
request 
More than 50% of all 
patients who are 
discharged from an 
eligible hospital or 
CAH’s inpatient 
department or 
emergency 
department (POS 21 or 
23) and who request 
an electronic copy of 
their discharge 
instructions are 
provided it 
This objective is 
eliminated from Stage 1 
in 2014 and is no longer a 
separate objective for 
Stage 2 
This measure has been 
incorporated into the 
View, Download, and 
Transmit objective for 
Stage 2 
Capability to 
exchange key 
clinical information 
(for example, 
problem list, 
medication list, 
medication 
allergies, diagnostic 
test results), among 
providers of care 
and patient 
authorized entities 
electronically 
Performed at least one 
test of certified EHR 
technology's capacity 
to electronically 
exchange key clinical 
information 
This objective is 
eliminated from Stage 1 
in 2013 and is no longer 
an objective for Stage 2 
This measure is 
eliminated from Stage 1 
in 2013 and is no longer a 
measure for Stage 2 
Protect electronic Conduct or review a Protect electronic health Conduct or review a 
health information security risk analysis information created or security risk analysis in 
created or per 45 CFR 164.308 maintained by the accordance with the 
maintained by the (a)(1) and implement Certified EHR Technology requirements under 45 
certified EHR security updates as through the CFR 164.308 (a)(1), 
technology through necessary and correct implementation of including addressing the 
the implementation identified security appropriate technical encryption/security of 
of appropriate deficiencies as part of capabilities data at rest and 
technical its risk management implement security 
capabilities process updates as necessary and 
correct identified security 
deficiencies as part of its 
risk management process 
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Implement drug- 
formulary checks 
The eligible 
hospital/CAH has 
enabled this 
functionality and has 
access to at least one 
internal or external 
drug formulary for the 
entire EHR reporting 
period 
No longer a separate 
objective for Stage 2 
This measure is 
incorporated into the e- 
Prescribing measure for 
Stage 2 
Incorporate clinical 
lab-test results into 
certified EHR 
technology as 
structured data 
More than 40% of all 
clinical lab tests results 
ordered by an 
authorized provider of 
the eligible hospital or 
CAH for patients 
admitted to its 
inpatient or 
emergency 
department (POS 21 or 
23) during the EHR 
reporting period 
whose results are 
either in a 
positive/negative or 
numerical format are 
incorporated in 
certified EHR 
technology as 
structured data 
Incorporate clinical lab- 
test results into Certified 
EHR Technology as 
structured data 
More than 55% of all 
clinical lab tests results 
ordered by authorized 
providers of the eligible 
hospital or CAH for 
patients admitted to its 
inpatient or emergency 
department (POS 21 or 23 
during the EHR reporting 
period whose results are 
either in a 
positive/negative or 
numerical format are 
incorporated in Certified 
EHR Technology as 
structured data 
Generate lists of Generate at least one Generate lists of patients Generate at least one 
patients by specific report listing patients by specific conditions to report listing patients of 
conditions to use of the eligible hospital use for quality the eligible hospital or 
for quality or CAH with a specific improvement, reduction CAH with a specific 
improvement, condition of disparities, research, or condition 
reduction of outreach 
disparities, research 
or outreach 
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Use certified EHR 
technology to 
identify patient- 
specific education 
resources and 
provide those 
resources to the 
patient if 
appropriate 
More than 10% of all 
unique patients 
admitted to the 
eligible hospital’s or 
CAH’s inpatient or 
emergency 
department (POS 21 or 
23) are provided 
patient-specific 
education resources 
Use certified EHR 
technology to identify 
patient-specific education 
resources and provide 
those resources to the 
patient if appropriate 
More than 10% of all 
unique patients admitted to 
the eligible hospital's or 
CAH's inpatient and 
emergency departments 
(POS 21 and 23) are 
provided patient- specific 
education resources 
identified by Certified EHR 
Technology 
The eligible hospital 
or CAH that 
receives a patient 
from another 
setting of care or 
provider of care or 
believes an 
encounter is 
relevant should 
perform medication 
reconciliation 
The eligible hospital or 
CAH performs 
medication 
reconciliation for more 
than 50% of transitions 
of care in which the 
patient is admitted to 
the eligible hospital’s 
or CAH’s inpatient or 
emergency 
department (POS 21 or 
23) 
The eligible hospital or 
CAH that receives a 
patient from another 
setting of care or provider 
of care or believes an 
encounter is relevant 
should perform 
medication reconciliation 
The eligible hospital or CAH 
performs medication 
reconciliation for more than 
50% of transitions of care in 
which the  patient  is 
admitted to the eligible 
hospital’s or CAH’s inpatient 
or emergency department 
(POS 21 or 23) 
The eligible hospital 
or CAH that 
transitions their 
patient to another 
setting of care or 
provider of care or 
refers their patient 
to another provider 
of care should 
provide summary 
of care record for 
each transition of 
care or referral 
The eligible hospital or 
CAH that transitions or 
refers their patient to 
another setting of care 
or provider of care 
provides a summary of 
care record for more 
than 50% of transitions 
of care and referrals 
The eligible hospital or 
CAH that transitions their 
patient to another setting 
of care or provider of care 
or refers their patient to 
another provider of care 
should provide summary 
of care record for each 
transition of care or 
referral 
1. The eligible hospital, or 
CAH that transitions or 
refers their patient to 
another setting of care 
or provider of care 
provides a summary of 
care record for more 
than 50% of transitions 
of care and referrals 
2. The eligible hospital or 
CAH that transitions or 
refers their patient to 
another setting of care 
or provider of care 
provides a summary of 
care record either a) 
electronically 
transmitted to a 
recipient using CEHRT or 
b) where the 
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recipient receives the 
summary of care 
record via exchange 
facilitated by an 
organization that is a 
NwHIN Exchange 
participant or is 
validated through an 
ONC‑established 
governance 
mechanism to 
facilitate exchange for 
10% of transitions and 
referrals 
3. The eligible hospital or 
CAH that transitions or 
refers their patient to 
another setting of care 
or provider of care 
must either a) conduct 
one or more 
successful electronic 
exchanges of a 
summary of care 
record with a recipient 
using technology that 
was designed by a 
different EHR 
developer than the 
sender’s, or b) 
conduct one or more 
successful tests with 
the CMS-designed test 
EHR during the EHR 
reporting period 
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Capability to submit 
electronic data to 
immunization 
registries or 
Immunization 
Information 
Systems and actual 
submission except 
where prohibited 
and in accordance 
with applicable law 
and practice 
Performed at least one 
test of certified EHR 
technology's capacity 
to submit electronic 
data to immunization 
registries and follow 
up submission if the 
test is successful 
(unless none of the 
immunization 
registries to which the 
eligible hospital or CAH 
submits such 
information have the 
capacity to receive the 
information 
electronically) 
Capability to submit 
electronic data to 
immunization registries or 
Immunization Information 
Systems and actual 
submission except where 
prohibited and in 
accordance with 
applicable law and 
practice 
Successful ongoing 
submission of electronic 
immunization data from 
Certified EHR Technology 
to an immunization 
registry or immunization 
information system for the 
entire EHR reporting 
period 
Capability to submit Performed at least one Capability to submit Successful ongoing 
electronic data on test of certified EHR electronic data on submission of electronic 
reportable (as technology’s capacity reportable (as required by reportable laboratory 
required by state or to provide electronic state or local law) lab results from Certified EHR 
local law) lab submission of results to public health Technology to public 
results to public reportable lab results agencies and actual health agencies for the 
health agencies and to public health submission except where entire EHR reporting 
actual submission agencies and follow-up prohibited and in period as authorized, and 
except where submission if the test accordance with in accordance with 
prohibited and in is successful (unless applicable law and applicable State law and 
accordance with none of the public practice practice 
applicable law and health agencies to 
practice which eligible hospital 
or CAH submits such 
information have the 
capacity to receive the 
information 
electronically) 
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Capability to submit 
electronic 
syndromic 
surveillance data to 
public health 
agencies and actual 
submission except 
where prohibited 
and in accordance 
with applicable law 
and practice 
Performed at least one 
test of certified EHR 
technology's capacity 
to provide electronic 
syndromic surveillance 
data to public health 
agencies and follow-up 
submission if the test 
is successful (unless 
none of the public 
health agencies to 
which an eligible 
hospital or CAH 
submits such 
information have the 
capacity to receive the 
information 
electronically) 
Capability to submit 
electronic syndromic 
surveillance data to public 
health agencies and actual 
submission except where 
prohibited and in 
accordance with 
applicable law and 
practice 
Successful ongoing 
submission of electronic 
syndromic surveillance 
data from Certified EHR 
Technology to a public 
health agency for the 
entire EHR reporting 
period 
NEW NEW Automatically track 
medications from order to 
administration using 
assistive technologies in 
conjunction with an 
electronic medication 
administration record 
(eMAR) 
More than 10% of 
medication orders created 
by authorized providers of 
the eligible hospital's or 
CAH's inpatient or 
emergency department 
(POS 21 or 23) during the 
EHR reporting period for 
which all doses are 
tracked are tracked using 
eMAR 
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Stage 1 
Objective 
Stage 1 Measure Stage 2 Objective Stage 2 Measure 
Record advance 
directives for 
patients 65 years 
old or older 
More than 50% of 
all unique patients 
65 years old or 
older admitted to 
the eligible 
hospital’s or CAH’s 
inpatient 
department (POS 
21) have an 
indication of an 
advance directive 
status recorded 
Record whether a 
patient 65 years old 
or older has an 
advance directive 
More than 50% of all unique 
patients 65 years old or older 
admitted to the eligible 
hospital's or CAH's inpatient 
department (POS 21) during the 
EHR reporting period have an 
indication of an advance 
directive status recorded as 
structured data 
NEW NEW Record electronic 
notes in patient 
records 
Enter at least one electronic 
progress note created, edited 
and signed by an EP for more 
than 30% of unique patients 
admitted to the eligible hospital 
or CAH’s inpatient or emergency 
department during the EHR 
reporting period 
NEW NEW Imaging results 
consisting of the image 
itself and any 
explanation or other 
accompanying 
information are 
accessible through 
CEHRT. 
More than 10% of all scans and 
tests whose result is an image 
ordered by an authorized 
provider of the eligible hospital 
or CAH for patients admitted to 
its inpatient or emergency 
department (POS 21 and 
23) during the EHR reporting 
period are incorporated into or 
accessible through Certified 
EHR Technology 
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NEW NEW Record patient family 
health history as 
structured data 
More than 20% of all 
unique patients admitted 
to the eligible hospital or 
CAH's inpatient or 
emergency department 
(POS 21 or 23) during the 
EHR reporting period have 
a structured data entry for 
one or more first-degree 
relatives or an indication 
that family health history 
has been reviewed 
NEW NEW Generate and transmit 
permissible discharge 
prescriptions electronically 
(eRx) 
More than 10% of hospital 
discharge medication 
orders for permissible 
prescriptions (for new or 
changed prescriptions) are 
compared to at least one 
drug formulary and 
transmitted electronically 
using Certified EHR 
Technology 
NEW NEW Provide structured 
electronic lab results to 
ambulatory providers 
Hospital labs send 
structured electronic 
clinical lab results to the 
ordering provider for 
more than 20% of 
electronic lab orders 
received 
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As part of the American Recovery and Reinvestment Act of 2009 (ARRA), Congress mandated payment 
adjustments to be applied to Medicare eligible hospitals, and critical access hospitals (CAHs) that are not 
meaningful users of Certified Electronic Health Record (EHR) Technology under the Medicare EHR 
Incentive Programs. These payment adjustments will be applied beginning on October 1, 2014, for 
Medicare eligible hospitals. Payment adjustments for CAHs will be applied beginning with the fiscal year 
2015 cost reporting period. Medicaid eligible hospitals that can only participate in the Medicaid EHR 
Incentive Program and do not bill Medicare are not subject to these payment adjustments. 
 
Eligible hospitals and CAHs that can participate in either the Medicare or Medicaid EHR Incentive 
Programs will be subject to the payment adjustments unless they are meaningful users under one of the 
EHR Incentive Programs in the time periods specified below. 
Payment Adjustment for Medicare Subsection (d) Eligible Hospitals 
Medicare Subsection (d) eligible hospitals that are not meaningful users will be subject to a payment 
adjustment beginning on October 1, 2014. This payment adjustment is applicable to the percentage 
increase to the Inpatient Prospective Payment System (IPPS) payment rate for those eligible hospitals 
that are not meaningful EHR users. These hospitals will receive a reduced update to the IPPS 
standardized amount. The payment adjustment is cumulative for each year that a Medicare Subsection 
(d) eligible hospital is not a meaningful EHR user. The table below illustrates the application of the 
reduced update to the IPPS standardized amount. 
 
  
2015 
 
2016 
 
2017 
 
2018 
 
2019 
 
2020+ 
 
% Decrease 
 
25% 
 
50% 
 
75% 
 
75% 
 
75% 
 
75% 
 
For example if the increase to IPPS for 2015 was 2%, then an Medicare subsection (d) eligible hospital 
that is not a meaningful user would only receive a 1.5% increase in 2015. 
 
Medicare Subsection (d) eligible hospitals that first demonstrated meaningful use in fiscal year 2011 or 
2012 must demonstrate meaningful use for a full year in fiscal year 2013 to avoid payment adjustments 
in 2015. They must continue to demonstrate meaningful use every year to avoid payment adjustments 
in subsequent years. The table below illustrates the timeline to avoid payment adjustments for 
Medicare Subsection (d) eligible hospitals that must demonstrate meaningful use for a full year in 2013. 
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Medicare Subsection (d) eligible hospitals that first demonstrate meaningful use in fiscal year 2013 must 
demonstrate meaningful use for a 90-day reporting period in 2013 to avoid payment adjustments in 
2015. They must continue to demonstrate meaningful use every year to avoid payment adjustments in 
subsequent years. The table below illustrates the timeline to avoid payment adjustments for EPs who 
demonstrate meaningful use for a 90-day reporting period in 2013. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
90 day EHR Reporting Period 
 
2013 
     
 
Full Year EHR Reporting Period 
  
2013 
 
2013 
 
2013 
 
2013 
 
2013 
 
Medicare Subsection (d) eligible hospitals that first demonstrate meaningful use in fiscal year 2014 must 
demonstrate meaningful use for a 90-day reporting period in 2014 to avoid payment adjustments in 
2015. This reporting period must occur in the first 9 months of fiscal year 2014, and Medicare 
Subsection (d) eligible hospitals must attest to meaningful use no later than July 1, 2014, in order to 
avoid the payment adjustments. Medicare Subsection (d) eligible hospitals must continue to 
demonstrate meaningful use every year to avoid payment adjustments in subsequent years. The table 
below illustrates the timeline to avoid payment adjustments for Medicare Subsection (d) eligible 
hospitals that first demonstrate meaningful use in 2014. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
90 day EHR Reporting Period 
 
2014* 
 
2014 
    
 
Full Year EHR Reporting Period 
   
2015 
 
2016 
 
2017 
 
2019 
* Medicare Subsection (d) eligible hospitals must attest to meaningful use no later than April 1, 2014. 
 
 
 
 
  
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
Full Year EHR Reporting Period 
 
2013 
 
2014 
 
2015 
 
2016 
 
2017 
 
2019 
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Payment Adjustment for Critical Access Hospitals 
Critical Access Hospitals (CAHs) that are not meaningful users will be subject to a payment adjustment 
for fiscal year 2015. This payment adjustment is applicable to a CAH's Medicare reimbursement for 
inpatient services during the cost reporting period in which they failed to demonstrate meaningful use.  
If a CAH has not demonstrated meaningful use for an applicable reporting period, then for a cost 
reporting period that begins in FY 2015, its reimbursement would be reduced from 101 percent of its 
reasonable costs to 100.66 percent. For a cost reporting period beginning in FY 2016, its reimbursement 
would be reduced to 100.33 percent of its reasonable costs. For a cost reporting period beginning in FY 
2017 and each subsequent FY, its reimbursement would be reduced to 100 percent of reasonable costs. 
The table below illustrates the application of the payment adjustments to CAHs that fail to demonstrate 
meaningful use. 
 
 
2015 2016 2017 2018 2019 2020+ 
 
% of reasonable costs 
 
100.66% 
 
100.33% 
 
100% 
 
100% 
 
100% 
 
100% 
 
In order to avoid the payment adjustments, CAHs must demonstrate meaningful use within the full 
Federal fiscal year that is the same as the payment adjustment year. The adjustment would then apply 
based upon the cost reporting period that begins in the payment adjustment year (that is, fiscal year 
2015 and thereafter). Thus, if a CAH is not a meaningful user for fiscal year 2015, and thereafter, then 
the adjustment would be applied to the CAH's reasonable costs incurred in a cost reporting period that 
begins in that affected fiscal year. The table below illustrates the timeline to avoid payment adjustments 
for CAHs that demonstrate meaningful use for the first time prior to fiscal year 2015. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
Full Year EHR Reporting Period 
 
2015 
 
2016 
 
2017 
 
2018 
 
2019 
 
2020 
 
The table below illustrates the timeline to avoid payment adjustments for CAHs that demonstrate 
meaningful use for the first time in fiscal year 2015. 
 
Payment Adjustment Year 2015 2016 2017 2018 2019 2020 
 
90 day EHR Reporting Period 
 
2015 
     
 
Full Year EHR Reporting Period 
  
2016 
 
2017 
 
2018 
 
2019 
 
2020 
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Note: CAHs are required to submit their attestations for meaningful use by November 30th of the 
following fiscal year. For example, if a CAH is attesting that it was a meaningful EHR user for fiscal year 
2015, the attestation must be submitted no later than November 30, 2015 in order to avoid payment 
adjustments. 
Hardship Exceptions for Medicare Eligible Hospitals and CAHs 
Eligible hospitals and CAHs may apply for hardship exceptions to avoid the payment adjustments 
described above. Hardship exceptions will be granted only under specific circumstances and only if CMS 
determines that providers have demonstrated that those circumstances pose a significant barrier to 
their achieving meaningful use. Information on how to apply for a hardship exception will be posted on 
the CMS EHR Incentive Programs website (www.cms.gov/EHRIncentivePrograms) in the future. 
 
Medicare Subsection (d) eligible hospitals can apply for hardship exceptions in the following categories: 
 
 Infrastructure — Eligible hospitals must demonstrate that they are in an area without sufficient 
internet access or face insurmountable barriers to obtaining infrastructure (e.g., lack of 
broadband). 
 New eligible hospitals — Eligible hospitals with new CMS Certification Numbers (CCNs) that 
would not have had time to become meaningful users can apply for a limited exception to 
payment adjustments. The hardship exception is limited to one full-year cost reporting period. 
 Unforeseen Circumstances — Examples may include a natural disaster or other unforeseeable 
barrier. 
 
Critical Access Hospitals (CAHs) can apply for hardship exceptions in the following categories: 
 
 Infrastructure — CAHs must demonstrate that they are in an area without sufficient internet 
access or face insurmountable barriers to obtaining infrastructure (e.g., lack of broadband). 
 New CAHs — CAHs with new CMS Certification Numbers (CCNs) that would not have had time 
to become meaningful users can apply for a limited exception to payment adjustments. The 
hardship exception is limited to one full year after the CAH accepts its first patient. 
 Unforeseen Circumstances — Examples may include a natural disaster or other unforeseeable 
barrier. 
Frequently Asked Questions 
Does a hospital have to achieve meaningful use each year to avoid the payment adjustments or can it 
avoid the payment adjustments by achieving meaningful use only once? 
Hospitals must demonstrate meaningful use every year according to the timelines detailed above in 
order to avoid Medicare payment adjustments. For example, eligible hospital that demonstrates 
meaningful use for the first time in 2013 will avoid the payment adjustment in 2015, but will need to 
demonstrate meaningful use again in 2014 in order to avoid the payment adjustment in 2016. Similarly, 
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   i l  i  i l   ill i     i  
  l    i l  i  i l    i     i
 
 
 
 
 
 
 
 
An eligible hospital or CAH demonstrates meaningful use by successfully attesting through either the 
CMS Medicare EHR Incentive Programs Attestation System (https://ehrincentives.cms.gov/) or through 
its state’s attestation system. 
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CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS 
BEGINNING WITH FY 2014 
 
 
CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
55 0495 Emergency 
Department (ED)-1 
Emergency 
Department 
Throughput – Median 
time from ED arrival 
to ED departure for 
admitted ED patients 
Median time from 
emergency department 
arrival to time of 
departure from the 
emergency room for 
patients admitted to the 
facility from the 
emergency department. 
For Meaningful Use 
Stage 2 reporting: 
Median time (in minutes) 
from ED arrival to ED 
departure for patients 
admitted to the facility 
from the emergency 
department. 
For Meaningful Use 
Stage 2 reporting: All ED 
patients admitted to the 
facility from the ED and 
stratified according to 
Inpatient Admission or 
Diagnosis of 
Psychiatric/Mental 
Health condition 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=470&print=0& 
entityTypeID=1 
111 0497 ED-2 Emergency 
Department 
Throughput – 
admitted patients – 
Admit decision time 
to ED departure time 
for admitted patients 
Median time (in minutes) 
from admit decision time 
to time of departure from 
the emergency 
department for 
emergency department 
patients admitted to 
inpatient status. 
For Meaningful Use 
Stage 2 reporting: 
Median time (in minutes) 
from Decision to Admit 
to ED departure for 
patients admitted to the 
facility from the 
emergency department. 
For Meaningful Use 
Stage 2 reporting:  All 
ED patients admitted to 
the facility from the ED 
and stratified according 
to Inpatient Admission or 
Diagnosis of 
Psychiatric/Mental 
Health condition. 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=472&print=0& 
entityTypeID=1 
104 0435 Stroke-2 Ischemic 
stroke – Discharged 
on anti-thrombotic 
therapy. 
Ischemic stroke patients 
prescribed antithrombotic 
therapy at hospital 
discharge. 
Ischemic stroke patients 
prescribed 
antithrombotic therapy at 
hospital discharge. 
Ischemic stroke patients. The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=672&print=0& 
entityTypeID=1 
71 0436 Stroke-3 Ischemic 
stroke – 
Anticoagulation 
Therapy for Atrial 
Fibrillation/Flutter 
Ischemic stroke patients 
with atrial fibrillation/flutter 
who are prescribed 
anticoagulation therapy at 
hospital discharge. 
Ischemic stroke patients 
prescribed 
anticoagulation therapy 
at hospital discharge. 
Ischemic stroke patients 
with documented atrial 
fibrillation/flutter. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=673&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
91 0437 Stroke-4 Ischemic 
stroke – Thrombolytic 
Therapy 
Acute ischemic stroke 
patients who arrive at this 
hospital within 2 hours 
(120 minutes) of time last 
known well and for whom 
IV t-PA was initiated at 
this hospital within 3 
hours (180 minutes) of 
time last known well. 
Acute ischemic stroke 
patients for whom IV 
thrombolytic therapy was 
initiated at this hospital 
within 3 hours (less than 
or equal to 180 minutes) 
of time last known well. 
Acute ischemic stroke 
patients whose time of 
arrival is within 2 hours 
(less than or equal to 
120 minutes) of time last 
known well. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=674&print=0& 
entityTypeID=1 
72 0438 Stroke-5 Ischemic 
stroke – 
Antithrombotic 
therapy by end of 
hospital day two 
Ischemic stroke patients 
administered 
antithrombotic therapy by 
the end of hospital day 
two. 
Ischemic stroke patients 
who had antithrombotic 
therapy administered by 
end of hospital day two. 
Ischemic stroke patients. The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=675&print=0& 
entityTypeID=1 
105 0439 Stroke-6 Ischemic 
stroke – Discharged 
on Statin Medication 
Ischemic stroke patients 
with LDL greater than or 
equal to 100 mg/dL, or 
LDL not measured, or, 
who were on a lipid- 
lowering medication prior 
to hospital arrival are 
prescribed statin 
medication at hospital 
discharge. 
Ischemic stroke patients 
prescribed statin 
medication at hospital 
discharge. 
Ischemic stroke patients 
with an LDL greater than 
or equal to 100 mg/dL, 
OR LDL not measured, 
OR who were on a lipid- 
lowering medication prior 
to hospital arrival. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=676&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
107 0440 Stroke-8 Ischemic or 
hemorrhagic stroke – 
Stroke education 
Ischemic or hemorrhagic 
stroke patients or their 
caregivers who were 
given educational 
materials during the 
hospital stay addressing 
all of the following: 
activation of emergency 
medical system, need for 
follow-up after discharge, 
medications prescribed at 
discharge, risk factors for 
stroke, and warning signs 
and symptoms of stroke. 
Ischemic or hemorrhagic 
stroke patients with 
documentation that they 
or their caregivers were 
given educational 
material addressing all 
of the following: 
1. Activation of 
emergency medical 
system 
2. Need for follow-up 
after discharge 
3. Medications 
prescribed at 
discharge 
4. Risk factors for stroke 
5. Warning signs and 
symptoms of stroke. 
Ischemic stroke or 
hemorrhagic stroke 
patients discharged to 
home. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=678&print=0& 
entityTypeID=1 
102 0441 Stroke-10 Ischemic 
or hemorrhagic 
stroke – Assessed for 
Rehabilitation 
Ischemic or hemorrhagic 
stroke patients who were 
assessed for 
rehabilitation services. 
Ischemic or hemorrhagic 
stroke patients assessed 
for or who received 
rehabilitation services. 
Patients admitted to the 
hospital for inpatient 
acute care with a 
principal diagnosis code 
for ischemic or 
hemorrhagic stroke with 
hospital stays <= 120 
days during the 
measurement period for 
patients age 18 and 
older at the time of 
hospital admission. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=680&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
108 0371 Venous 
Thromboembolis
m (VTE)-1 VTE 
prophylaxis 
This measure assesses 
the number of patients 
who received VTE 
prophylaxis or have 
documentation why no 
VTE prophylaxis was 
given the day of or the 
day after hospital 
admission or surgery end 
date for surgeries that 
start the day of or the day 
after hospital admission. 
Patients who received 
VTE prophylaxis or have 
documentation why no 
VTE prophylaxis was 
given: 
 the day of or the day 
after hospital 
admission 
 the day of or the day 
after surgery end date 
for surgeries that start 
the day of or the day 
after hospital 
admission 
All patients in the initial 
patient population. 
The Joint 
Commissio
n 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=270&print=0& 
entityTypeID=1 
190 0372 VTE-2 Intensive Care 
Unit (ICU) VTE 
prophylaxis 
This measure assesses 
the number of patients 
who received VTE 
prophylaxis or have 
documentation why no 
VTE prophylaxis was 
given the day of or the 
day after the initial 
admission (or transfer) to 
the ICU or surgery end 
date for surgeries that 
start the day of or the day 
after ICU admission (or 
transfer). 
Patients who received 
VTE prophylaxis or have 
documentation why no 
VTE prophylaxis was 
given: 
 the day of or the day 
after ICU admission 
(or transfer) 
 the day of or the day 
after surgery end date 
for surgeries that start 
the day of or the day 
after ICU admission 
(or transfer) 
Patients directly admitted 
or transferred to ICU. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=267&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
73 0373 VTE-3 VTE Patients 
with Anticoagulation 
Overlap Therapy 
This measure assesses 
the number of patients 
diagnosed with confirmed 
VTE who received an 
overlap of parenteral 
(intravenous [IV] or 
subcutaneous [subcu]) 
anticoagulation and 
warfarin therapy. For 
patients who received 
less than five days of 
overlap therapy, they 
must be discharged on 
both medications or have 
a reason for 
discontinuation of overlap 
therapy. Overlap therapy 
must be administered for 
at least five days with an 
international normalized 
ratio (INR) greater than or 
equal to 2 prior to 
discontinuation of the 
parenteral anticoagulation 
therapy, discharged on 
both medications or have 
a reason for 
discontinuation of overlap 
therapy. 
Patients who received 
overlap therapy 
(warfarin and parenteral 
anticoagulation): 
 Five or more days, 
with an INR greater 
than or equal to 2 prior 
to discontinuation of 
parenteral therapy, OR 
 Five or more days, 
with an INR less than 
2 and discharged on 
overlap therapy, OR 
 Less than five days 
and discharged on 
overlap therapy, OR 
 With documentation of 
reason for 
discontinuation of 
overlap therapy, OR 
 With documentation of 
a reason for no 
overlap therapy 
Patients with confirmed 
VTE who received 
warfarin. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=271&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
109 0374 VTE-4 VTE Patients 
Receiving 
Unfractionated 
Heparin (UFH) with 
Dosages/Platelet 
Count Monitoring by 
Protocol (or 
Nomogram) 
This measure assesses 
the number of patients 
diagnosed with confirmed 
VTE who received 
intravenous (IV) UFH 
therapy dosages AND 
had their platelet counts 
monitored using defined 
parameters such as a 
nomogram or protocol. 
Patients who have their 
IV UFH therapy dosages 
AND platelet counts 
monitored according to 
defined parameters such 
as a nomogram or 
protocol. 
Patients with confirmed 
VTE receiving IV UFH 
therapy. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=268&print=0& 
entityTypeID=1 
110 0375 VTE-5 VTE discharge 
instructions 
This measure assesses 
the number of patients 
diagnosed with confirmed 
VTE that are discharged 
to home, home care, 
court/law enforcement or 
home on hospice care on 
warfarin with written 
discharge instructions 
that address all four 
criteria: compliance 
issues, dietary advice, 
follow-up monitoring, and 
information about the 
potential for adverse drug 
reactions/interactions. 
Patients with 
documentation that they 
or their caregivers were 
given written discharge 
instructions or other 
educational material 
about warfarin that 
addressed all of the 
following: 
1. compliance issues 
2. dietary advice 
3. follow-up monitoring 
4. potential for adverse 
drug reactions and 
interactions 
Patients with confirmed 
VTE discharged to home 
or court/law enforcement 
on warfarin therapy. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=269&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
114 0376 VTE-6 Incidence of 
potentially 
preventable VTE 
This measure assesses 
the number of patients 
diagnosed with confirmed 
VTE during 
hospitalization (not 
present at admission) 
who did not receive VTE 
prophylaxis between 
hospital admission and 
the day before the VTE 
diagnostic testing order 
date. 
Patients who received 
no VTE prophylaxis prior 
to the VTE diagnostic 
test order date. 
Patients who developed 
confirmed VTE during 
hospitalization. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=272&print=0& 
entityTypeID=1 
100 0142 AMI-2-Aspirin 
Prescribed at 
Discharge for AMI 
AMI patients who are 
prescribed aspirin at 
hospital discharge. 
Acute Myocardial 
Infarction patients who 
are prescribed aspirin at 
hospital discharge. 
All AMI patients age 18 
and older with an ICD-9- 
CM Principal Diagnosis 
Code for Acute 
Myocardial Infarction. 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=1145&print=0 
&entityTypeID=1 
113 0469 PC-01 Elective 
Delivery Prior to 39 
Completed Weeks 
Gestation 
Patients with elective 
vaginal deliveries or 
elective cesarean 
sections at >= 37 and < 
39 weeks of gestation 
completed. 
Patients with elective 
deliveries. 
Patients delivering 
newborns with >= 37 and 
< 39 weeks of gestation 
completed. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=296&print=0& 
entityTypeID=1 
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CMS 
eMeasure 
ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
60 0164 AMI-7a Fibrinolytic 
Therapy Received 
Within 30 minutes of 
Hospital Arrival 
Acute myocardial 
infarction (AMI) patients 
with ST-segment 
elevation or LBBB on the 
ECG closest to arrival 
time receiving fibrinolytic 
therapy during the 
hospital stay and having 
a time from hospital 
arrival to fibrinolysis of 30 
minutes or less. 
AMI patients whose time 
from hospital arrival to 
fibrinolysis is 30 minutes 
or less. 
AMI patients age 18 and 
older with ST-elevation 
or LBBB on ECG who 
received fibrinolytic 
therapy with an ICD-9- 
CM Principal Diagnosis 
Code for AMI AND ST- 
segment elevation or 
LBBB on the ECG 
performed closest to 
hospital arrival AND 
Fibrinolytic therapy 
within 6 hours after 
hospital arrival AND 
Fibrinolytic therapy is 
primary reperfusion 
therapy. 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=1152&print=0 
&entityTypeID=1 
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ID 
 
NQF 
# 
 
 
Measure Title 
 
 
Measure Description 
 
 
Numerator Statement 
 
Denominator 
Statement 
 
Measure 
Steward 
 
Link to NQF 
website 
53 0163 AMI-8a Primary PCI Acute myocardial AMI patients whose time Principal diagnosis of CMS http://www.qualityfor 
Received Within 90 
Minutes of Hospital 
Arrival 
infarction (AMI) patients 
with ST-segment 
elevation or LBBB on the 
from hospital arrival to 
primary PCI is 90 
minutes or less. 
AMI (International 
Classification of 
Diseases, 9th revision, 
OFMQ is the 
developer 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=1151&print=0 
ECG closest to arrival Clinical Modification &entityTypeID=1 
time receiving primary [ICD-9-CM] principal 
PCI during the hospital diagnosis code: 410.00, 
stay with a time from 410.01, 410.10, 410.11, 
hospital arrival to PCI of 410.20, 410.21, 410.30, 
90 minutes or less. 410.31, 410.40, 410.41, 
410.50, 410.51, 410.60, 
410.61, 410.70, 410.71, 
410.80, 410.81, 410.90, 
410.91); and PCI 
procedure ICD-9-CM 
principal or other 
procedure code for PCI: 
00.66); and AMI patients 
age 18 and older with 
ST-elevation or LBBB on 
ECG who received 
primary PCI with an ICD- 
9-CM Principal 
Diagnosis Code for AMI 
AND PCI (ICD-9-CM 
Principal and Other 
Procedure Codes for 
PCI) AND ST-segment 
elevation or LBBB on the 
ECG performed closest 
to hospital arrival; and 
PCI performed within 24 
hours after hospital 
arrival. 
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Link to NQF 
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30 0639 AMI-10 Statin 
Prescribed at 
Discharge 
Acute Myocardial 
Infarction (AMI) patients 
who are prescribed a 
statin at hospital 
discharge. 
AMI patients who are 
prescribed a statin 
medication at hospital 
discharge. 
AMI patients. CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=102&print=0& 
entityTypeID=1 
188 0147 PN-6 Initial Antibiotic 
Selection for 
Community-
Acquired Pneumonia 
(CAP) in 
Immunocompetent 
Patients 
Immunocompetent 
patients with CAP who 
receive an initial antibiotic 
regimen during the first 
24 hours that is 
consistent with current 
guidelines. 
Pneumonia patients who 
received an initial 
antibiotic regimen 
consistent with current 
guidelines during the 
first 24 hours of 
hospitalization. 
Numerator 1 (in 
population 1) defines 
appropriate antibiotics 
for ICU patients. 
Numerator 2 (in 
population 2) defines 
appropriate antibiotics 
for non-ICU patients. 
Pneumonia patients 18 
years of age and older 
with an ICD-9-CM 
Hospital Measures- 
Principal Diagnosis Code 
of pneumonia, OR ICD- 
9-CM Hospital 
Measures-Principal 
Diagnosis Code of 
septicemia or respiratory 
failure (acute or chronic) 
and also a secondary 
ICD-9-CM Other 
Diagnosis Code of 
pneumonia, and 
abnormal findings on 
chest x-ray or CT scan of 
the chest within 24 hours 
prior to hospital arrival or 
during the 
hospitalization. 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=1134&print=0 
&entityTypeID=1 
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171 0527 SCIP-INF-1 
Prophylactic 
Antibiotic Received 
within 1 Hour Prior to 
Surgical Incision 
Surgical patients with 
prophylactic antibiotics 
initiated within one hour 
prior to surgical incision. 
Patients who received 
Vancomycin or a 
Fluoroquinolone for 
prophylactic antibiotics 
should have the 
antibiotics initiated within 
2 hours prior to surgical 
incision. Due to the 
longer infusion time 
required for Vancomycin 
or a Fluoroquinolone, it is 
acceptable to start these 
antibiotics within 2 hours 
prior to incision time. 
Number of surgical 
patients with 
prophylactic antibiotics 
initiated within one hour 
prior to surgical incision 
(two hours if receiving 
vancomycin, in Appendix 
C, Table 3.8, or a 
fluoroquinolone, in 
Appendix C, Table 3.10). 
All selected surgical 
patients 18 years of age 
and older with no 
evidence of prior 
infection with an ICD-9- 
CM Principal Procedure 
Code of selected 
surgeries. 
Denominator for 
population 1 – Coronary 
artery bypass graft 
(CABG) procedures 
Denominator for 
population 2 – Other 
cardiac surgery 
Denominator for 
population 3 – Hip 
arthroplasty 
Denominator for 
population 4 – Knee 
arthroplasty 
Denominator for 
population 5 – Colon 
surgery 
Denominator for 
population 6 – 
Abdominal hysterectomy 
Denominator for 
population 7 – Vaginal 
hysterectomy 
Denominator for 
population 8 – Vascular 
surgery 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=1154&print=0 
&entityTypeID=1 
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website 172 0528 SCIP-INF-2 
Prophylactic 
Antibiotic Selection 
for Surgical Patients 
Surgical patients who 
received prophylactic 
antibiotics consistent 
with current guidelines 
(specific to each type 
of surgical procedure). 
Number of surgical 
patients who received 
recommended 
prophylactic antibiotics 
for their specific surgical 
procedures. 
All selected surgical patients 
18 years of age and older 
with no evidence of prior 
infection with an ICD-9- CM 
Hospital Measures- Principal 
Procedure Code of selected 
surgeries. 
Denominator for population 
1 – Coronary artery bypass 
graft (CABG) procedures 
Denominator for 
population 2 – Other 
cardiac surgery 
Denominator for 
population 3 – Hip 
arthroplasty 
Denominator for 
population 4 – Knee 
arthroplasty 
Denominator for 
population 5 – Colon 
surgery 
Denominator for population 
6–- Abdominal hysterectomy 
Denominator for 
population 7 – Vaginal 
hysterectomy 
Denominator for population 
8 – Vascular surgery 
CMS 
OFMQ is 
the 
developer 
http://www.qualityf
or 
um.org/QPS/Meas
ur 
eDetails.aspx?sta
nd 
ardID=1155&print
=0 
&entityTypeID=1 
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178 0453 SCIP-INF-9 Urinary 
catheter removed on 
Postoperative Day 1 
(POD1) or 
Postoperative Day 2 
(POD2) with day of 
surgery being day 
zero 
Surgical patients with 
urinary catheter removed 
on Postoperative Day 1 
or Postoperative Day 2 
with day of surgery being 
day zero. 
Number of surgical 
patients whose urinary 
catheter is removed on 
POD 1 or POD 2 with 
day of surgery being day 
zero. 
All selected surgical 
patients 18 years of age 
and older with a 
catheter in place 
postoperatively with an 
ICD-9-CM Principal 
Procedure Code of 
selected surgeries. 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=648&print=0& 
entityTypeID=1 
32 0496 ED-3 Median time 
from ED arrival to ED 
departure for 
discharged ED 
patients 
Median time from 
emergency department 
arrival to time of 
departure from the 
emergency room for 
patients discharged from 
the emergency 
department. 
For Meaningful Use 
Stage 2 reporting: 
Median time (in minutes) 
from ED arrival to ED 
departure for patients 
discharged from the 
emergency department. 
For Meaningful Use 
Stage 2 reporting:  All 
ED patients discharged 
from the ED and 
stratified according to 
Discharge Home, 
Diagnosis of 
Psychiatric/Mental 
Health condition, 
Observation status, 
Transferred to Another 
Acute Care Hospital, or 
other patients not 
discharged from the ED. 
Do Not Include in any of 
the Strata: Patients who 
are not an ED Patient; 
Patients who expire in 
the ED; Patients 
admitted to the hospital 
from the ED. 
CMS 
OFMQ is the 
developer 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=471&print=0& 
entityTypeID=1 
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26 0338 Home Management 
Plan of Care (HMPC) 
Document Given to 
Patient/Caregiver 
An assessment that there 
is documentation in the 
medical record that a 
Home Management Plan 
of Care document was 
given to the pediatric 
asthma patient/caregiver. 
Pediatric asthma 
inpatients with 
documentation that they 
or their caregivers were 
given a written HMPC 
document that 
addresses all of the 
following: 
1. Arrangements for 
follow-up care 
2. Environmental control 
and control of other 
triggers 
3. Method and timing of 
rescue actions 
4. Use of controllers 
5. Use of relievers 
Pediatric asthma 
inpatients with an age of 
2 through 17 years, 
length of stay less than 
or equal to 120 days, 
and discharged to home 
or police custody. 
The Joint 
Commissio
n 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=348&print=0& 
entityTypeID=1 
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9 0480 Exclusive Breast Milk 
Feeding 
Exclusive breast milk 
feeding during the 
newborn's entire 
hospitalization. 
Newborns that were fed 
breast milk only since 
birth. 
Single term newborns 
discharged from the 
hospital who have no 
diagnosis of 
galactosemia, no 
procedure of parenteral 
infusion, no diagnosis of 
premature newborn, and 
length of stay less than 
or equal to 120 days. 
The Joint 
Commission 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=307&print=0& 
entityTypeID=1 
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185 0716 Healthy Term 
Newborn 
Percent of term singleton 
live births (excluding 
those with diagnoses 
originating in the fetal 
period) who DO NOT 
have significant 
complications during birth 
or in nursery care. 
The absence of 
conditions or procedures 
reflecting morbidity that 
happened during birth 
and nursery care to an 
otherwise normal infant. 
The denominator is 
composed of singleton, 
term (>=37 weeks), 
inborn, livebirths in their 
birth admission. The 
denominator further has 
eliminated fetal 
conditions likely to be 
present before labor. 
Maternal and obstetrical 
conditions (e.g., 
hypertension, prior 
cesarean, 
malpresentation) are not 
excluded unless 
evidence of fetal effect 
prior to labor (e.g., 
IUGR/SGA). 
California 
Maternal 
Quality Care 
Collaborativ
e 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=171&print=0& 
entityTypeID=1 
31 1354 EHDI-1a Hearing 
screening before 
hospital discharge 
This measure assesses 
the proportion of births 
that have been screened 
for hearing loss before 
hospital discharge. 
All live births during the 
measurement time 
period born at a facility 
and screened for 
hearing loss prior to 
discharge, or screened 
but still not discharged; 
or not screened due to 
medical reasons or 
medical exclusions. 
All live births during the 
measurement time 
period born at a facility 
and, discharged without 
being screened, or 
screened prior to 
discharge, or screened 
but still not discharged. 
Centers for 
Disease 
Control and 
Prevention 
http://www.qualityfor 
um.org/QPS/Measur 
eDetails.aspx?stand 
ardID=1354&print=0 
&entityTypeID=1 
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CLINICAL QUALITY MEASURES FOR CMS’S 2014 EHR INCENTIVE PROGRAM 
FOR ELIGIBLE HOSPITALS 
RELEASE NOTES 
 
In August 2012, the Centers for Medicare & Medicaid Services (CMS) finalized the clinical 
quality measures (CQMs) for the 2014 Medicare and Medicaid Electronic Health Record (EHR) 
Incentive Program for Eligible Hospitals, also known as Meaningful Use Stage 2 (MU2) for Eligible 
Hospitals.
1 
This list of CQMs for MU2 includes measures retained from Meaningful Use Stage 1 (MU1) 
for use in MU2. All retained MU1 measures have been updated based on advances in technology and 
tools for eMeasure development, comments from stakeholders, changes initiated by measure developers, 
and CMS’s standards as defined in the agency’s Measures Management System Blueprint, Version 8 
(Blueprint).2 
2
 
CMS recognizes the importance of providing support, training, and information to MU 
stakeholders, particularly as the EHR Incentive Programs transition to MU2. The purpose of this 
document is to inform eligible hospitals and the vendor community about updated program requirements 
related to the CQMs. This update includes information about global changes incorporated across all 
measures as well as specific changes to the measures retained in MU2. Global changes are listed first and 
include structural modifications; updates to value sets; and data elements and standards revised in 
accordance with the Blueprint. Specific changes to measures include changes to measure components, 
such as initial patient populations, denominators, numerators, exclusions, and exceptions, as well as logic 
changes that affect how data elements interrelate during the measurement period. 
 
This document is intended for readers who are familiar with eMeasure components and the 
current standards for construction an eMeasure. For more information on eMeasures, please visit the 
CMS website (http://www.cms.gov/Regulations-and- 
Guidance/Legislation/EHRIncentivePrograms/ClinicalQualityMeasures.html) 
 
 
 
1 CMS. “Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 2.” 2012. 
Available at [ http://www.ofr.gov/(X(1)S(uzclbwrx5fwqm2w2mipkysrh))/OFRUpload/OFRData/2012-21050_PI.pdf ]. Accessed August 
28, 2012. 
2 CMS. “CMS Measure Management System Blueprint, .” Available at [ http://www.cms.gov/Medicare/Quality-Initiatives-Patient- 
Assessment-Instruments/MMS/MeasuresManagementSystemBlueprint.html ]. Accessed August 28, 2012. Since the completion of MU2 
CQM’s the latest Blueprint version is 9.0. 
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Global Edits 
 Introduced a new measure-identification scheme that combines the eMeasure identifier, National Quality 
Forum (NQF) number (if applicable), and eMeasure version number. 
 Updated the rationale, clinical recommendation statements, and references to include the latest clinical 
guidance related to the measures. 
 Provided additional guidance to help implementers interpret the calculation requirements for the measures 
as well as instructional and clarifying notes. 
 Updated the eMeasure header to reflect Blueprint requirements (such as using the initial patient population 
to define the denominator and including stratification variables in the header) and modified other fields, 
such as population criteria, to reflect these changes. 
 Changed the standardization of the measurement period from “year” to “period.” 
 Updated the measure logic to reflect the changes to the Quality Data Model (QDM), to reflect consistent 
use of relative timing across measures (including age calculation), occurrencing, and denominator 
exclusions. 
 Assigned data elements based on version 2.1.1.1 of the QDM3 to each clinical concept, adding attributes as 
needed to precisely define QDM elements. 
 For measures using the QDM of “Medication, Active,” added the AND / AND NOT construct to 
compensate for varying interpretations of the relative timing “during.” The “Medication, Active” period 
can start at any time but cannot end before “Occurrence A of Encounter, Performed.” 
 Incorporated supplemental data elements (race, ethnicity, sex, and payer) as required by the Blueprint. 
 Reorganized and retitled the encounter value sets to standardize them across developers. Also incorporated 
encounter value sets using SNOMED-CT to align with the Health Information Technology Standards 
Committee (HITSC) vocabulary recommendation for the QDM data type “Encounter.” 
 Updated existing value sets and added new value sets to align with the transitional and final vocabularies, 
based on the HITSC recommendations and required by the Blueprint. 
 Value sets include fully-specified ICD-9-CM and ICD-10-CM codes. 
 Provided grouping object identifiers for each data element. 
 Added copyright information for vocabularies. 
 
 
 
 
 
 
 
3 
For more on the Quality Data Model, visit the NQF website at http://www.qualityforum.org/QualityDataModel.aspx 
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NQF 0495 Median time from ED arrival to ED departure for admitted ED patients 
 Added length of stay check for initial patient population of <=120 days 
 Observation services no longer used for stratification 
 ED visit must end within one hour of the inpatient encounter to associate the ED encounter with the 
inpatient encounter. 
 
NQF 0497 Median admit decision time to ED departure time for admitted patients 
 Added length of stay check for initial patient population of <=120 days 
 Observation services no longer use for stratification 
 ED visit must end within one hour of the inpatient encounter to associate the ED encounter with the 
inpatient encounter. 
 
NQF 0435 Ischemic stroke – Discharged on anti-thrombotic therapy 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Specified that a medication order for antithrombotic therapy could be present within one day prior to 
discharge. 
 
NQF 0436 Ischemic stroke – Anticoagulation Therapy for Atrial Fibrillation/Flutter 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Created the Atrial Ablation procedure value set to only include procedures specifically done for atrial 
fibrillation/flutter. 
 
NQF 0437 Ischemic stroke – Thrombolytic Therapy 
 Revised “Last Known Well” data element to create value sets for neurologic symptoms of stroke or 
baseline state symptom documented within 120 minutes of ED arrival. 
 ED visit must end within one hour of the inpatient encounter to associate the ED encounter with the 
inpatient encounter. 
 Added denominator exclusion if Thrombolytic Therapy (t-PA) was administered within two days prior 
to inpatient encounter. 
 Added denominator exclusion for risk category of National Institute of Health Stroke Scale = 0. 
 
NQF 0438 Ischemic stroke – Antithrombotic therapy by end of hospital day two 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Added logic to denominator exclusion to identify patients with Thrombolytic Therapy (t-PA) 
administered during their ED encounter for ED encounters within one hour of the inpatient encounter. 
196 
 
NQF 0439 Ischemic stroke – Discharged on Statin Medication 
 Added logic to denominator to evaluate timing of LDL-c laboratory results or Lipid-Lowering 
medication in relation to the ED encounter for ED encounters within one hour of the inpatient 
encounter. 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Specified that a medication order for statin could be present within one day prior to discharge. 
 Removed denominator exclusion for patients without evidence of atherosclerosis. 
 
NQF 0440 Ischemic or hemorrhagic stroke – Stroke education 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 
NQF 0441 Ischemic or hemorrhagic stroke – Assessed for Rehabilitation 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Added numerator statement to include patients transferred to a rehabilitation facility. 
 
NQF 0371 Venous Thromboembolism Prophylaxis 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Added denominator exclusion for patients with palliative care (comfort measures only) orders within 
one day of a procedure using general or neuraxial anesthesia occurring the day of or the day after the 
inpatient encounter. 
 VTE prophylaxis medication and VTE prophylaxis mechanical device value sets separated into 
individual value sets based on type of medication and device. 
 Added numerator statement for patient assessment of low risk for VTE. 
 
NQF 0372 Intensive Care Unit (ICU) Venous Thromboembolism Prophylaxis 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Added denominator exclusion for patients with palliative care (comfort measures only) orders within 
one day of a procedure using general or neuraxial anesthesia occurring the day of or the day after the 
ICU admission or transfer. 
 VTE prophylaxis medication and VTE prophylaxis mechanical device value sets separated into 
individual value sets based on type of medication and device. 
 Added numerator statement for patient assessment of low risk for VTE. 
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NQF 0373 Venous Thromboembolism Patients with Anticoagulation Overlap Therapy 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Removed denominator exclusion for patients not discharged on warfarin. 
 Added denominator exclusions for the following discharge status values: 
o Discharge to Another Hospital 
o Discharge to Home for Hospice Care 
o Discharge to Health Care Facility for Hospice Care 
o Patient expired 
o Left against advice 
 Added denominator statement to include patients with warfarin administration starting within one day 
prior to inpatient encounter. 
 Clarified calculation method for determining patients who were on 5 or more days of overlap therapy. 
 Added numerator statements to include patients with documented reason for no overlap or 
discontinuation of overlap therapy. 
 Added numerator statements to check for the administration of parenteral anticoagulant during the ED 
encounter for ED encounters within one hour of the inpatient encounter. 
 
NQF 0374 Venous Thromboembolism Patients Receiving Unfractionated Heparin (UFH) with 
Dosages/Platelet Count Monitoring  by Protocol (or Nomogram) 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 Added denominator exclusions for the following discharge status values: 
o Discharge to Another Hospital 
o Discharge to Home for Hospice Care 
o Discharge to Health Care Facility for Hospice Care 
o Patient expired 
o Left against advice 
 Added denominator statement to use confirmed VTE from diagnostic study performed up to two days 
prior to inpatient encounter. 
 Added denominator statement to use confirmed VTE from diagnostic study performed up to two days 
prior to ED encounter for ED encounters within one hour of the inpatient encounter. 
 
NQF 0375 Venous Thromboembolism Discharge Instructions 
 Added denominator statement to use confirmed VTE from diagnostic study performed up to two days 
prior to inpatient encounter. 
 Added denominator statement to use confirmed VTE from diagnostic study performed up to two days 
prior to ED encounter for ED encounters within one hour of the inpatient encounter. 
 Revised description and updated denominator statement to include patients discharged to court/law 
enforcement. 
 Added denominator statement to include patients with warfarin administration starting within one day 
prior to inpatient encounter 
 Added numerator statement to include patients who refused discharge instructions. 
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NQF 0376 Incidence of potentially preventable Venous Thromboembolism 
 Added denominator statement to use confirmed VTE from diagnostic study performed up to two days 
prior to inpatient encounter. 
 Added denominator statement to use confirmed VTE from diagnostic study performed up to two days 
prior to ED encounter for ED encounters within one hour of the inpatient encounter. 
 Added logic to denominator exclusion to accept documentation of palliative care (comfort measures 
only) order during ED encounter for ED encounters within one hour of the inpatient encounter. 
 VTE prophylaxis medication and VTE prophylaxis mechanical device value sets separated into 
individual value sets based on type of medication and device. 
  
